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ABSTRACT 
 The distinctiveness of brain structures and circuits depends on interacting gene 
products, yet the organization of these molecules (the "transcriptome") within and across 
brain areas remains unclear.  High-throughput, neuroanatomically-specific gene 
expression datasets such as the Allen Human Brain Atlas (AHBA) and Allen Mouse 
Brain Atlas (AMBA) have recently become available, providing unprecedented 
opportunities to quantify molecular neuroanatomy.  This dissertation seeks to clarify how 
transcriptomic organization relates to conventional neuroanatomy within and across 
species, and to introduce the use of gene expression data as a bridge between genotype 
and phenotype in complex behavioral disorders. 
 The first part of this work examines large-scale, regional transcriptomic 
organization separately in the mouse and human brain.  The use of dimensionality 
reduction methods and cross-sample correlations both revealed greater similarity between 
samples drawn from the same brain region.  Sample profiles and differentially expressed 
genes across regions in the human brain also showed consistent anatomical specificity in 
a second human dataset with distinct sampling properties. 
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 The frequent use of mouse models in clinical research points to the importance of 
comparing molecular neuroanatomical organization across species.  The second part of 
this dissertation describes three comparative approaches.  First, at genome scale, 
expression profiles within homologous brain regions tended to show higher similarity 
than those from non-homologous regions, with substantial variability across regions.  
Second, gene subsets (defined using co-expression relationships or shared annotations), 
which provide region-specific, cross-species molecular signatures were identified.  
Finally, brain-wide expression patterns of orthologous genes were compared.  Neuron 
and oligodendrocyte markers were more correlated than expected by chance, while 
astrocyte markers were less so. 
 The localization and co-expression of genes reflect functional relationships that 
may underlie high-level functions.  The final part of this dissertation describes a database 
of genes that have been implicated in speech and language disorders, and identifies brain 
regions where they are preferentially expressed or co-expressed.  Several brain structures 
with functions relevant to four speech and language disorders showed co-expression of 
genes associated with these disorders.  In particular, genes associated with persistent 
developmental stuttering showed stronger preferential co-expression in the basal ganglia, 
a structure of known importance in this disorder. 
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CHAPTER 1:  INTRODUCTION 
1.1 Gene expression and neuroanatomy 
 The cytoarchitecture and myeloarchitecture that traditionally define regional brain 
organization arise from molecular events: the actions and interactions of genes and their 
products, resulting in proteins and other molecules which are present at varying levels 
across different cell populations throughout the brain.  These events guide the 
development and differentiation of the brain and are integral to its function throughout 
life, but are difficult to observe.  The technologies to measure mRNA abundance (an 
approximation of protein level) simultaneously for thousands of sequences were 
developed in the 1990s, allowing investigators to take a genome-wide "snapshot" of gene 
expression from a biological sample (see Lockhart and Winzeler, 2000 for an overview of 
DNA microarrays; and Lennon, 2000 for a brief historical overview).  The resulting 
datasets, known as "high-throughput" datasets for their genome-wide coverage, include 
gene expression profiles of samples from diverse brain areas (composed of varying cell 
populations).  High-throughput gene expression datasets open the possibility of 
characterizing the brain's transcriptome: the RNA sequences present, which varies by 
brain tissue as well as time. 
 The molecular scale that underlies conventional neuroanatomy is reflected by 
spatial organization (i.e., patterns of common gene expression) within high-throughput 
gene expression datasets.  This dissertation examines global and local transcriptomic 
organization within three high-throughput, brain-wide, neuroanatomically-specific gene 
expression datasets, and uses observed transcriptomic correspondence with conventional 
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neuroanatomy to make necessary initial steps towards connecting the functions of groups 
of genes with those of brain structures. 
 
1.2  Gene expression and development 
 The expression datasets studied here are from adult brains (24-57 years old in the 
human; 56 days old in the mouse).  The adult brain, however, must be understood as the 
outcome of developmental processes at regional, cellular, and molecular scales. 
 Regional organization in the mature mammalian brain can be traced back to the 
embryonic neural tube (the form assumed by the first neural tissue; see Sanes et al., 2012, 
Ch. 2, for a review that includes a discussion of molecular mechanisms).  Vesicles form 
along the length of the neural tube, each of which generates cells destined for a different 
part of the brain.  Telencephalic structures share a common developmental origin in the 
anterior-most vesicle; diencephalic structures all rise from the adjacent vesicle, and so on 
through three vesicles which generate the midbrain, pons, and medulla, respectively.  At 
the boundary between the midbrain and hindbrain, a transient structure called the 
rhombic lip generates cerebellar neurons (Wingate, 2001; Fink, 2006), as well as some 
other parts of the hindbrain (Wang et al., 2005).  Organization of brain areas along the 
rostrocaudal axis thus emerges from the order of vesicles along the neural tube.  Some 
connections between these areas begin to form even while neurogenesis and cell 
migration to the area is still taking place, and this early connectivity further refines areal 
differentiation.  In particular, the developing dorsal thalamus sends projections to the 
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neocortex (and other parts of the telencephalon), and is vital to cortical arealization (see 
O’Leary et al., 2007 for a review).  
 Like the (relatively) stable organization of the mature brain, these developing 
structures and circuits have cellular and molecular underpinnings.  Early brain 
development involves a fantastically complex set of interacting cellular-scale events.  
Cells proliferate and migrate to specific destinations while taking on a wide variety of 
forms, both neurons and glia; cell processes and synapses appear; cells and synapses die 
in vast numbers; the intricate circuitry of the brain begins to form.  These events are 
effected and regulated, with temporal and spatial precision, by gene products.  The first 
appearance of neural tissue in the embryo requires interactions between gene products 
working in, at a minimum, three signaling pathways (Stern, 2005; Sanes et al., 2012).  
The differentiation of that tissue into distinct brain areas is orchestrated by a growing list 
of transcription factors; for example, morphogens such as TGF-8 regulate rostrocaudal 
gradients of expression that influence neuron fate towards forming motor cortex (Pax2, 
Sp8) or visual cortex (Emx2; see Sansom and Livesey, 2009 for a review).  Rapid 
changes in the developing human brain are reflected by genome-scale transcriptomic 
change, which is accordingly greatest through infancy (Kang et al., 2011b; also see Fig. 2 
in Cahoy et al., 2008).  Region-dependent changes continue throughout the lifespan, 
however, and multiple studies have identified changes related to aging and 
neurodegenerative disease (Lee et al., 2000; Fraser et al., 2005; Berchtold et al., 2008; 
Colantuoni et al., 2011). 
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1.3  Overview of data collection techniques 
 This section briefly describes the two experimental techniques for measuring 
mRNA abundance that were used to produce the datasets analyzed in this dissertation 
(i.e., DNA microarrays and in situ hybridization, or ISH).  Chapter 2 formally describes 
these datasets and the normalization procedures applied to them. 
 Gene expression from neuroanatomically-specific samples in human donor brains 
can be measured using microarray technology, as is the case in two of the datasets 
analyzed here (Gibbs et al., 2010; Hawrylycz et al., 2012).  A microarray chip consists of 
a surface (usually made of glass) that is covered in microscopic spots, each containing 
many synthesized copies of a given DNA sequence, or "probes".  "Targets" are created 
by extracting mRNA strands from the sample tissue and converting them into 
complementary DNAs (cDNAs).  The cDNAs are labelled with fluorescent dye and 
hybridized to the spots containing the DNA probes.  There, they bind to the probe 
sequences to which they are complementary.  After removing cDNAs that failed to bind 
to any probes, the remaining cDNA at a given spot is revealed by the fluorescent label.  
Quantification of that signal then yields an estimate of the abundance of the original 
transcript in the sample tissue. A variety of commercial and custom microarray platforms 
are now available for performing genome-scale profiling of individual samples. 
 Microarrays and ISH are essentially complementary ways of expression profiling.  
Where microarrays involve affixing the probe to a surface and then applying the labelled 
target, ISH requires affixing the sample tissue and applying the labelled probe.  In the 
ISH method, the probe is complementary RNA, and the target is mRNA present within 
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the tissue, which has been treated to facilitate the probe's access to the target.  After 
hybridization, the tissue is washed, and the label indicates how much of the probe bound 
to its target, and thus the abundance of the target transcripts in the tissue.  This is a more 
direct measure of mRNA abundance than microarrays can provide, with a higher signal-
to-noise ratio.  However, because it requires individual sections of brain tissue, each 
tested for the presence of a different transcript, ISH is highly labor-intensive and less 
suitable for high-throughput genomic screening.  The small size of the mouse brain, as 
well as the ability to use many mice, make ISH a more practicable approach for the 
mouse than the human brain when genome-wide coverage and / or good spatial resolution 
is desired. 
 
1.4  Large-scale molecular neuroanatomy 
 The advent of large gene expression datasets from the brains of multiple species 
offers unprecedented opportunities to investigate molecular neuroanatomy.  These 
datasets show varying gene expression levels across different brain tissues for thousands 
of genes, allowing us to study not only the pattern of expression of a gene of interest, but 
the relationships between many genes' spatial expression patterns, or, conversely, the 
expression profiles of different regions of the brain.  Large expression datasets have 
inspired efforts to map the brain's transcriptome at a large scale, revealing systematic, 
region-dependent variation of gene expression across the brains of rodents and primates 
(Lein et al., 2007; Hawrylycz et al., 2012; Ng et al., 2009; Bohland et al., 2010; Bernard 
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et al., 2012; Ji, 2011), as well as regional differences in the co-expression relationships 
between different genes (Oldham et al., 2008; Ko et al., 2013; Grange et al., 2014). 
 The characterization of data pertaining to thousands of genes poses a daunting 
problem.  Conventional neuroanatomy, while sometimes plagued by difficulties in clearly 
and consistently defining brain regions, is generally based on simple markers and, 
usually, visually observable features.  By contrast, the gene expression profile of a 
sample is a multidimensional observation of its molecular composition, and the extraction 
of useful information from these large datasets has demanded the application of a variety 
of tools from statistics, machine learning, and graph theory.  One way to deal with this 
complexity is to investigate samples one gene at a time to identify genes whose 
expression patterns distinguish certain samples (see Pavlidis and Noble, 2001, for 
example, for an examination of these methods).  The proportion of genes which are 
differentially expressed can then be used to quantify dissimilarity between samples from 
different brain regions (e.g. Hawrylycz et al., 2012; Khaitovich, 2004).  Alternatively, the 
correlation between two samples' expression profiles can be used as a measure of 
similarity, often followed by clustering of samples based on those similarities (e.g. 
Hawrylycz et al., 2012; Roth et al., 2006) in order to determine molecularly 
homogeneous groups of samples and/or samples with discriminable transcriptomes.  
Similarly, data reduction and visualization methods such as multi-dimensional scaling 
(MDS), principal components analysis (PCA), or t-Distributed Stochastic Neighbor 
Embedding (t-SNE) may be used to assign each sample a set of coordinates in a low-
dimensional space such that proximity between samples reflects the similarity of the 
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expression profiles, providing a simple visual representation of the “landscape” of gene 
expression across samples (Khaitovich, 2004; Mahfouz et al., 2015).   
 Chapter 3 of this dissertation begins with an overview of the literature on large-
scale transcriptomic organization as it relates to neuroanatomy, followed by a study of 
this organization in the human and mouse, showing relationships between brain samples 
based on gene expression that correspond to the samples' regions of origin.  The chapter 
also quantitatively compares two expression datasets from the adult human brain, one 
with high spatial resolution and the other with large sample size, to determine the 
consistency of anatomically specific expression signatures across datasets and microarray 
platforms. 
 
1.5 Comparative molecular neuroanatomy 
 Given the common usage of mouse models to study human neuropathologies, 
there is a striking paucity of such disease models that have proven to be clinically useful 
(Le et al., 2014; Duff, 2004; Hardy, 2006).  While much is known about the similarities 
and differences between the human and mouse brain from conventional neuroanatomical 
methods (based on features such as cytoarchitecture and inter-regional connectivity), 
mouse models fundamentally rely on cross-species correspondences that are realized at 
the much smaller, intracellular scale that involves interactions between gene products.  
Currently, relatively little is known about how these molecular mechanisms, which vary 
substantially across cell populations and brain regions in each animal, compare across the 
two species.  This lack of an established basis for comparison at the relevant scale may 
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cause some of the difficulty in developing successful mouse models (Burns et al., 2015). 
 Chapter 4 briefly reviews cross-species studies of molecular neuroanatomy before 
presenting three quantitative comparisons of the adult human and mouse transcriptome.  
A whole-brain, genome-wide comparison based on sample profile correlations is 
followed by a novel approach to identifying region-specific gene expression signatures 
that are consistent across the two species.  Finally, the brain-wide profiles of orthologous 
genes are compared between the two species, with a particular focus on genes that mark 
certain cell types.  The ultimate goal of this approach is to inform brain research that 
relies on mouse models by illuminating gene interactions that are similar, and that impact 
similar brain areas, in the human and mouse brain. 
 
1.6 Expression of genes associated with speech and language disorders 
 Transcriptomic data from the brain have the potential to help illuminate how 
functionally relevant genes impact neuronal and cognitive processes at a larger scale.  In 
the many heritable disorders characterized by behavioral phenotypes, there is currently a 
large genotype-phenotype gap; knowledge is becoming available about either the genes 
potentially involved in these disorders or about the brain regions and circuits that are 
atypically functioning, but little is known about the intermediate pathological 
mechanisms. Chapter 5 describes an attempt to begin bridging this gap, specifically in the 
area of language-related functions.  Disorders of speech and language are highly 
heritable, and variants in over three dozen genes to date have been associated with 
language abilities and disabilities, with varying degrees of evidence (see e.g. Fisher et al., 
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2003; Graham et al., 2015).  Many of these genes have known roles in brain processes 
such as cortical migration and pre-synaptic signaling (e.g. Wang et al., 2006; Yang et al., 
2011), but little is known of the causal links between variants in a given gene and 
behavioral traits.  Chapter 5 begins with a brief overview of the candidate genes and 
associated phenotypes, followed by a description of a manually curated database intended 
to facilitate the integration of genetic and transcriptomic information with neuroimaging 
results from research into speech and language function.  The rest of the chapter 
examines the expression patterns and co-expression relationships of these genes in 
regions throughout the adult human brain in an effort to identify the parts of the brain 
through which the genes may affect language-related functions, and to consider how this 
might relate to known or suspected functions of the genes at a smaller scale.   
 
 Finally, Chapter 6 discusses the data-driven nature of the approach taken in this 
research, and summarizes the contributions of the dissertation as well as common themes 
in the future research proposed in the previous chapters. 
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CHAPTER 2:  OVERVIEW OF MATERIALS AND METHODS 
2.1 Introduction 
 This dissertation focuses primarily on two publicly available, high-throughput 
gene expression datasets.  The Allen Human Brain Atlas (AHBA), a microarray dataset 
from six adult human donors, comprises thousands of samples from several hundred 
finely labelled brain structures (Hawrylycz et al., 2012; www.human.brain-map.org).  
While not at single cell resolution, this is a far higher spatial resolution than is typically 
available in microarray data from brain tissue.  Practical considerations such as the 
smaller size of the mouse brain allow for even more comprehensive sampling using in 
situ hybridization. This method was used in a systematic, brain-wide survey resulting in 
the Allen Mouse Brain Atlas (AMBA), which has been cast as a three dimensional atlas 
at 200 micron resolution (Lein et al., 2007; www.mouse.brain-map.org/).  In both the 
AHBA and the AMBA, the locations of samples have been labeled according to 
conventionally defined brain atlases at multiple levels of granularity, allowing analysis of 
both broad and fine neuroanatomical regions.  Though based on different data collection 
techniques, the high resolution and multi-level structure labelling of these datasets make 
them well-suited for investigating molecular neuroanatomy.  Additionally, Chapter 3 
compares the AHBA to another publicly available microarray dataset from the adult 
human brain, previously described by Gibbs et al. (2010).  This chapter provides a 
description of these datasets, details a procedure for standardization used in Chapters 3 
and 4, and briefly discusses some of the methodological decisions made in processing 
these datasets. 
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2.2  Allen Human Brain Atlas (AHBA) 
 The AHBA includes six genome-wide microarray datasets from adult donors aged 
24-57 with no history of neuropathology (Hawrylycz et al., 2012; www.human.brain-
map.org/).  These data were collected from post-mortem samples and analyzed using a 
custom Agilent 8x60k cDNA array chip. Microarray results were preprocessed (including 
normalization to account for array-specific biases, within-batch intensity differences, 
within-donor batch-level effects, and cross-brain effects) by the research team at the 
Allen Institute for Brain Science (AIBS).  Between 300 and 450 anatomically distinct 
samples were available from the left hemisphere for each donor.  Although samples were 
also available from the right hemisphere for two donors, only left-hemisphere samples 
were used here.  The neuroanatomical region from which each sample was obtained is 
annotated according to a hierarchical classification scheme (using standardized 
nomenclature and based on gyral / sulcal landmarks in the cerebral cortex), and the 
~60,000 probes were annotated with relevant gene symbols by the AIBS group. 
2.2.1  Probe selection 
 For genes represented by two probes, the probe with the highest mean intensity 
across all samples for all donors was selected.  For genes represented by more than two 
probes, each probe's Pearson Product-Moment Correlation Coefficient (PCC) with each 
of the other probes for this gene across all samples for all donors was calculated, and the 
probe with the highest mean PCC (the "most average" probe) was selected.  The “probe-
per-gene” data includes ~32,000 genes.  The subset of genes from this dataset that are 
treated here varies by analysis, and is specified in each case. 
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2.3  Allen Mouse Brain Atlas (AMBA) 
 The AMBA provides cellular resolution expression profiles based on non-isotopic 
in situ hybridization (ISH) for ~20,000 genes in the 56-day-old male C57BL/6J mouse.  
Volumetric datasets were used here, in which sections from each experiment were 
registered to a common three-dimensional template and binned into voxels with 200µm 
resolution (Lein et al., 2007; Ng et al., 2007). In this volumetric space, the expression of a 
gene is summarized by a measure of expression energy (i.e., the average intensity of 
pixels in the ISH image intersecting a given voxel). For this analysis, we used data from 
image series in the coronal plane, comprising 4,108 genes with restricted expression 
patterns, which had been selected by the AIBS team for a brain-wide survey. For 
consistency with the human data, only voxels from the left hemisphere were used in these 
analyses. 
 
2.4 Gibbs dataset. 
 Microarray expression data from 4 distinct neuroanatomical regions - the frontal 
lobe (FL, Brodmann areas 9 and 46), temporal lobe (TL, Brodmann areas 21, 41, and 42), 
cerebellum (CB), and pons (PO) - were obtained from Gene Expression Omnibus (GEO), 
Accession Number GSE15745.  These data were previously reported by Gibbs et al. 
(2010).  Gene expression profiling was performed using Illumina humanRef-8 v2.0 
Expression BeadChips as described in van der Brug et al. (2008).  Expression data were 
processed and quality controlled using procedures similar to those described in Wolock et 
al (2013).  The un-normalized mRNA microarray expression data were downloaded from 
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GEO and associated with the sample phenotype annotations and the mRNA microarray 
probe annotations for the platform used, GEO platform accession GPL6104.  Low quality 
and technical probes as annotated using illuminaHumanv2.db from the Bioconductor 
package were removed from further analysis.  Quantile normalization (Bolstad et al., 
2003) was applied using normalized exponential quantile normalization (Shi et al., 2010) 
with the neqc function from Bioconductor (Ritchie et al., 2011).  Categorical covariates 
were controlled using ComBat (Johnson et al., 2007), which corrected for effects of 
batch, tissue source and sex.  ComBat has been previously shown to have the best overall 
performance, relative to other commonly used methods, in removing artifactual 
correlations induced by group effects (Chen et al., 2011), including when applied to 
Illumina platforms (Kitchen et al., 2010).  The correctBatchEffect routine from limma 
(Smyth, 2005) was used to correct for the continuous covariates age, ancestry and post-
mortem interval (PMI) using linear regression.  After preprocessing, the Gibbs dataset 
consisted of 19,910 features (i.e., probes) and the number of samples that passed quality 
control varied by tissue source (NFL = 137, NTL = 134, NCB = 135, NPO = 137). 
 
2.5 Probe standardization 
 Some form of normalization is necessary for meaningful comparisons across 
expression values from different probes in microarray datasets such as the AHBA and the 
Gibbs dataset.  For consistency, normalization procedures described here were also 
applied to the AMBA. 
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 A “weighted z-scoring” procedure (described in Ch. 2; see also Myers et al., 
2015) was designed to give equal weight to brain structures regardless of the number of 
available samples.  To some extent, this corrects for bias resulting from non-uniform 
sampling - in particular, the AHBA dataset included a greater number of samples from 
human cerebral cortex (1216 samples) than from any subcortical structure (1043 samples 
total).  Because the Gibbs dataset includes one sample per region from each donor (i.e., 
uniform sampling across regions), weighted z-scoring amounts to equally weighting all 
samples in that dataset.   
 Details of the weighted z-scoring procedure are given below.  Briefly, for each 
gene (probe), weighted means and standard deviations were calculated across available 
samples such that the set of all samples from a set of selected brain regions received 
equal overall weight, and these were used to normalize all expression values.  Note, 
however, that the differential expression analysis in Chapter 3 required data that had not 
been standardized, and that all analyses in Chapter 5 used conventional z-scoring. 
 In this procedure, expression data are represented as a matrix E(g, s), indicating 
the expression level of gene g in sample s.  This matrix is partitioned into K distinct sets, 
R1, R2, . . .Rk, where Rj contains the indices of all samples in that set (i.e., brain region).  
For gene g and partitioning S, a weighted mean expression level is defined as: 
                                          𝜇𝑆(𝑔) =
1
𝐾
∑ (
1
|𝑅𝑘|
∑ 𝐸𝑖𝜖𝑅𝑘 (𝑔, 𝑖))
𝐾
𝑘=1         (1) 
and the weighted standard deviation is defined as: 
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                                   𝜎𝑆(𝑔)=√
∑
1
|Rk|
(∑ (𝐸(𝑔,𝑖)−𝜇𝑆(𝑔))
2
iϵRk
)Kk=1
𝐾(
∑ |𝑅𝑘|
𝐾
𝑘=1 −1
∑ |𝑅𝑘|
𝐾
𝑘=1
)
        (2) 
     The most basic case would be all samples in the dataset belonging to the same region, 
i.e. S = {R1} and R1 = {1, 2, ..., N}, where N is the total number of samples.  The 
weighted values would then reduce to the standard formulations for mean and standard 
deviation, and each sample would receive equal weight.  With different partitions S (i.e., 
different groupings of the samples based on neuroanatomical labels), these procedures 
give equal overall weight to the sets of samples in each region Rk.  The standardized 
expression level of gene g in sample i given partition S is then: 
?̃?𝑆(𝑔, 𝑖) =
(𝐸(𝑔,𝑖)−𝜇𝑆(𝑔))
𝜎𝑆(𝑔)
        (3) 
 
2.6  Data selection, processing, and labelling 
 Several methodological decisions contributed to the selection and processing of 
the data used in these analyses.  This section includes a brief discussion of some of these 
decisions. 
2.6.1  Weighted z-scoring   
 First, “weighted z-scoring” of probes (described above) was used as a means of 
addressing the presence of non-uniform sampling of brain regions in the AHBA dataset, 
and applied also to the AMBA dataset (as well as the Gibbs dataset, where it was 
equivalent to conventional z-scoring).  To examine the effect of weighted z-scoring, the 
AHBA and AMBA datasets used in Chapter 3.3 and Chapter 4 (which used this 
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procedure) were compared to the same datasets when probes were standardized using 
conventional z-scoring.  For the weighted z-scoring procedure, the following regions 
were used to partition the brain: the cerebral cortex, hippocampal formation, amygdala, 
striatum, globus pallidus, thalamus, hypothalamus, midbrain, pons, medulla, and 
cerebellum.  (Chapter 4 gives the numerical identifiers associated with these regions in 
the AHBA and AMBA databases; see Table 4.1.) 
 Weighted z-scoring has the effect of de-emphasizing the influence of more 
heavily sampled brain regions on brain-wide expression values; therefore, its effect 
varied somewhat by brain region.  Pearson's Product-Moment Correlation Coefficients 
(PCCs) were calculated between sample (or voxel) expression profiles within each region 
used to partition the brain after weighted z-scoring, and within each of the same regions 
after conventional z-scoring.  Mean within-region PCCs changed by an average (across 
regions) of ~0.1 in the human data, ~0.05 in the mouse data, and ~0.03 across species, 
with the cortex (and to a lesser extent the hippocampus and amygdala) showing increased 
correlations and other regions showing decreases. 
2.6.2  Standardization of probes in the AMBA 
 For consistency, the same standardization procedure was applied to probes in the 
mouse dataset as to probes in the human dataset, though it is not strictly necessary to cast 
the mouse in situ hybridization based datasets in relative terms as is necessary for the 
human microarray-based datasets.  Within-probe standardization of the mouse data has 
the effect of emphasizing differences between voxel expression profiles.  Mean within-
region PCCs for broad mouse regions decrease by an average of ~0.5 when either 
  
17 
weighted or unweighted z-scoring is applied to the mouse expression data; however, the 
mean PCC between two expression profiles drawn randomly from anywhere in the mouse 
decreases by ~0.65, suggesting that mouse regions appear more distinct after 
standardization. 
2.6.3  Restriction to the left hemisphere 
 Similarly, because right-hemisphere samples were discarded from the two whole-
brain human datasets, right-hemisphere voxels in the mouse brain were also discarded to 
maintain consistency across species.  Not surprisingly, results did not substantially 
change when the mouse data were restricted to left-hemisphere voxels due to the strong 
left-right symmetry in the AMBA: mean left-hemisphere expression profiles are highly 
correlated with mean right-hemisphere expression profiles for the 11 broad mouse 
regions (mean cross-hemisphere PCC ~0.92; ± ~0.06).  This was also true of 9 finer sub-
cortical regions (dentate gyrus, Ammon's horn, subiculum, caudoputamen, nucleus 
accumbens, external globus pallidus, internal globus pallidus, cerebellar cortex, and 
cerebellar nuclei; mean cross-hemisphere PCC ~0.91, standard deviation ~0.06).  Sixteen 
cortical areas also showed high cross-hemisphere correlations (ectorhinal area, perirhinal 
area, temporal association areas, posterior parietal association areas, retrosplenial area, 
agranular insular area, orbital area, infralimbic area, prelimbic area, anterior cingulate 
area, visual areas, auditory areas, visceral area, gustatory areas, somatosensory areas, 
somatomotor areas, and frontal pole of the cerebral cortex; mean cross-hemisphere PCC 
~0.87, standard deviation ~0.06).  Additionally, within-region mean PCCs for the broad 
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mouse regions change by an average of only ~0.01 when right-hemisphere voxels were 
included. 
2.6.4  Neuroanatomical labels 
 In addition to decisions regarding pre-processing of the data, this study depends 
on the assignment of samples and voxels to conventionally defined neuroanatomical 
structures, and on decisions about which neuroanatomical labels to include in the 
definition of a structure.   For example, in the AHBA ontology, "Hippocampal formation" 
is a child (substructure) of "Cerebral cortex."  In order to study the hippocampal 
formation separately from the rest of the cortex, labels corresponding to any part of the 
hippocampal formation were excluded from the definition of the cerebral cortex.  More 
generally, conventional neuroanatomy sometimes struggles with conflicting opinions 
regarding the identities and borders of different structures and their homologs (Bota et al., 
2003).  Therefore, this work focuses on regions of the brain whose definitions are more 
or less well-established and agreed upon, but is subject to any bias introduced by the 
labeling schemes applied. 
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CHAPTER 3:  LARGE-SCALE, WITHIN-SPECIES PATTERNS OF 
NEUROANATOMICAL GENE EXPRESSION 
3.1 Introduction 
 Studies of gene expression across the brain have revealed a close relationship 
between molecular and conventional neuroanatomy in individual species.  This 
relationship is demonstrated by preferential or exclusive expression of certain genes in a 
given brain region, and a number of studies have identified such genes for coarsely-
defined regions throughout the mouse brain (e.g. Pavlidis and Noble, 2001; Zirlinger et 
al., 2001; Lein et al., 2007).  The Anatomic Gene Expression Atlas (AGEA), which 
includes online tools designed for exploring the AMBA, shows molecular relationships 
between brain regions based on both preferential gene expression in certain brain regions, 
and correlations between gene expression profiles from throughout the mouse brain (Ng 
et al., 2009).   
 The molecular underpinnings of conventional region boundaries emerge in 
striking detail in the AMBA.  Unsupervised clustering of voxels (based on multivariate 
patterns of gene expression at each location) yields clusters which correspond closely to 
mouse brain areas and cortical layers, with cluster boundaries appearing even between 
cortical areas (Bohland et al., 2010).  A similar analysis limited to expression of neuron 
marker genes yields clusters corresponding to over fifty brain areas (Ko et al., 2013).  
Voxel clustering also shows the molecular heterogeneity of brain structures, where 
expression profiles from subcortical nuclei break into small clusters while those from 
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more homogenous structures such as the cerebral cortex form large individual clusters 
(Lein et al., 2007). 
 Other studies have used a variety of computational techniques to elucidate the 
relationship between gene expression and neuroanatomy in the mouse brain, and 
specifically the AMBA.  Mahfouz and colleagues (2015) revealed distinctions between 
mouse brain regions by applying an optimized version of the data reduction technique t-
Distributed Stochastic Neighbor Embedding (t-SNE, Van der Maaten and Hinton, 2008) 
to the AMBA (and the AHBA; see below).  Grange et al. (2014) cast the AMBA dataset 
as a linear combination of cell types, using 64 previously measured expression profiles to 
model the spatial distribution of different transcriptomically defined cell types.  French 
and Pavlidis (2011), also using the AMBA as well as rat data from the Brain Architecture 
Management System (BAMS; Bota et al., 2005), found that regional gene expression 
profiles are statistically related to regional connectivity. 
 Comparable organization has been found based on human brain gene expression, 
where one of the first comprehensive applications of this approach showed brain samples 
clustering by region of origin (Roth et al., 2006).  Neocortical samples grouped together, 
and showed more similarity to the hippocampus and amygdala than to the rest of the 
subcortex, while the cerebellum stood out with a particularly unique molecular profile.  
Similar to the finding by Lein et al. (2007) in mouse, Hawrylycz and colleagues (2012) 
showed much higher internal homogeneity for gene expression profiles in the human 
neocortex than in many subcortical structures, whose varying cellular architecture is 
reflected by higher numbers of differentially expressed genes.  Still, topographical 
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relationships between human cortical areas were preserved in their gene expression 
profiles, reflecting graded differences in cortical cell populations and possibly relative 
positions of progenitor cells in early development.  Application of t-SNE to the AHBA 
also revealed few within-cortex distinctions, but did show separation between broader 
brain regions (Mahfouz et al., 2015). 
 Nearly all of the human studies mentioned above use the AHBA, which offers 
uniquely high spatial resolution (as compared to other gene expression datasets from the 
human brain) but low sample size (six donors).  Similar sampling properties are shared 
by the datasets used in Roth (2006), Johnson (2009), and Khaitovich (2004), though 
without such high spatial resolution (19, 13, and 8 brain areas, respectively).  In contrast, 
Oldham et al. (2008) and Gibbs et al. (2010) use datasets from over 100 donors each, but 
with samples from only 3 or 4 brain regions in each donor.  Relatively fine 
neuroanatomical specificity and broad coverage (i.e. sampling from areas throughout the 
brain) comes at a price of low sample size, which limits the ability to distinguish 
individual variability from noise.  These trade-offs emphasize the need for validation 
across datasets.  Most of the work described in this dissertation focuses on the AHBA and 
AMBA; however, a comparison of the AHBA with the dataset from Gibbs et al. (2010) is 
presented below. 
 This chapter examines large-scale structure in gene expression data from the 
human and mouse brain, using a largely exploratory approach applied to the AHBA and 
the AMBA.  Transcriptomic structure in the AHBA is cross-validated through 
comparison to a second dataset with larger sample size and coarser spatial resolution.  
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Visualizations revealing organization of samples based on gene expression and its 
correspondence to neuroanatomical labels serve to lay the groundwork for the studies 
presented in Chapters 4 and 5. 
 
3.2 Modes of variability 
 The singular value decomposition (SVD, described briefly below) is useful for de-
noising and reducing the dimensionality of high-dimensional datasets.  Essentially, the 
singular value decomposition of a matrix yields (1) an orthonormal basis for its columns, 
(2) an orthonormal basis for its rows, and (3) "singular values" indicating how each 
vector in each orthonormal basis is scaled.  In a sample-by-gene expression matrix, (1) 
defines a rotated coordinate system for genes and (2) for samples, while (3) indicates the 
spread of datapoints along each axis in the new system. 
 To understand why this is useful, compare the new space defined by (2) to the 
coordinate space of the original sample data.  This original space is defined by thousands 
of axes, one per gene, and each sample is represented in the space by as many 
coordinates.  Because genes do not vary independently, the way samples are spread out in 
the space may be effectively described by a smaller number of orthogonal axes, each of 
which captures as much variability across samples as possible.  If we know how much 
variability each axis captures, we can assess how many sources of variability there are in 
the data.  Singular values give us this information.  (This is also true if we reverse 
"samples" and "genes" in the above example; singular values describe the variability 
captured by each axis in either of the orthonormal vector sets). 
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 Below, the first use made of SVD is to see how much of the original variability in 
the data is captured as more axes (dimensions) in the new coordinate space are included, 
beginning with those which capture the most variability (i.e. those with the highest 
corresponding singular values).  If most of the variability in the data can be captured by 
just a few orthogonal axes, then the structure of the data (i.e., its correlations across 
anatomical space and across genes) is relatively simple.  The more dimensions are 
required to describe variability in the data, the more rich the structure of that data.  The 
second use of SVD made below is to project the sample data down to the three-
dimensional space defined by the three axes in the new space with the highest singular 
values; i.e., those that capture the most variability.  The resulting visualization of sample 
locations in this three-dimensional space gives a sense of whether and how samples 
separate based on region of origin. 
 Bohland et al. (2010) applied SVD to the AMBA, finding rich structure in the 
data as well as region-based separation of voxels in the three-dimensional space capturing 
the most variability.  Here, SVD is applied to both a the AMBA, and also to the AHBA.  
Note that since Bohland et al.'s (2010) study, a new algorithm has been applied to the 
AMBA to register the expression data to the reference space; therefore these analyses use 
a different version of the AMBA (see documentation for the AMBA dataset at 
www.mouse.brain-map.org/). 
3.2.1  Gene selection and standardization 
 Human orthologs were identified for 3,792 of the genes available in the mouse 
dataset using NCBI HomoloGene (NCBI Resource Coordinators, 2015; 
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www.ncbi.nlm.nih.gov/homologene).  Expression data for these genes (in both species) 
constituted a common dataset, which was used in both this section and Section 3.3.  
Expression data for each gene was standardized using the weighted z-scoring procedure 
described in Chapter 2, with the following 11 broad brain regions used to partition the 
data: cerebral cortex, hippocampus, amygdala, striatum, globus pallidus, thalamus, 
hypothalamus, midbrain, pons, medulla, and cerebellum.  For the human data, this 
standardization was performed separately for each donor. 
3.2.2  Singular value decomposition 
Formally, the singular value decomposition of a p x q matrix M is defined as M = USVT, 
where U is a p x q matrix, and both S and V are q x q matrices.  The columns of U and S 
are known as left and right singular vectors, respectively.  The matrix S is only non-zero 
along the diagonal, which contains singular values.  Each singular value corresponds to 
both a right and a left singular vector. 
 When M is centered such that row and column means are 0, each right singular 
vector is an eigenvector of the covariance matrix M'M (the covariance between rows of 
M, without standardizing by number of columns, since singular values will scale the 
eigenvector), while the square of the corresponding singular value is the variance 
described by that eigenvector.  In other words, if M is a sample-by-gene matrix (as here), 
the first right singular vector indicates the direction of the greatest "spread" among the 
samples (and the first singular value indicates its extent); the second right singular vector 
indicates the direction of second-greatest spread that is orthogonal to the first (and the 
second singular value indicates its extent); and so on.  The same is true of left singular 
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vectors, the covariance matrix of MM', and the variance / covariance of genes.  Right 
singular vectors are referred to here as spatial modes, and left singular vectors as gene 
modes (borrowing from Bohland et al., 2010).  These are equivalent to the orthogonal 
axes of the rotated coordinate spaces described at the beginning of this section. 
 The first use of SVD in this section (mentioned above) is to see how much of the 
original variability in the data is captured as more modes are included.  As the variance 
captured by a mode is the square of the corresponding singular value, the proportion of 
the total variance captured by that mode is that variance divided by the sum of squared 
singular values.  The cumulative sum of this proportion, moving from the first singular 
value onward, shows how many modes are required to capture a given proportion of 
variance in the data. 
 The second use of SVD in this section is to project the samples to a 3-dimensional 
subspace that captures the largest possible proportion of their variance.  Because MV = 
US, the matrix US is computed while retaining only the first 3 singular values in S.  This 
is the projection of the sample data in M onto the first spatial modes contained in V, but is 
easier to compute than using M and V directly, due to S having non-zero values only 
along the diagonal.  (This projection is performed only for samples; however, since M has 
been double-centered, the same procedure could be applied to project genes onto the first 
three gene modes.) 
 SVD was applied to the AMBA, to each donor in the AHBA separately, and to a 
single expression matrix combining samples from all human donors (the latter for 
visualization of samples projected into a 3D space).  In each case, the expression matrices 
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included data from the 3,792 probes described in above in "Gene selection and 
standardization", and from left-hemisphere samples / voxels from the 11 broad regions 
listed in that section.  All expression matrices were double-centered (i.e., row and column 
means were subtracted from each value) before SVD was performed.  For comparability 
to Bohland et al. (2010), mouse probes were not converted to z-scores for this analysis.  
Note that probe and voxel selection differ between the two studies:  Bohland et al. (2010) 
used 3,041 probes chosen for consistency with a second dataset (also part of the AMBA, 
but not used here), and used data from the whole brain rather than the left hemisphere 
only. 
3.2.3  Results 
 The proportion of variance explained by each singular value (i.e. that value 
squared divided by the sum of squares of all singular values in S) is shown as a 
cumulative sum in Fig 3.1 for the AMBA and the six donors of the AHBA.  Over 100 
modes are required to explain at least 90% of the variance in the human data, while 222 
are required to explain the same proportion in the mouse data.  The higher spatial 
resolution of the mouse data may explain its comparatively rich structure; different 
voxels can reflect different cell type distributions that would be averaged together in a 
sample from the AHBA.  The spread of values across human donors is relatively small, 
with donor H0351.2001 requiring more modes than the others to account for the same 
proportion of the variance.  Donor sample counts, in ascending number of modes 
required to explain 90% of the variance, were: 363, 292, 392, 374, 434, 404. 
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Fig 3.1.  Cumulative proportion of variance captured by modes in the human (A) and mouse (B) expression 
matrices.  Circles and triangles indicate number of modes required to capture at least 80% and 90% of the 
variance in the data, respectively.  SVD was performed separately in each human donor.  In A, colors 
correspond to donors, and inset shows the spread of values across human donors for number of modes required 
to capture at least 90% of the variance. 
 
 When human samples and mouse voxels were projected onto the first three 
modes, clusters appeared corresponding roughly to several broad regions (Fig 3.3).  The 
cerebellum was particularly distinct from other parts of the brain in both species, 
particularly the human; however, the hippocampal formation, amygdala, striatum, and 
thalamus also show some separation. 
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Fig 3.2.  Projection of human samples (A) and mouse voxels (B) onto the first three spatial modes (i.e. right 
singular vectors).  Additional plots show projection onto each pair of those modes.  Dot color indicates region of 
origin. 
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3.3 Correlations between expression profiles from different locations in the brain 
3.3.1  Calculation and comparison to empirical null distribution 
 To assess the regional organization of transcriptomic relationships, tissues 
throughout the brain were compared in each species using Pearson's Product-Moment 
Correlation Coefficient (PCC) calculated between pairs of profiles.  Genes were selected 
and standardized as described in Section 3.2.  PCCs were calculated (i) between all pairs 
of samples from the human data, and (ii) between all pairs of voxels from the mouse data. 
 Two additional calculations were made to assess the strength of within-region 
similarity.  First, the quartiles of all within-region PCCs were calculated for each of 11 
broad regions and a number of finer regions (varying by species).  Second, PCCs for each 
region were compared to a distribution of 1000 PCCs calculated between sample pairs 
(or, in the mouse data, voxel pairs) for which one sample originated within the region, 
and the other did not.  For each region, the mean of the resulting percentile ranks was 
calculated to assess specificity of within-region correlations. 
3.3.2  Results  
 Heatmaps of PCCs between expression profiles show organization based on brain 
region in both species (Fig 3.3).  Overall, PCC values are higher in the human than 
mouse.  This probably results from the lower spatial resolution of the AHBA.  Samples 
average across more cells than voxels, making them both less prone to noise and less 
revealing of distinct cell type populations. 
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 In both species, blocks of high values (in comparison to the rest of the matrix) 
correspond to brain regions including the cerebral cortex, thalamus, hypothalamus, 
striatum, amygdala, and cerebellum.  Striatal expression profiles show particularly high 
PCCs with each other in comparison to other within-region PCCs.  In some cases, 
expression profiles from different regions show slightly elevated PCCs.  This is true of 
the cerebral cortex and the hippocampal formation, and to a lesser extent of the cerebral 
cortex and amygdala.  The midbrain, pons, and medulla are represented by a single block 
of positive-valued PCCs.  Fig 3.3E shows elevated PCCs within the mouse caudal 
pallidum and globus pallidus, with the internal segment showing even higher PCCs, 
while PCCs between samples from the human globus pallidus do not appear to 
distinguish between the internal and external segments (Fig 3.3B).  However, it is 
possible that coarse sampling of the human globus pallidus has obscured distinctions 
between cell type distributions in the GPi and GPe.  In both species, the cerebellum panel 
(Fig 3.3C, F) shows higher correlations within the cerebellar cortex and cerebellar nuclei 
than across those sub-structures. 
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Fig 3.3 (cont. on next page).  Correlations between expression profiles of human samples and mouse voxels, 
within-species.  Color bar applies to all plots. 
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Fig 3.3 (cont. on next page).  Correlations between expression profiles of human samples and mouse voxels, 
within-species.  Color bar applies to all plots.  Voxels from the cerebellum without a more specific label are 
grouped at the end. 
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Fig 3.3.  Correlations between expression profiles of human samples and mouse voxels, within-species.  Color 
bar applies to all plots.  In F, voxels without a more specific label than "Cerebellum" are not included. 
 
 Fig 3.4 summarizes within-region distributions of PCCs using “box plots.”  For 
the most part, the median PCC within a fine region was higher than for the parent region 
(though not always to a great extent), pointing to the distinct molecular compositions of 
sub-structures within broad regions.  Exceptions included human cerebellar nuclei, with 
no PCCs reaching the mean value for the cerebellum as a whole (Fig 3.4A), and human 
cerebral cortex, where cortical areas showed mean PCCs very similar to the mean for the 
parent lobe (Fig 3.4B). 
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Fig 3.4 (cont. on next page).  Median correlation between expression profiles from within the same brain region.  
Box edges represent the 25th and 75th percentile values and whiskers extend to any data points within 1.5 times 
the interquartile range from the rendered boxes.  Box colors correspond to parent brain regions.  Black vertical 
lines show median cross-species correlation of parent structure.  Numbers in parentheses are sample / voxel 
counts.  Numbers in square brackets are mean percentile rank of within-region correlations in distributions of 
correlations where one expression profile belongs to the region in question and the other is from elsewhere in the 
brain. 
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Fig 3.4 (cont. on next page).  Median correlation between expression profiles from within the same brain region.  
Box edges represent the 25th and 75th percentile values and whiskers extend to any data points within 1.5 times 
the interquartile range from the rendered boxes.  Box colors correspond to parent brain regions.  Black vertical 
lines show median cross-species correlation of parent structure.  Numbers in parentheses are sample / voxel 
counts.  Numbers in square brackets are mean percentile rank of within-region correlations in distributions of 
correlations where one expression profile belongs to the region in question and the other is from elsewhere in the 
brain. 
  
36 
 
Fig 3.4 (cont. on next page).  Median correlation between expression profiles from within the same brain region.  
Box edges represent the 25th and 75th percentile values and whiskers extend to any data points within 1.5 times 
the interquartile range from the rendered boxes.  Box colors correspond to parent brain regions.  Black vertical 
lines show median cross-species correlation of parent structure.  Numbers in parentheses are sample / voxel 
counts.  Numbers in square brackets are mean percentile rank of within-region correlations in distributions of 
correlations where one expression profile belongs to the region in question and the other is from elsewhere in the 
brain. 
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Fig 3.4 (cont. on next page).  Median correlation between expression profiles from within the same brain region.  
Box edges represent the 25th and 75th percentile values and whiskers extend to any data points within 1.5 times 
the interquartile range from the rendered boxes.  Box colors correspond to parent brain regions.  Black vertical 
lines show median cross-species correlation of parent structure.  Numbers in parentheses are sample / voxel 
counts.  Numbers in square brackets are mean percentile rank of within-region correlations in distributions of 
correlations where one expression profile belongs to the region in question and the other is from elsewhere in the 
brain. 
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Fig 3.4.  Median correlation between expression profiles from within the same brain region.  Box edges 
represent the 25th and 75th percentile values and whiskers extend to any data points within 1.5 times the 
interquartile range from the rendered boxes.  Box colors correspond to parent brain regions.  Black vertical 
lines show median cross-species correlation of parent structure.  Numbers in parentheses are sample / voxel 
counts.  Numbers in square brackets are mean percentile rank of within-region correlations in distributions of 
correlations where one expression profile belongs to the region in question and the other is from elsewhere in the 
brain. 
 
 For each fine brain region, the mean percentile rank of within-region PCCs 
against an empirical null distribution is given in Fig 3.4 (bracketed value following 
region name and sample count).  High percentile ranks indicate that samples within the 
region resemble each other more strongly, overall, than they resemble samples from 
elsewhere in the brain.  Except for the mean ranks of cortical areas, most exceed the 90th 
percentile in both species.  The distribution of within-region mean percentile ranks 
(grouping cortical and subcortical areas) for both the human and mouse is significantly 
different from (with higher values than) a normal distribution with a mean at the 50th 
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percentile (p < 0.03x10-8 and p < 0.06x10-12 for the human and mouse, respectively; one-
tailed Kolmogorov-Smirnov test). 
 The distribution of correlations from expression profiles within the same region 
tends to have a smaller range in the human than mouse data, and a greater tendency 
toward negative skew (Fig 3.4).  This is probably also a result of lower spatial resolution 
in the AHBA, where larger samples can be expected to smooth variation in cell type 
distributions within a region, so that sample profiles tend to be similar. 
 
3.4. Cross-dataset validation of anatomical relationships (in human brain) 
3.4.1  Selection of probes for common gene set 
 Each of the 19,910 probes available in the preprocessed and quality controlled 
Gibbs dataset (see Section 2.4 for description) was mapped, where possible, to a unique 
gene symbol using the Illumina annotation file Human-Ref-
8_V3_0_R3_11282963_A.txt. This resulted in 12,202 unique gene symbols, and 1,041 
duplicate gene symbols (i.e., multiple probes mapping to the same gene). For the majority 
of genes, two or more relevant probes were available in the AHBA dataset. To create a 
common gene set across datasets, a simple algorithm was used to choose a single probe 
per gene from each dataset. For each gene, the probe with the highest mean correlation 
(across samples) with other probes for the same gene was chosen; in cases with exactly 
two probes, the probe with highest mean intensity was chosen. This resulted in a set of 
11,841 genes represented by individual probes in both the Gibbs and AHBA datasets, 
which was used in the below analyses. 
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3.4.2  Differential expression of individual genes 
 Differential expression (DEX) of a gene was quantified by contrasting the 
expression levels in all samples from one brain region with expression levels in all 
samples from another region. In the Gibbs dataset, paired t-tests (pairing samples from 
the same donors) were performed, excluding any donors for whom samples were not 
available from both brain regions. In the AHBA dataset, 2-sample t-tests were performed 
across all samples (pooled across donors) within each of the two regions of interest, 
allowing for different population variances (i.e., Welch’s t-test). P-values were corrected 
for multiple comparisons using the linear step-up false 
discovery rate (Benjamini and Hochberg, 1995). A minimum fold-change parameter was 
used, with its value varied to assess the sensitivity of results to the particular parameter 
choice. 
3.4.3  Comparing region-specific expression profiles 
 From either dataset, a set of brain region specific expression profiles, each of 
which is a vector of length 11,841 encoding the average (over samples from that region) 
relative expression level of each of the genes in the common gene set, was calculated. To 
compensate for differences in probe efficacies and, especially, to account for the non-
uniformities in sampling across brain regions, we standardized expression values based 
on a partition of samples into the 4 gross neuroanatomical areas represented in the Gibbs 
datasets (frontal cortex - FCTX, temporal cortex - TCTX, cerebellum - CB, and pons). 
For the Gibbs dataset, this amounted to equally weighting all samples. For the AHBA, 
this meant that means and standard deviations were computed over only the samples from 
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these four brain areas (or their sub-regions), and that each region was given the same total 
weight regardless of numbers of samples. In the AHBA, these standardization procedures 
were performed independently for each donor. Standardizing the AHBA expression 
profiles based on expression values in only the regions represented in the Gibbs sample 
enabled a ‘‘fair’’ comparison between datasets. PCCs were computed between the 4 
region-specific expression profiles derived from the Gibbs dataset and the expression 
profiles from a set of AHBA regions in each of the 6 donor brains. 
3.4.4  Results 
 Fig 3.5 shows three comparisons of DEX across regions in the AHBA and Gibbs 
datasets.  In both datasets, over 20% of genes in the common gene set showed significant 
DEX between all pairs of the four brain regions except the frontal and temporal cortex 
(paired t-tests, p < 0.05 after correction using FDR and a minimum log2 fold change of 
0.5).  A volcano plot (showing log2 fold change against -log10 corrected p-value) for all 
genes in the FCTX / TCTX comparison based on the Gibbs data set is shown in Fig 3.5B.  
Only 26 genes (represented by dark blue circles) were differentially expressed between 
the two cortical areas in both datasets (Table 3.1).  However, in general, there is greater 
agreement in the set of DEX genes across datasets (i.e., >63% overlap relative to the 
smaller gene set for all other region pairs).  Fig 3.5C shows that the fraction of genes that 
show DEX in both datasets for each region pair remains relatively stable even as the fold 
change threshold is varied, again with the exception of FCTX / TCTX. Even as fewer 
genes meet the FC threshold, the number of overlapping genes is far greater than would 
be expected by chance for all tested FC values (hypergeometric tests, p < 1 x 10-275 for all 
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tests). The overlap in DEX genes in cortex is less stable; however, for fold changes below 
1.0, the size of the overlapping DEX gene set is larger than expected by chance 
(hypergeometric tests, p < 0.025 for all tests). Because the FCTX / TCTX comparisons 
have fewer DEX genes overall, the estimated proportion is likely to be somewhat 
imprecise even below a FC of 1.0. Therefore, larger datasets may ultimately be necessary 
to provide an improved estimate of the number of genes with differential expression 
across cortical regions. 
Symbol Name Location 
TGFBI transforming growth factor, beta-induced, 68kDa 5q31 
TNNT2 troponin T type 2 (cardiac) 1q32 
ZBBX zinc finger, B-box domain containing 3q26.1 
CNTN6 contactin 6 3p26-p25 
COL5A2 collagen, type V, alpha 2 2q14-q32 
DUSP13 dual specificity phosphatase 13 10q23.1 
GAL galanin/GMAP prepropeptide 11q13.2 
GPX3 glutathione peroxidase 3 (plasma) 5q23 
GSTM5 glutathione S-transferase mu 5 1p13.3 
APOC1 apolipoprotein C-I 19q13.2 
KCTD4 potassium channel tetramerization domain containing 4 13q14.12-q14.13 
KNG1 kininogen 1 3q27.3 
LAMP5 lysosomal-associated membrane protein family, member 5 20p12 
LGR6 leucine-rich repeat containing G protein-coupled receptor 6 1q32.1 
LXN latexin 3q25.32 
MET MET proto-oncogene, receptor tyrosine kinase 7q31 
ARL9 ADP-ribosylation factor-like 9 4q12 
NECAB2 N-terminal EF-hand calcium binding protein 2 16q23.3-q24.1 
NEFH neurofilament, heavy polypeptide 22q12.2 
ASGR2 asialoglycoprotein receptor 2 17p 
PCP4 Purkinje cell protein 4 21q22.2 
PDGFD platelet derived growth factor D 11q22.3 
PDYN prodynorphin 20p13 
PRRX1 paired related homeobox 1 1q24.3 
BHLHE22 basic helix-loop-helix family, member e22 8q12.1 
STC2 stanniocalcin 2 5q35.2 
Table 3.1.  Common DEX genes between Gibbs and AHBA datasets for TCTX vs. FCTX.  DEX genes have log2 
fold change > 0.5, FDR-corrected p-value < 0.05. 
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Fig 3.5.  Cross-dataset comparison of differential expression across regions.  A.  Proportion of genes in the 
common gene set that are differentially expressed between pairs of structures in each dataset (minimum log2 
fold change of 0.5 and p < 0.05, FDR-corrected).  Light blue bars indicate proportions of DEX genes in the 
AHBA dataset (2-sample t-test), green bars in the Gibbs dataset (paired t-test), and dark blue bars show the 
fraction of overall genes showing DEX in both datasets. B. Volcano plot showing DEX in FCTX vs. TCTX for all 
genes in Gibbs dataset. Gray dots are not significant, green dots show DEX in Gibbs only, light blue dots in 
AHBA only, and dark blue dots show DEX in both datasets. C.  Percentage overlap in DEX genes vs. log2 fold 
change threshold (in all cases p < 0.05, FDR corrected). 
 
 Fig 3.6A shows correlations between each of the Gibbs regions and several 
regions from the AHBA.  These correlations are preferentially high between each Gibbs 
region and the profile from the corresponding region in the AHBA, consistently across 
donors.  The cerebellum profile in each dataset is negatively correlated with all non-
cerebellar profiles in the other dataset. FCTX and TCTX profiles are positively correlated 
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with all AHBA cortical structures, although each shows a slightly but not significantly 
higher correlation with the corresponding cortical lobe in the AHBA. Gibbs cortical 
profiles are also positively correlated with AHBA hippocampal profiles. Figs 3.6B and 
3.6C show finer anatomical resolution for cortical, cerebellar and pons regions. From Fig 
3.6C it is clear that the Gibbs CB profile compares with the AHBA cerebellar cortex and 
not the cerebellar nuclei, which are actually more molecularly similar to the Gibbs PONS 
samples. 
 
Fig 3.6.  Cross-dataset comparison of region expression profiles. Correlations between Gibbs cerebellum (CB; 
orange bars), frontal cortex (FCTX; green bars), pons (PONS; yellow bars), and temporal cortex (TCTX; blue 
bars) samples and expression profiles derived from AHBA regions.  Bar heights represent average PCC across 
AHBA donor brains, and individual dots indicate PCC for each donor. A. Correlations with broad regions. B.  
FCTX and TCTX correlations with individual gyri in the frontal lobe (top) and temporal lobe (bottom). C. CB 
and PONS correlations with cerebellar and pontine sub-structures. 
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3.5 Discussion 
 The visualizations and summary statistics presented above consistently show 
correspondence between transcriptomic and neuroanatomical organization in both the 
human and mouse brain.  The number of modes required to account for 90% of the 
variance suggests rich structure in each of these datasets, and is similar across the six 
human donors.  Even when sample and voxel expression profiles were projected onto a 
three-dimensional subspace (a reduction in dimensionality by at least two orders of 
magnitude in each data set), however, groups emerged corresponding to coarse brain 
regions, suggesting a dominant regional structure present in the expression patterns of 
sets of genes.  These results generally agree with Bohland et al. (2010)'s findings in the 
AMBA, where 67 and 271 modes were required to explain 80 and 90% of the variability 
in the data, respectively, and where the cerebral cortex, striatum and cerebellum were 
particularly distinct in the subspace defined by the first three spatial modes. 
 Subsequent analyses showed this transcriptomic organization at multiple 
neuroanatomical scales.  The broadest of these scales is apparent in Fig 3.3, where most 
telencephalic structures (the cerebral cortex, hippocampal formation, amygdala, and to a 
lesser extent the striatum) show a modest degree of transcriptomic similarity that is not 
shared with the rest of the brain.  This result echoed the clustering of human cortex, 
hippocampus, and amygdala samples observed by Roth et al. (2006) and of mouse cortex, 
hippocampus, and striatal voxels observed by Lein et al. (2007).  Similarly, Zapala et al. 
(2005) found that adult mouse brain samples group transcriptomically according to 
  
46 
position along the neural tube during development, with the included telencephalic 
structures (neocortex, hippocampus and olfactory bulbs) forming one cluster. 
 The globus pallidus was an exception to the relative similarity of telencephalic 
structures, sharing this weak similarity only with the striatum and tending to group with 
brainstem structures and the cerebellar nuclei (Fig 3.3).  In early development, neurons of 
the globus pallidus and striatum originate primarily from the medial and lateral 
ganglionic eminence (Olsson et al., 1998).  These transient, raised areas of the developing 
telencephalon do generate cells for other telencephalic structures; for example, most 
cortical interneurons may originate there (Kriegstein and Noctor, 2004).  However, the 
striatum and pallidum derive most of their neurons from these structures, and develop 
into the two main components of the basal ganglia.  Notably, in addition to its projections 
to the thalamus in the main "loop" of basal ganglia motor control, the mature internal 
globus pallidus projects to motor control centers in the brainstem (Hikosaka, 2007).  It is 
possible that the development of this circuitry influenced the transcriptomic profile of the 
globus pallidus such that traces of its earlier origins are obscured.   
 The substructures of the diencephalon did not, on the other hand, show this broad-
level similarity, with the thalamus and hypothalamus having near-zero or slightly 
negative correlations with each other within each species (Fig 3.3).  This result differs 
from Lein et al.'s study (Lein et al., 2007), where the mouse thalamus and hypothalamus 
both showed positive correlations with samples from the brainstem.  This difference may 
be explained by the fact that those authors used a list of over 5000 genes selected to 
contain many genes with expression patterns restricted to certain regions.  It is possible 
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that some of the genes included in their study (but not ours) distinguished the 
diencephalon and brainstem from the telencephalon and cerebellum.  Note also that the 
status of the hypothalamus as part of the diencephalon, based on diencephalic 
development, is subject to debate (e.g. Larsen et al., 2001; Puelles and Rubenstein, 2003; 
see also Lim and Golden, 2007). 
 The brainstem also showed a slight but consistent tendency towards large-scale 
similarity between samples / voxels from across the midbrain, pons, and medulla.  
Finally, in our analyses, the cerebellum (Fig 3.2) and specifically cerebellar cortex (Fig 
3.3) did not consistently group with other regions in either the mouse or the human brain.  
This distinct pattern of gene expression reflects the distinct cellular composition of 
cerebellar cortex, with the Purkinje and granular layers in particular each dominated by 
one cell type.   These results are consistent with Zapala et al. (2005; in the mouse) and 
Roth et al. (2006; in the human), though Roth et al.’s (2006) unsupervised clustering of 
brain samples found that sub-structures of the midbrain, pons and medulla clustered with 
samples from the thalamus and hypothalamus as well as with each other.  Note that (as 
Zapala et al., 2005 point out) the midbrain, pons and medulla develop primarily from 
three adjacent vesicles of the neural tube, while the cerebellum originates from the 
rhombic lip, a distinct, transient structure at the boundary between midbrain and 
hindbrain (Wingate 2001, Fink et al. 2006).  However, cerebellar nuclei (which do show 
elevated correlations with the brainstem; Fig 3.3) as well as some brainstem nuclei also 
originate from the rhombic lip.  The correspondence between mature transcriptomic 
relationships and position along the neural tube may still hold, but if so must be traced to 
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more specific locations of origin, and timing of neurogenesis must also be considered 
(see e.g. Ray and Dymecki, 2009; Landsberg et al., 2005; Wang et al., 2005).  
 At a finer scale, most neuroanatomical regions of greater specificity showed 
somewhat stronger within-region similarity than their parent regions (Fig 3.4).  The most 
striking exception, the human cerebellar nuclei, reinforces that a key takeaway of this 
analysis is the importance of neuroanatomical resolution.  There are too few samples to 
examine individual cerebellar nuclei in the human dataset, but the increase in mean 
within-region correlation for individual cerebellar nuclei in the mouse data suggests that 
these nuclei have distinct patterns of gene expression (Fig 3.4C).  Combining samples 
from different substructures may help to increase the signal-to-noise ratio of a 
characteristic profile of gene expression; however, in cases like the cerebellar nuclei, it 
also means combining substructures that may have quite heterogeneous cellular 
composition, and thus distinct molecular profiles.   Hence, our analysis faces a trade-off 
between signal-to-noise ratio (which increases with additional samples from a brain 
region) and specificity of expression profiles (which requires fine resolution of samples 
taken from consistent cellular environments).  The different trade-off made by the AHBA 
and the AMBA is also likely to be responsible for the lower correlations between mouse 
voxels than human samples (Fig 3.3), the lack of genome-scale molecular distinctions 
between sub-structures of the human globus pallidus (Fig 3.3B), and the tendency toward 
within-region correlations between human samples to have a narrower range and more 
negative skew than mouse voxels (Fig 3.4).  Future studies might help to address the 
optimal partitioning of the dataset to balance these two considerations.  Additionally, it 
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would be informative to make cross-dataset comparisons with some form of 
normalization for tissue sample size. 
 The AHBA makes it possible to examine the human brain at different scales, 
while a second human dataset including only four coarsely defined regions offers greater 
confidence in representing the population due to the relatively large number of donors 
(the “Gibbs dataset”; Gibbs et al., 2010).  Genes that were differentially expressed across 
those four regions (the frontal lobe, temporal lobe, pons, and cerebellum) in the second 
dataset overlapped significantly with genes differentially expressed across the same 
regions in the AHBA (Fig 3.5).  The small number of differentially expressed genes 
across frontal and temporal lobe in both datasets is consistent with previous studies, 
showing relatively (though not entirely) uniform gene expression across cortical areas 
(e.g. Bohland et al., 2010; Hawrylycz et al., 2012; Mahfouz et al., 2015).  Genome-scale 
expression profiles of those four regions within the AHBA dataset showed 
correspondence to those within the Gibbs dataset, consistently across the six AHBA 
donors (Fig 3.6).  This correspondence also showed some specificity at a finer level.  
Gibbs frontal lobe samples were taken from BA9/46, which cover portions of the middle 
and superior frontal gyri; these are among the AHBA regions that are most correlated 
with the Gibbs frontal cortex profile (along with the adjacent precentral gyrus).  
Additionally, the Gibbs cerebellum profile is strongly correlated with the AHBA 
cerebellar cortex, but negatively correlated with cerebellar nuclei profiles.  This suggests 
that Gibbs cerebellar samples were selectively taken from the cerebellar cortex.  Gene 
expression profiles sampled from the cerebellum exhibit broad negative correlations with 
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most other brain regions, confirming the very distinct mode of cerebellar gene expression 
observed in Figs 3.2 and 3.3. 
 It is important to note that with the exception of this comparison to the Gibbs 
dataset, all human analyses presented here and throughout this dissertation were 
performed using the AHBA.  Comparison across AHBA donors in assessing sources of 
variability in the AHBA (Fig 3.1) and tissue correlations between the AHBA and Gibbs 
datasets (Fig 3.6) provide some degree of validation.  However, confidence in these 
results will require eventual replication in other datasets.  Similarly, not only the analyses 
presented but most of the works cited regarding the mouse brain use the AMBA.   The 
Allen Brain atlases offer an extremely high level of spatial resolution, and systematic 
comparisons to other datasets will need to account for different sampling properties, as in 
the comparison to the Gibbs data discussed above. 
 One difference that this work does not directly address, particularly in 
comparisons between the AHBA and the AMBA, is in the size of tissue samples (or 
voxels).  Lower correlations between mouse voxels, as well as greater transcriptomic 
distinctions between fine regions in the mouse, probably result from the higher spatial 
resolution of the AMBA.  Normalization for tissue sample size might be difficult, given 
that in a dataset such as the AHBA this can vary by brain structure.  Nevertheless, given 
the importance of cross-dataset comparisons, it would be well worth an attempt in future 
work. 
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CHAPTER 4:  A COMPARATIVE STUDY OF MOLECULAR ORGANIZATION 
IN THE MOUSE AND HUMAN BRAIN 
 
4.1 Introduction 
 Anatomical homologies between the human and mouse brain are relatively well-
understood.  Despite substantial divergence--most notably in the folds and elaborate areal 
patterning of the human cerebral cortex as opposed to that of the mouse--neuroanatomists 
are able to identify homologs of broad human brain structures in the mouse brain, and of 
many finer regions as well.  Cytoarchitecture, myeloarchitecture, and inter-areal neuronal 
connectivity, observable by such long-established techniques as light microscopy and 
histochemical assays, form the conventional basis for these definitions of brain regions.  
Such conventional markers are, however, dependent upon local molecular phenomena 
operating at a much smaller scale, either directly resulting in the signal of interest or 
giving rise to the observable structure through a developmental program.  With the 
development in recent years of technology to measure gene expression with high 
throughput, brain regions can now be characterized and delineated from the perspective 
of gene products and their interactions.  The molecular mechanisms effected by these 
interactions form the cellular environment underlying conventional markers of region 
identity and support the functions associated with the region.  In contrast to homologies 
defined at the macro/structural level, regional correspondences between molecular 
environments of the human and mouse brain remain largely unexplored.  The elucidation 
of molecular-level homologies has substantial implications for the use of mouse models 
of human neuropathologies, which often rely on the implicit assumption of conserved 
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molecular mechanisms that underlie the homologous neuroanatomical features.  This 
chapter describes the development and application of tools for the evaluation of 
molecular correspondences across species using gene expression profiles, and for the 
identification of groups of genes which may preferentially drive those molecular 
correspondences for specific regions.  These analyses use the Allen Human Brain Atlas  
(AHBA; Hawrylycz et al., 2012) and the Allen Mouse Brain Atlas (AMBA; Lein et al., 
2007), which are described in greater detail in Chapter 2. 
4.1.1  Surveying regional gene expression 
 Comparative studies confirm that the relationships between conventional and 
molecular neuroanatomy extend across species, with structural homologies carrying 
molecular-level correspondences.  Such correspondences between the human and 
chimpanzee (one of the closest living relatives to humans) have been identified by cross-
species comparisons of (i) differential expression across regions, (ii) similarity 
relationships between gene expression profiles from different brain regions, and (iii) 
networks based on co-expression relationships between genes (Khaitovich, 2004; Oldham 
et al., 2006).  These analyses revealed strong conservation of gene networks across 
species, but also specializations thought to be introduced by evolution, particularly 
impacting the cerebral cortex.  In a study spanning phylogenetic classes, Pfenning et al. 
(2014) found molecular specialization specific to regions responsible for vocal motor 
function, which appeared in the human and zebra finch brain but not in other species that 
do not engage in vocal learning.  Strand et al. (2007) made several comparisons between 
the human and C57BL/6 mouse brain.  Using samples from the caudate, cerebellum, and 
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motor cortex, they found that genes which show preferential expression in a human 
region tend to show the same preference in the homologous mouse region.  Additionally, 
unsupervised clustering of samples from both species (based on genes with high variance 
of expression across samples) yielded clusters corresponding perfectly to region 
labelings. 
 This evidence for a strong cross-species molecular relationship between these 
three brain regions points to the possibility for a direct, high-resolution comparative study 
of gene expression in regions throughout the brain, which the AHBA and AMBA 
together make possible.  One such comparison was recently performed by Hawrylycz et 
al. (2015).  In this study, a brain-wide co-expression consensus network (Langfelder et 
al., 2011) was defined based on the AHBA, and 32 “core transcriptional modules” were 
identified using weighted gene co-expression network analysis (WGCNA; Zhang and 
Horvath, 2005). Several of these modules were well preserved in the AMBA (based on an 
aggregate preservation score across all genes in the module; Langfelder et al., 2011), 
including modules with strong expression in the striatum, thalamus, and cerebellum.  
Even in well-preserved modules, however, a small proportion of individual genes in the 
mouse were poorly correlated with the human module eigengene and, in some cases, 
genes showed strong associations with a different module.  Furthermore, a number of 
modules, particularly those not enriched for neuronal expression, were poorly preserved 
across species. These results suggest the conservation of co-expression relationships that 
are relevant to specific brain regions, but also indicate points of divergence within the 
larger co-expression networks. 
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4.1.2  Challenges of molecular neuroanatomy and mouse models 
 The neocortex is of special interest in comparative studies of humans and other 
mammals, as the seat of profound cognitive differences as well as a key structure in many 
of the human neuropathologies modelled in other mammals.  However, identifying 
molecular-level similarities and differences that are relevant to cortical function is made 
exceptionally difficult by the fact that both human and mouse neocortex show relatively 
uniform gene expression across cortical areas (see e.g., Hawrylycz et al., 2012; Bohland 
et al., 2010; Mahfouz et al., 2015).  Variation of gene expression across the cortex is 
present, and shows some consistency between the human and the mouse, with genes that 
group together in the one tending to group together in the other (Oldham et al., 2008; 
Miller et al., 2010).  These two studies, though, defined gene clusters based on co-
expression across cortical samples regardless of the area of origin.  In the rhesus 
macaque, Bernard et al. (2012) did take area of origin into account and identified groups 
of genes with cortical area preferences, with striking differences between V1 and the rest 
of the neocortex appearing largely consistent with the human brain but less so with the 
mouse.  Many expression preferences were heavily influenced by proximity between 
cortical areas, reflecting the rostrocaudal gradients of gene expression that are a part of 
brain development (see Sansom and Livesey, 2009 for a review of gradients in human 
cortical development).  Genes may also be expressed in different types of patterns (e.g., 
laminar, widespread, or sparse) in the cortex.  Such patterns show high conservation 
across human cortical areas--more so than across species when compared with mouse 
cortex (Zeng et al., 2012).  Laminar variation in cell type densities results in neocortical 
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layers showing different gene expression patterns (Ng et al., 2009; Belgard et al., 2011; 
Bernard et al., 2012); however, the AHBA lacks laminar specificity because cortical 
samples were taken across layers rather than tangentially through the cortex (Hawrylycz 
et al., 2012).  In addition to the relatively homogenous molecular nature of the neocortex, 
many neocortical areas in the human brain lack clear neuroanatomical homologs in  the 
mouse, making molecular-level homologies doubly challenging to identify. 
 Mouse models used to investigate learning and memory, and sometimes 
Alzheimer's Disease specifically, make the hippocampal formation another structure of 
particular interest.  The broad structure of the hippocampal formation is consistent 
between the human and mouse, each including the dentate gyrus, Ammon's horn, and 
subicular complex (see Ding, 2013 for a detailed comparison of the subicular complex in 
human, monkey, and rodent).  Additionally, the role of the striatum in Parkinson's 
Disease (PD) has made it the focus of a large number of studies in mice (see Le et al., 
2014 for a review of mouse models of PD).  The most substantial divergence of the 
human and mouse striatum lies in the separation of the human caudate nucleus from the 
putamen by the internal capsule, where the mouse caudoputamen is a single structure.  
Unlike the neocortex, the hippocampal formation and striatum are composed of 
substructures with identifiable homologs in the mouse and human, and which are more 
molecularly distinct from each other than are neocortical areas (Bohland et al., 2010; 
Hawrylycz et al., 2012). 
 Nevertheless, developing effective and reproducible mouse models of AD and 
PD, in which these brain structures play central roles, has proved difficult (Duff, 2004; 
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Hardy, 2006; Le et al., 2014).  A probable source of some of this difficulty has been 
identified by Burns et al. (2015) through analysis of the expression profiles of disease-
implicated genes.  This study found striking differences between the up- and down-
regulation of genes of interest in several human diseases (as well as aging in the human 
brain) and the up- and down-regulation of these genes in the various mouse models they 
examined.  Burns et al.'s findings suggest that mouse models of human disease may 
benefit from better knowledge of similarities and differences in the transcriptomic 
environments present in relevant brain structures and systems. This reinforces an 
argument made by Strand et al. (2007), suggesting that understanding the initial 
conditions (i.e., healthy state) of the transcriptome in the human and mouse brain is 
highly relevant to comparisons of disease conditions in the two species. 
4.1.3  Overview of the current approach 
     Rather than focusing on specific genes of interest, the current study deals primarily 
with groups of genes and their co-expression relationships, which underlie the molecular 
environment that influences any given gene.  We evaluated the overall similarity of gene 
expression in regions throughout the human and mouse brain by correlating expression 
profiles, both within- and across-species.  We also sought to identify groups of genes 
which preferentially “drive” cross-species similarity for different regions.  To do this, we 
developed a quantitative measure to assess the extent to which a given set of genes 
provides a region-specific molecular signature that is consistent across species.  Because 
it is not computationally feasible to assess all possible subsets of genes, we defined 
candidate gene sets in two ways.  The first was data-driven, where genes were divided 
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into sets based on their co-expression relationships.  Co-expression is an indicator of 
functional relationships between genes (Eisen et al., 1998; Lee, 2004; Wei et al., 2006); 
therefore, this approach is influenced by relationships – both known and unknown – 
between genes.  In the second approach, gene sets were defined based on common 
annotations; for example, a gene set might include all genes known to distinguish a 
certain cell type or to be involved in a certain metabolic pathway.  In addition to these 
region-specific analyses, gene-gene similarity was evaluated across species by comparing 
each gene's brain-wide expression pattern in the human with its expression pattern in the 
mouse, and examined genes that showed very high or very low cross-species similarity.  
Brain-wide co-expression relationships between cell-type marker genes (for neurons, 
oligodendrocytes, and astrocytes) were also assessed, both within- and between-species. 
 The overall aim of this chapter is to better quantify molecular-level 
correspondences between the human and mouse brain at a large scale, and to provide 
inroads for further study of neural homologies.  The efficacy of mouse models depends 
upon homology at all scales, including preservation of the molecular mechanisms 
underlying the function of individual brain regions, making this area of study important 
in biomedical research and in the development of drugs or other neurotherapeutic 
interventions.  While homologies can be considered in terms of individual genes, the 
expression of one gene always occurs under the influence of others.  This raises the 
question of which aspects of the molecular environment as a whole are conserved across 
species.  Like conventional neuroanatomical markers, this environment varies across the 
brain, reflecting the localization of brain function and dysfunction to specific structures 
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and circuits.  To our knowledge, this study is the first to comprehensively quantify the 
similarity between local transcriptomic environments in the human brain and their 
equivalents in one of the most common model organisms. 
 
4.2 Methods 
 See Chapter 2 for formal descriptions of the Allen Human Brain Atlas (AHBA) 
and the Allen Mouse Brain Atlas (AMBA). 
4.2.1  Gene selection 
 Human orthologs were identified for 3,792 of the genes available in the mouse 
dataset using NCBI HomoloGene  (NCBI Resource Coordinators, 2015; 
www.ncbi.nlm.nih.gov/homologene).  Expression data for these genes constituted a 
common dataset, which was used in all comparisons of the AMBA and AHBA reported 
here. 
4.2.2  Regions of the brain 
 In the AHBA and AMBA, human samples and mouse voxels are assigned 
neuroanatomical labels at multiple levels of granularity based on detailed reference 
atlases.  For effective interspecies comparison, the subsequent analyses treat eleven 
coarsely defined brain structures (Table 4.1).  Only samples and voxels belonging to one 
of these eleven broad brain regions were used in any part of these analyses.  Analyses 
which examine finer subdivisions of these regions focus primarily on those regions in the 
second column of Table 4.1.  In the AHBA ontology, the "cerebral cortex" includes the 
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hippocampal formation.  Here, the hippocampal formation was excluded from the 
definition of cerebral cortex in order to study it as a separate structure.  Human cerebral 
cortex was therefore defined as the neocortex (the frontal, temporal, parietal, and 
occipital lobes, and the insula), cingulate cortex, and parahippocampal gyrus.  In the 
AMBA ontology, "cerebral cortex" also includes the hippocampal formation as well as 
amygdalar nuclei; to study these structures separately, mouse cerebral cortex was defined 
here using the AMBA term "isocortex." 
 
Broad regions (11) Fine regions (9) 
Cerebral cortex  (4008 [excluding 4249] / 315)  
Hippocampal formation (4249 / 1089) Dentate gyrus (12891 / 726) 
Ammon's horn (12892-12895 / 375) 
Subiculum (12896 / 502) 
Amygdala (4327 / 278, 131, 295, 319, 780)  
Striatum (4277 / 672, 56) Caudoputamen (4278, 4287 / 672) 
Nucleus accumbens (4290 / 56) 
Globus pallidus / Pallidum or dorsal pallidum2 
(4293 /  803 or 818) 
External segment of globus pallidus (12897 / 1022) 
Internal segment of globus pallidus (12898 / 1031) 
Thalamus (4392 / 549)  
Hypothalamus (4540 / 1097)  
Midbrain (9001 / 313)  
Pons (9131 / 771)  
Medulla (9512 / 354)  
Cerebellum (4696 / 512) Cerebellar cortex (4697 / 528) 
Cerebellar nuclei (4780 / 519) 
Table 4.1.  List of brain regions.  Regions were defined using the neuroanatomical labels associated with the 
given numeric identifiers (human / mouse) in the AHBA and AMBA ontologies. 1 
1.  The relevant reference atlases can be viewed at http://atlas.brain-map.org/atlas?atlas=265297125 (human) 
and http://atlas.brain-map.org/atlas?atlas=1 (mouse), or downloaded directly (with associated IDs and other 
metadata) from http://api.brain-map.org/api/v2/structure_graph_download/10.xml (human) or http://api.brain-
map.org/api/v2/structure_graph_download/1.xml (mouse). 
2.  Neuroanatomical labels for the ventral, caudal, and medial as well as the dorsal pallidum (globus pallidus) 
are included in the AMBA, but not the AHBA.  In comparisons of homologous brain structures, the human 
globus pallidus was compared only to the mouse dorsal pallidum. 
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4.2.3  Probe standardization 
 Probes in both the AHBA and AMBA were standardized using the weighted z-
scoring procedure described in Chapter 2, with the broad regions given in Table 4.1 given 
equal weight.  Weighted z-scoring in the AHBA was performed within-donor. 
4.2.4  Correlations between individual samples / voxels 
 To assess the regional organization of transcriptomic relationships, tissues 
throughout the brain were compared across species using Pearson's Product-Moment 
Correlation Coefficient (PCC) calculated between pairs of profiles.  These coefficients 
were calculated between each human sample and each mouse voxel. The cross-species 
sample/voxel PCCs were pooled into distributions corresponding to the 121 pairings of 
broad regions in the human and mouse brain (Table 4.1).  The same procedures were 
followed using the 9 fine brain regions listed in Table 4.1.  Cross-species PCC 
distributions for some structure pairs were compared using two-sample Kolmogorov-
Smirnov tests, with p-values corrected for multiple comparisons using the Bonferroni 
method. 
 For each putatively homologous cross-species region pair, the quartiles of all 
sample-voxel PCCs was calculated to assess the strength of cross-species similarity for 
each region at a global scale. Additionally, sample-voxel PCCs for homologous regions 
were compared to a distribution of 1000 PCCs calculated between sample/voxel pairs for 
which either the sample or the voxel originated within the region, and the other member 
of the pair did not. Means of the resulting percentile ranks were calculated to assess 
specificity of regional correlations. 
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4.2.5  Region-specific homology score 
 A "homology score" was defined to quantify the extent to which a given gene set 
provides a molecular signature that is specific to a given brain region, and which is 
consistent across species (see below for selection of gene sets).  Homology scores were 
calculated separately for each human donor brain.  A gene set's homology score for a 
given brain region was based on correlations between its human expression profile for 
that region (averaged across all samples available for a given donor brain) and the 
orthologous expression profile at each voxel in the mouse data. This yields a map of 
correlations across the entire mouse brain, as schematized in Fig 4.1.  Before using 
specific subsets of genes, correlation maps and homology scores were calculated for each 
of the 11 broad seed regions using the full list of 3,792 orthologous genes. 
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Fig 4.1.  Schematic of method for calculating correlation maps.  Color bar at bottom left applies to all panels in 
this figure.  A.  All left-hemisphere samples from a "seed" brain region are selected from one human donor.  B.  
The standardized profiles of those samples are averaged into a mean profile for the seed region.  C.  
Standardized expression profiles for all mouse voxels located within any of the broad brain regions listed in 
Table 1 were used for comparison.  D.  The correlations between the expression profile of the human seed region 
and each mouse voxel are computed to generate a map of correlations across the mouse brain. Reference atlas 
images adapted from files downloaded from the Allen Institute for Brain Science. Image credit: Allen Institute. 
 
 The procedure for calculating a homology score based on a correlation map is 
formalized below.  We compare the mean correlation across voxels falling within a 
mouse target region (usually the putative homolog to the human seed region) to the mean 
correlation across voxels falling elsewhere in the mouse brain.  If the former value is 
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larger than the latter, then the expression of the gene set carries preferential molecular 
similarity between the human seed region and the mouse target region.  Because this 
score is intended to measure region-specific similarity, a penalty for non-specificity is 
then applied to ensure that a gene set does not receive a high homology score if its 
expression profile for the human seed region is highly similar to a non-target mouse 
region in addition to the target mouse region. 
4.2.6  Definition (Correlation map) 
 We define EG(i) as a vector representing the standardized expression levels for 
human sample i across gene set G.  𝐸𝑅
𝐺then represents the average expression profile 
(across N available samples) for a given human seed region R: 
 
𝐸𝑅
𝐺 =
1
𝑁
∑ 𝐸𝐺(𝑖)𝑁𝑖=1                (1) 
 
     For each mouse voxel, we then calculate the PCC between the seed region profile 𝐸𝑅
𝐺  
and the mouse expression vector defined across orthologs of gene set G at each voxel v, 
denoted as 𝑃𝐶𝐶𝑅
𝐺(𝑣).  If any gene had missing data for certain voxels, that gene was 
excluded from the calculation of  𝑃𝐶𝐶𝑅
𝐺(𝑣) for those voxels.  This procedure yields a 
map of PCCs across the mouse brain. 
4.2.7  Definition (Homology score) 
 Given the map of voxelwise PCCs with 𝐸𝑅
𝐺 , we calculate the average of the PCC 
values within the mouse target region R': 
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𝐼𝑁𝑅′
𝐺 =
1
𝑉𝑅′
∑ 𝑃𝐶𝐶𝑅
𝐺(𝑣)𝑣∈𝑅′                (2) 
where VR’  is the number of voxels in R’.  We then calculate the average of the PCC 
values outside the target region R’: 
𝑂𝑈𝑇𝑅′
𝐺 =
1
(𝑉total−𝑉𝑅′)
∑ 𝑃𝐶𝐶𝑅
𝐺(𝑣)𝑣∉𝑅′        (3) 
where Vtotal  is the total number of voxels analyzed in the mouse brain.  Negative mean 
PCCs (i.e., patterns of gene expression that are inversely related across species) would 
affect the homology score without having a clear biological interpretation; therefore, we 
threshold 𝐼𝑁𝑅′
𝐺  and 𝑂𝑈𝑇𝑅′
𝐺  at zero.   
 The difference of these quantities, [𝐼𝑁𝑅′
𝐺 ]
+
  −    [𝑂𝑈𝑇𝑅′
𝐺 ]
+
, provides information 
about cross-species homology.  However, while this difference is sensitive to a 
concentration of high PCCs in the target region, it is not necessarily specific to such a 
concentration.  It may yield a high value even if some non-target region also has a 
concentration of high PCCs, provided that the overall average (𝑂𝑈𝑇𝑅′
𝐺 ) remains low.  
Therefore, we introduced a penalty for non-specificity.  This penalty is based on the 
highest mean PCC with the seed region for any single non-target mouse region: 
𝑟𝑚𝑎𝑥
′ = argmax
r≠R′
(𝐼𝑁𝑟
𝐺)              (4) 
 The penalty term 𝜆 is defined as the mean of the differences between the mean 
PCC for 𝑟𝑚𝑎𝑥
′  and each mean PCC yielded by another non-target region: 
𝜆𝑅′
𝐺 =
1
𝑀−2
∑ ([𝐼𝑁𝑟𝑚𝑎𝑥′
𝐺 ]+ −   [𝐼𝑁𝑟
𝐺]+)𝑟≠𝑅′,𝑟≠𝑟𝑚𝑎𝑥′       (5) 
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where M is the total number of mouse regions analyzed (i.e., those which are homologs to 
the eleven broad seed regions; see "Human seed regions and mouse target regions," 
below).  This penalty will have a large value if one mouse region outside the target has a 
much larger mean PCC than the others, showing that gene set G drives cross-species 
similarity between the human seed region and a mouse region that is not the target. It will 
have no impact (value of zero) if the PCCs are uniform outside the target region. 
 The homology score 𝐻𝑅
𝐺 of gene set G for human seed region R is then defined as: 
𝐻𝑅
𝐺  = ( [𝐼𝑁𝑅′
𝐺 ]
+
  −    [𝑂𝑈𝑇𝑅′
𝐺 ]
+
 )  − 𝜆𝑅′
𝐺                (6) 
 Thus, the homology score quantifies the extent to which higher PCCs are 
concentrated within the mouse homolog to the human seed region (relative to the rest of 
the mouse brain), and are not specifically  concentrated in any other mouse region. 
 The difference of thresholded mean PCCs falls in the interval [−1,1], where a 
value of one would indicate a PCC of 1 with each voxel in the mouse target region and a 
maximum PCC of zero with any non-target voxel.  Conversely, a value of -1 one would 
indicate a PCC of 1 with each non-target voxel, and a maximum average PCC of zero 
inside the target region.  The value of 𝐻𝑅
𝐺, however, may fall below -1 due to the penalty 
term 𝜆𝑅′
𝐺 .  This asymmetrical range reflects the fact that a seed region may be correlated 
only with the target region (𝐻𝑅
𝐺 = 1), only with voxels outside the target region (𝐻𝑅
𝐺 = -1), 
or only with a specific non-target region (𝐻𝑅
𝐺 < -1).  In practice, however, values below -1 
did not occur. 
 Each homology score was converted to a percentile rank in an empirical chance 
distribution.  For each candidate gene set, 1,000 sets of randomly selected genes were 
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generated, each of the same size as the original gene set.  Homology scores were 
computed for these random sets, and the resulting distribution was used to calculate the 
percentile rank of  𝐻𝑅
𝐺 for the original gene set. 
4.2.8  Human seed regions and mouse target regions 
Candidate gene sets (see below) were first scored using each of the 11 broad human brain 
regions (Table 4.1) as seeds.  Target regions in the mouse (i.e., homologous regions) 
were determined based on common nomenclature and through surveys of the anatomical 
literature.  Gene sets were then scored using the fine human regions of Table 4.1 as seeds, 
which also have relatively well-established homologs in the mouse.  In the case of the 
caudate nucleus and putamen, which are distinct structures in the human but not the 
mouse, the mouse caudoputamen was used as the target region for each. 
 Our purpose in using the additional set of fine seed regions was to determine 
whether the specificity of a gene set's cross-species correspondence relative to the rest of 
the brain was affected by increasing the specificity of the neuroanatomical region of 
interest.  Therefore, computation of homology scores for a given fine seed region 
excluded the part of the PCC map falling within the parent structure but outside the target 
region.  For example, a gene set's homology score for the dentate gyrus was not affected 
by PCCs falling within Ammon's horn, the subiculum, or any of the mouse 
retrohippocampal regions. 
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4.2.9  Candidate gene set identification:  Data-driven gene sets 
 Initial candidate gene sets were identified based on co-expression relationships by 
applying weighted gene co-expression network analysis (WGCNA; Zhang and Horvath, 
2005) to the mouse dataset using a publicly available R package (Langfelder and 
Horvath, 2008).  A network of genes was defined in which edge weights encoded the 
absolute value of the correlation between pairs of genes' spatial expression patterns.  Co-
expression similarity was measured by topological overlap (TO; Zhang and Horvath, 
2005)).  Average linkage hierarchical clustering was then applied, and the resulting 
dendrogram was cut using a dynamic tree-cutting algorithm (Langfelder and Horvath, 
2008). 
 WGCNA was applied to the full-brain, unweighted, standardized mouse data.  In 
order to emphasize relationships across the brain structures that would be used as broad 
seed regions when calculating homology scores, the mouse expression dataset was 
averaged (across voxels) into the homologs of those regions, with the exception that the 
striatum and pallidum were treated as a single structure (in later analyses they would be 
treated separately, as in Table 4.1).  WGCNA was performed on the resulting 10 x 3,792 
matrix with default parameters, which sets the minimum gene set size to 20.  Each of the 
resulting gene modules was used as a candidate gene set and assessed for region-specific 
molecular similarity across species. 
4.2.10  Candidate gene set identification:  Annotation-based gene sets 
 A second group of candidate gene sets was defined, consisting of all genes 
associated with a series of annotations representing some function, cellular mechanism, 
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or other association.  Three of these sets were composed of genes which show cell-type 
specific expression for neurons, astrocytes, and oligodendrocytes in the postnatal mouse 
brain (Cahoy et al., 2008); these genes (those intersecting our common gene set) had 
significant differential expression in each of these three cell types compared to the others 
and a fold change of at least 20. 
 Additional gene sets were defined using annotations which were statistically over-
represented in the data-driven gene sets.  We examined over-represented annotations for 
data-driven gene sets whose homology scores ranked at the 80th percentile or higher for 
at least one broad seed region. Such annotations were expected to more specifically 
correspond to groups of genes which had common, conserved roles across the two 
species.     
 The Molecular Signatures Database (MSigDB; Subramanian et al., 2005) includes 
over 10,000 gene annotations from many sources, including publications and online 
neuroinformatics resources such as the Gene Ontology (Ashburner et al., 2000) and the 
KEGG pathways database (Kanehisa and Goto, 2000; Kanehisa et al., 2014).  All 
available annotation terms and their associated gene lists were downloaded from 
MSigDB.  The genes associated with each annotation were limited to those appearing in 
our common set of 3,792 genes.  Over-representation in the selected data-driven sets was 
assessed using the hypergeometric test, with p-values corrected for multiple comparisons 
using the linear step-up false-discovery rate (FDR; Benjamini and Hochberg, 1995).  
Additionally, annotations had to be represented in a gene set by at least 3 genes to be 
considered over-represented in that set.  
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 Annotations that were over-represented with FDR-corrected p-value less than 
0.01 in any of the selected data-driven sets were then manually curated to select only 
annotations that could be specifically related to brain structure or function.  Annotations 
were selected from this list to define gene sets, each of which was composed of all genes 
in our common gene set that were associated with the annotation.  Homology scores were 
then calculated and converted to percentile ranks for both the cell-type marker gene sets 
and these additional annotation-based gene sets, using both the broad and fine seed 
regions. 
4.2.11  Brain-wide similarity of orthologous gene expression profiles across species 
 We measured the similarity between each gene's pattern of expression across the 
human brain and the pattern of expression of its ortholog across the mouse brain.  The 
expression matrix for each human donor was averaged into 16 brain regions by starting 
with the 11 broad regions listed in Table 4.1 and replacing the hippocampal formation, 
globus pallidus, striatum, and cerebellum with their corresponding fine regions.  To allow 
a one-to-one correspondence with brain regions in the mouse, the human caudate nucleus 
and putamen were treated as a single structure for this analysis.  The region-averaged 
AHBA data was then averaged across donors, yielding a single 3,792 x 16 expression 
matrix.   The AMBA dataset was averaged into the same 16 structures, and PCCs 
between expression vectors for orthologous genes in mouse and human were calculated. 
 Genes with PCCs in the top 5% (190 genes) were clustered based on their 
expression patterns across the 16 human brain regions using average linkage hierarchical 
clustering.  Leaf order of the resulting dendrogram was used to order genes in heatmap 
  
70 
representations of their expression patterns across the 16 regions of interest in both the 
human and mouse brain.  Genes with PCCs in both the top and bottom 5% were 
examined for over-represented annotations, using the MSigDB as described above (see 
"Annotation-based gene sets"). 
4.2.12  Effects of penalty score and regional expression 
 The effect of the penalty term 𝜆 on the homology scores was evaluated by 
converting un-penalized scores to percentile ranks in a distribution of un-penalized scores 
from randomly selected gene sets.  These ranks were compared to those obtained using 
the penalty term. 
 To assess the relationship between a gene set's homology score for a brain region 
and its expression in that region, percentile ranks of 𝐻𝑅
𝐺were compared to percentile 
ranks of mean expression values in each broad region, for all gene sets.  The same 
randomly selected gene sets used to calculate percentile ranks for 𝐻𝑅
𝐺were used to 
calculate percentile ranks for mean expression values in a region.  In separate analyses, 
the mean regional expression was calculated in mouse and human brain by averaging 
entries in the expression sub-matrix that indexes all genes in the set and all samples or 
voxels in the region.  For human data, this mean value and its percentile rank were 
calculated for each donor individually before being averaged across donors. 
4.2.13  Cell-type markers 
 An additional analysis was performed on the three cell-type marker gene sets 
(Cahoy et al., 2008; see “Annotation-based sets”, above).  To assess the similarity of 
expression patterns related to cell types across the human and mouse brain, cross-species 
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PCCs between gene expression patterns (calculated as above) were averaged within each 
cell-type marker gene set.  This average PCC was compared to a distribution of average 
PCCs calculated from 10,000 randomly selected gene sets of the same size as the 
original, and its percentile rank in this empirical chance distribution was calculated. 
 
4.3 Results 
4.3.1  Correlation heatmaps 
 Heatmaps of cross-species PCCs between expression profiles for individual 
AHBA samples and AMBA voxels show global organization based on brain region (Fig 
4.2).  Blocks of high values (in comparison to the rest of the matrix) correspond to brain 
regions including the cerebral cortex, thalamus, hypothalamus, amygdala, and 
cerebellum, with striatal expression profiles showing especially high PCCs with each 
other.  In some cases, expression profiles between non-homologous regions show 
somewhat elevated PCCs.  The midbrain, pons, and medulla are represented by a single 
block of positive-valued PCCs, in addition to showing elevated PCCs with the cerebellar 
nuclei.  To a lesser extent, this is also true of the cerebral cortex, hippocampal formation, 
amygdala, and striatum.  These features also appear in the within-species correlation 
heatmaps (see Chapter 3, Fig 3.3), which show higher within-region PCCs overall than 
those in Fig 4.2.  Fig 4.2 also shows this organization at a finer level for the pallidum and 
cerebellum, where the dorsal pallidum, cerebellar cortex, and cerebellar nuclei show 
higher PCCs with their homologs than with non-homologous sub-structures. 
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Fig  4.2.  Correlations between gene expression profiles of human samples and mouse voxels.  A.  Correlations 
between each human sample (horizontal axis) and each mouse voxel (vertical axis).  B.  Correlations between the 
human and mouse pallidum.  C.  Correlations between the human and mouse cerebellum.  Of the voxels from 
the mouse cerebellum included in this figure, 473 were labelled only with the term "Cerebellum," with no finer 
structure specified.  Correlations between these voxels and human samples are along the bottom of A, and are 
not included in C. 
 
4.3.2  Cross-species correlation distributions 
 Each distribution in Fig 4.3 represents a histogram of all values within a 
submatrix of the correlation matrix shown in Fig 4.2.  For the broad regions (Fig 4.3A), 
these distributions highlight patterns described above in the correlation matrix.  
Distributions of PCCs between homologous regions (along the main diagonal) generally 
showed a rightward shift relative to those between most non-homologous regions.  
Slightly right-shifted distributions also appeared between the groups of regions noted 
above (the cerebral cortex, hippocampal formation, amygdala, and striatum as opposed to 
the midbrain, pons, and medulla).  The thalamus had a bimodal distribution, as did 
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several non-homologous region pairs.  Closer examination revealed that the human 
ventral and mouse dorsal thalamus have a median correlation of only 0.002, while the 
medians for the human dorsal / mouse dorsal, human ventral / mouse ventral, and human 
dorsal / mouse ventral thalamus distributions fall between 0.068 and 0.081.  The shapes 
of the distributions between the human cerebellum and all mouse homologous regions 
includes a high peak near 0, which reflect human cerebellar cortex (Figs 4.2 and 4.3B).  
In most cases, human cerebellum also showed a smaller number of more positive PCCs 
(with mouse brainstem structures and pallidum), or negative PCCs (with other mouse 
telencephalic structures); these are due to human cerebellar nuclei (Figs 4.2 and 4.3B).  
Mouse cerebellar correlations with non-homologous human brain structures do not show 
this shape.  In the AMBA, layers of cerebellar cortex are distinct; in the AHBA, 
cerebellar cortical samples may include more than one layer.  This combination of cell 
type distributions may obscure consistent similarities and differences between human 
cerebellar cortical profiles and most of the mouse brain, although it does not appear to 
obscure similarity with the mouse cerebellar cortex. 
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Fig 4.3. Distributions of correlations between expression profiles from a human region and a mouse region.  
Homologous region pairs are outlined in red. Horizontal axis limits are -0.5 and 0.5; red vertical lines indicate 
zero.  A. Broad brain regions.  B. Fine brain regions. Dashed yellow vertical line indicates median correlation 
for parent brain region.  C. Median correlation between all sample-voxel pairs where sample and voxel are from 
homologous regions. Box edges represent the 25th and 75th percentile values; whiskers extend to any data points 
within 1.5 times the interquartile range from the rendered boxes.  Box colors correspond to parent brain 
regions.  Black vertical lines show median cross-species correlations of parent structures. 
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 For the most part, the PCC distributions for fine regions shown in Fig 4.3B 
echoed the organization shown for broad regions, with a tendency towards higher PCCs 
between profiles of homologous regions than between profiles from regions thought to be 
anatomically and functionally distinct.  This was largely true even for sub-structures of 
the same broad region.  The difference between the distribution of correlations for any 
homologous fine region pair and the pooled distributions of correlations for non-
homologous pairs within the same broad region (those not outlined in red) was significant 
for all sub-structures after Bonferroni correction (one-tailed two sample Kolmogorov-
Smirnov test, p < 0.01, N = 9 homologous pairs) except for the nucleus accumbens (p > 
0.6) and GPe (p > 0.3).  Surprisingly, the cerebellar nuclei showed elevated PCCs with 
the GPe and GPi, and several bimodal distributions were observed for fine structure 
pairings, suggesting further anatomical specificity of gene expression relationships that 
go beyond the labeling available. 
 Fig 4.3C summarizes the above data, showing medians of the PCC distributions 
for homologous structures (outlined in red in Fig 4.3A and 4.3B).  As Fig 4.2 indicated, 
the striatum showed the highest median cross-species PCC; this primarily reflects 
transcriptomic similarity between the human and mouse caudoputamen.  These values are 
consistently lower than within-species PCCs between expression profiles of a given 
region (compare Fig 4.3C to Fig 3.2).  However, they did tend to be higher than cross-
species PCCs where the sample and the voxel were from non-homologous regions (Fig 
4.4A).  At a finer scale, this tendency held only within the cerebellum; expression 
  
76 
profiles within the other broad regions were not more similar when originating from the 
same sub-region than when originating from different sub-region (Fig 4.4B).  
 
 
Fig 4.4.  Mean percentile rank of within-region correlations in empirical null distributions.  Bars correspond to 
brain regions and bar length to mean percentile rank of correlations within the region, based on the appropriate 
simulated distribution.  Error bars show standard deviation.  Bar colors correspond to parent brain regions.  A.  
Correlations in null distribution are between expression profiles within the region and expression profiles from 
elsewhere in the brain.  Solid horizontal lines show the mean percentile rank within the parent region.  B.  
Correlations in null distribution are between expression profiles within the region and expression profiles from 
elsewhere within the parent region. 
 
4.3.3  Genome-scale correlation maps 
 The initial analysis of region-specific expression used the full list of 3,792 
orthologous genes to generate correlation maps (by the procedure schematized in Fig 
4.1).  Maximum intensity projections (Fig 4.5) show the similarity between an average 
expression profile from a human brain “seed” region (from one donor brain) and all 
voxels in the mouse brain.  These correlation maps show a varying degree of anatomical 
specificity, as anticipated from sample-based correlation results above (e.g., the human 
striatum profile has particularly high correlations with mouse striatal voxels). 
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Fig 4.5.  Maps of mouse voxel correlations with human seed regions.  Correlation maps for 11 broad brain 
regions, generated using left-hemisphere samples from a single donor (H0351.2002).  Correlation maps are 
shown as maximum intensity projections in each of the cardinal planes, in which the value at a given location in 
the two-dimensional plane is the maximum value found along the perpendicular axis at that location.  Mouse 
homologs to human seed regions are outlined in blue in the left hemisphere.  Bar plots show mean correlations 
across voxels inside and outside the mouse homolog to the seed region (green and yellow bars, respectively), for 
all donors.  Individual bars correspond to human donors.  Error bars show standard deviation across voxels. 
 
 The PCCs inside the homologous mouse brain region were then compared to 
those outside the homolog in each human donor, yielding extremely consistent results 
(Fig 4.5, bar plots).  All broad seed regions showed modest but positive mean PCCs 
inside their homologs (for each donor brain), with the striatum yielding the highest mean 
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across donors (r = 0.34).  Most showed near-zero (and usually slightly negative) mean 
PCC values for voxels outside their homologs.  The human hippocampal formation 
profile yielded small positive values outside its homolog due to a tendency towards 
positive PCCs with cortical, amygdalar, and striatal voxels (mean PCCs of 0.16, 0.10, 
and 0.07, respectively).  Similarly, the human amygdala showed a small positive value 
due to positive mean PCCs for cortical, hippocampal, and striatal voxels (mean PCCs of 
0.08, 0.09, and 0.09).  
4.3.4  Homology scores of candidate gene sets 
 Next we sought to quantify the degree to which specific sets of genes provided 
region-specific, cross-species homologies, based on the anatomical specificity of the 
calculated correlation maps.  Sets of genes were determined in either a data-driven 
manner using WGCNA or based on curated annotations. 
4.3.5  Data-driven sets 
 WGCNA applied to the region-averaged mouse expression data resulted in 31 
gene sets; see Fig 4.6 for dendrogram.  Un-penalized homology scores and penalties (see 
Equations 5 and 6) for the full list of 3,792 genes and for each of the 31 data-driven gene 
sets are shown in Fig 4.7 for each of the 11 broad seed regions.  For all seed regions, 
there were one or more gene sets that provide a higher un-penalized homology score than 
the full gene set.  Penalties were then subtracted from the un-penalized scores for each 
gene set.  After enforcing the penalty, at least one gene set per seed region increased the 
homology score relative to the full gene set, with the exception of the cerebral cortex.  
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Homology scores were then converted into percentile ranks, with average ranks across 
donors (in comparison to an empirical null distribution) shown in Fig 4.8A. 
 
 
 
Fig 4.6.  Dendrogram resulting from hierarchical clustering of genes using WGCNA on mouse data after 
averaging into the 10 broad regions shown in Table 1, with striatum and pallidum treated as a single structure.  
Dissimilarity is based on topological overlap.  Colors of horizontal band correspond to gene sets. 
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Fig 4.7 (cont. on next page).  Un-penalized homology scores and penalties of full gene list and data-driven 
subsets.  Green bar height indicates average un-penalized score across the six human donors.  Orange bar height 
indicates average penalty.  Yellow dots represent individual donors. 
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Fig 4.7 (cont. on next page).  Un-penalized homology scores and penalties of full gene list and data-driven 
subsets.  Green bar height indicates average un-penalized score across the six human donors.  Orange bar height 
indicates average penalty.  Yellow dots represent individual donors. 
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Fig 4.7.  Un-penalized homology scores and penalties of full gene list and data-driven subsets.  Green bar height 
indicates average un-penalized score across the six human donors.  Orange bar height indicates average penalty.  
Yellow dots represent individual donors. 
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Fig 4.8.  Homology score percentile ranks (in empirical null distributions) of data-driven gene sets.  Color bar 
applies to both panels.  White indicates chance (50th percentile) performance.  Yellow outlines indicate values of 
80th percentile or above.  A.  Broad regions.  B.  Sub-structures of the hippocampal formation, striatum, globus 
pallidus, and cerebellum. 
 
 In general, there was a sparse pattern of data-driven gene sets that provided strong 
homology scores for individual brain regions when compared to random gene sets. We 
established a threshold for identifying possible sets of interest for further investigation at 
the 80th percentile, with sets surpassing this threshold for any brain region highlighted in 
yellow in Fig 4.8.  Seven seed regions showed between one and five gene sets which 
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scored at or above this threshold.  For the most part, different gene sets yielded high 
percentile ranks for different brain regions (though there were exceptions; e.g., Sets 3 and 
23 in the globus pallidus, midbrain, and pons).  No data-driven gene sets scored at or 
above the 80th percentile for the cerebral cortex, hypothalamus, striatum, or medulla.  
This was due in part to the penalty term 𝜆 (Equation 5), which decreased the score when 
a relatively high concentration of correlations occurred in a specific non-homolog region 
of the mouse brain.  When un-penalized homology scores were compared to distributions 
of un-penalized scores from the randomly selected gene sets, at least one data-driven 
gene set met the cutoff for each of these seed regions except the cerebral cortex, for 
which the highest-ranking gene set was at the 77th percentile.  In one extreme example, 
Set 22's percentile rank for the striatum increased from 70 to 99.88 when it was no longer 
penalized for similarity to the pattern of expression in the globus pallidus. 
 For a subset of brain regions, homology scores were additionally computed for 
each of their sub-structures according to the Allen Reference Atlas hierarchy (Fig 4.8B).  
In some cases, a gene set showed a high rank for only some portion of the larger structure 
(e.g., Set 2 for the subiculum only); in others, a gene set maintained high ranks 
throughout the larger structure (e.g., Set 29 for the CA fields, dentate gyrus, and 
subiculum).  Fig 4.8B also shows that results for the striatum and cerebellum as a whole 
were largely determined by the caudoputamen and cerebellar cortex, respectively. 
4.3.6  Annotation-based sets 
 Three candidate gene sets were defined using neuron, oligodendrocyte, and 
astrocyte markers of the postnatal mouse brain (Cahoy et al., 2008).  Eleven additional 
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gene sets were defined by identifying over-represented annotations in the 14 data-driven 
gene sets which had a mean percentile rank of at least 80 for at least one broad seed 
region (Fig 4.8A).  Of the 255 annotations that were over-represented in these sets (FDR-
adjusted p-value < 0.01), 11 were selected to form candidate gene sets (Table 4.2). 
 
Name in MSigDB (Abbreviation) Description Enriched data-driven set 
REACTOME_OPIOID_SIGNALLING (OP)1, 2  48 genes Set 23 (5 occurrences) 
KEGG_LONG_TERM_POTENTIATION 
(LTP)3, 4 
32 genes Set 3 (9 occurrences) 
CIRCADIAN_RHYTHM (Circ)5  8 genes  Set 3 (5 occurrences) 
BLALOCK_ALZHEIMERS_DISEASE_DN 
(Alzdn)6  
461 genes down-regulated 
in human hippocampus 
with Alzheimer's Disease 
Set 3 (50 occurrences); 
Set 18 (14 occurrences) 
MCCLUNG_COCAINE_REWARD_5D (Coc)7 41 genes up-regulated in 
mouse nucleus accumbens 
after 5 days cocaine 
treatment 
Set 22 (11 occurrences) 
LU_AGING_BRAIN_DN (FLdn)8  77 genes down-regulated 
in human frontal lobe with 
age 
Set 18 (4 occurrences) 
LEE_AGING_CEREBELLUM_DN (CBdn)9  27 genes down-regulated 
in mouse cerebellum with 
age 
Set 18 (3 occurrences) 
LEIN_PONS_MARKERS (Po)10  63 genes  (those appearing 
in the current data) out of 
the 100 most specific to 
mouse pons 
Set 10 (31 occurrences) 
LEIN_MIDBRAIN_MARKERS (Mb)10  57 genes  out of the 100 
most specific to mouse 
midbrain 
Set 23 (8 occurrences) 
LEIN_MEDULLA_MARKERS (Med)10 53 genes  out of the 100 
most specific to mouse 
medulla 
Set 10 (23 occurrences) 
MODY_HIPPOCAMPUS_POSTNATAL 
(HFpost)11 
31 genes up-regulated in 
mouse postnatal 
hippocampus 
Set 18 (3 occurrences) 
Table 4.2.  Annotation terms selected to define new candidate gene sets.   Description field includes the number 
of genes with this annotation found in the list of 3,792 genes used here.  All annotations were over-represented 
with FDR-corrected p < 0.01 in the specified data-driven set (i.e., WGCNA module). 
1. Croft et al. (2014).  2. Milacic et al. (2012).  3. Kanehisa and Goto (2000).  4. Kanehisa et al. (2014).  5. 
Ashburner et al. (2000).  6. Blalock et al. (2004).  7. McClung and Nestler (2003).  8. Lu et al. (2004).  9. Lee et al. 
(2000).  10. Lein et al. (2007).  11. Mody et al. (2001). 
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 Percentile ranks of homology scores for all annotation-based gene sets are shown 
in Fig 4.9.  Neuron markers met or exceeded the 80th percentile for all regions except the 
hippocampal formation and the thalamus.  Analysis of hippocampal sub-structures shows 
that the neuron markers in fact yielded high region-specific correspondence for the 
dentate gyrus (99th percentile), but lower ranks for the CA fields and subiculum (Fig 
4.10).  This was due to a penalty for similarity to the cortex, causing the mean rank to 
drop from 91st to 66th for the CA fields, 92nd to 32nd for the subiculum, and 98th to 
74th for the hippocampal formation as a whole.  In the thalamus, even the un-penalized 
scores for neuron markers ranked, on average, only at the 42nd percentile. 
 
 
Fig 4.9.  Homology score percentile ranks of annotation-based gene sets for broad seed regions.  Bar height 
indicates average percentile rank across the six human donors; yellow dots are values for individual donors.  
Bar colors for cell-type marker sets correspond to Fig 4.13.  Grey shaded area denotes the 80th to the 95th 
percentile, and darker grey the 95th to 100th percentile values for random gene sets of the same size.  See Table 
4.2 for full names and descriptions of gene sets. 
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Fig 4.10.  Homology score percentile ranks of annotation-based gene sets for sub-structures of four broad 
regions.  Bar height indicates average percentile rank across the six human donors; yellow dots are values for 
individual donors.  Grey shaded area denotes the 80th to the 95th percentile, and darker grey the 95th to 100th 
percentile values for random gene sets of the same size.  See Table 4.2 for full names and descriptions of gene 
sets. 
 
 Homology scores for oligodendrocyte and astrocyte markers not only had low 
percentile ranks for most regions, but were almost always negative before being 
converted to percentile ranks.  Exceptions included oligodendrocyte markers in the 
amygdala and globus pallidus, the only two regions where either glial gene set showed 
homology scores with relatively high ranks compared to random gene sets (mean score 
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and rank 0.09 and 88th percentile for amygdala; 0.16 and 92nd percentile for globus 
pallidus). 
 For the most part, the other 11 annotation-based sets showed more variable results 
across the broad regions.  However, a striking number of annotation-based sets showed 
high region-specific correspondence for the striatum, globus pallidus, and cerebellum.  
This tendency appeared to be common to the three human striatal sub-structures and to 
the external and internal globus pallidus, but within the cerebellum it was specific to the 
cerebellar cortex (Fig 4.10). 
 For each of the other broad regions, at least one of these 11 annotation-based sets 
yielded a percentile rank of at least 80 (Fig 4.9).  In the cerebral cortex, for example, 
genes that have been found to be down-regulated in the aging human frontal lobe 
(“FLdn”; Lu et al., 2004) had a percentile rank of 97, notably higher than any of the data-
driven gene sets.  For the hippocampal formation, both FLdn and a set of genes down-
regulated in aging mouse cerebellum (“CBdn”; Lee et al., 2000) exceeded the 90th 
percentile.  The thalamus showed the strongest region-specific correspondence with 
mouse midbrain marker genes  (“MB”; Lein et al., 2007) and the hypothalamus with 
genes downregulated in the human hippocampus with Alzheimer's disease (“AlzDn”; 
Blalock et al., 2004).  Both gene sets ranked at the 99th percentile. 
 Genes involved in the long-term potentiation pathway (“LTP”; Kanehisa and 
Goto, 2000; Kanehisa et al., 2014) showed high percentile ranks for most regions, with a 
mean percentile rank of ~75 across the 11 seed regions.  The most striking exceptions, 
however, were the cerebral cortex, hippocampal formation, and globus pallidus (11th, 
  
89 
51st, and 56th percentile).  For the cerebral cortex and hippocampal formation, this was 
due to high penalties for similarity to the striatum (un-penalized scores ranked at the 99th 
and 86th percentile, respectively). 
4.3.7  Effects of penalty term and regional expression 
 Fig 4.11 shows homology score percentile ranks obtained using the penalty term 
(Equation 5) against percentile ranks obtained without it.  The penalty term sometimes 
had the effect of increasing percentile rank, and sometimes of decreasing it. 
 
 
Fig 4.11.  Homology score percentile rank against un-penalized score percentile rank.  Each datapoint results 
from one gene set for one brain regions.  Dashed horizontal and vertical lines mark the 80th percentile.  Dashed 
diagonal line runs from (0, 0) to (1, 1). 
 
 Fig 4.12 compares gene sets' homology scores for each broad region to their mean 
expression in that region (after converting both values to percentile ranks).  Most 
homology scores that rank over the 80th percentile occur in a brain region where the gene 
set showed either much lower or much higher expression than in other regions. 
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Fig 4.12. Homology score percentile rank against mean expression percentile rank.  Each datapoint represents 
results from one gene set for one brain region.  Mean expression percentile ranks that use human data are 
averaged across human donors (as are homology score percentile ranks).  Dashed horizontal lines show the 80th 
and 95th percentiles for homology scores. 
 
4.3.8  Brain-wide similarity across species 
 Finally, we analyzed the similarity of cross-species, brain-wide gene expression 
profiles for individual genes and for sets of cell-type marker genes.  Fig 13A shows the 
distribution of PCCs between each gene’s expression pattern (summarized into 16 
regions) across the human brain and its corresponding expression pattern across the 
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mouse brain (quartiles at -0.09, 0.24, 0.56).   For cell-type markers, the median PCC 
between a gene's expression profile across the human brain and its profile across the 
mouse brain was 0.65 for neuron markers, 0.63 for oligodendrocyte markers, and -0.18 
for astrocyte marker genes. When compared to an empirical chance distribution of 
average PCCs of 10,000 randomly selected gene sets of the same size, the percentile 
ranks of these values were 100 for neuron markers (higher than all random gene sets), 
~99 for oligodendrocyte markers, and 0.0001 for astrocyte markers. 
 
Fig 4.13.  Cross-species correlations and expression heatmaps of orthologous genes.  A.  Distribution of 
correlations between brain-wide expression profiles for orthologous genes.  Dashed orange lines mark the 5th 
and 95th percentiles.  Orange triangle indicates distribution median.  Cross-species correlations for cell-type 
markers are represented below, with median correlation for each group of cell-type markers indicated by a 
triangle.  B.  Heatmap of human brain-wide expression patterns of genes with cross-species correlations in the 
top 5%.  Genes are ordered by clusters obtained by hierarchical clustering of their human expression patterns.  
C.  Mouse brain-wide patterns of the same genes shown in B, in the same order. 
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 The top 5% of gene-gene PCCs ranged from 0.83 to 0.98.  Heatmaps of these 190 
genes’ expression patterns across the human and mouse brain show clusters of genes with 
higher expression values for the striatum, or hypothalamus, or cerebellar cortex than for 
the other regions (Fig 4.13).  Other genes were most strongly expressed in multiple 
regions, such as the cerebral cortex, hippocampal formation, and to a lesser extent the 
amygdala, or for these regions together with the striatum.  Finally, one cluster of genes 
showed slightly higher expression in the globus pallidus, thalamus, midbrain, pons, 
medulla, and cerebellar nuclei than in the rest of the human brain, though this cluster's 
preferences for those structures were less apparent in the mouse brain. 
 Table 4.3 shows the median within-species PCC for each group of cell-type 
marker genes.  Although these values were low, they were higher than for randomly 
selected genes, with the exception of astrocyte markers in the mouse.  Brain-wide 
expression patterns of neuron and oligodendrocyte markers are shown in Fig 4.14.  
Overall, neuron markers had their strongest expression in the cortex and hippocampal 
formation, and to a lesser extent the amygdala, of both species.  Oligodendrocyte markers 
showed higher expression in the brainstem and cerebellar nuclei. 
 
Cell type Human 
(samples) 
Human (region 
averages) 
Mouse (voxels) Mouse (region 
averages) 
Neuron 0.20 (100) 0.28 (100) 0.19 (100) 0.28 (99.9) 
Oligodendrocytes  0.34 (100) 0.46 (100) 0.19 (99.0) 0.32 (96.9) 
Astrocytes 0.14 (99.9) 0.26 (99.9) 0.05 (41.2) 0.16 (62.9) 
Table 4.3.  Within-species correlations of mouse cell-type markers.  The median of all correlations between the 
markers for a cell type is followed in parentheses by the percentile rank of that median correlation in a 
distribution of 10,000 randomly selected gene sets. 
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Fig 4.14 (cont. on next page).  Heatmaps of human and mouse brain-wide expression patterns of mouse cell-type 
marker genes.  Color scale is consistent across panels.  Expression in human brain regions was averaged across 
donors.  *In panel B, note that Sst has NaN values for all voxels of CbCtx and CbN in the AMBA. 
  
94 
 
Fig 4.14.  Heatmaps of human and mouse brain-wide expression patterns of mouse cell-type marker genes.  
Color scale is consistent across panels.  Expression in human brain regions was averaged across donors. 
 
4.3.9  Annotations of genes with high correlations across species 
 45 annotations were over-represented in the 5% most-correlated genes (FDR-
corrected p-value < 0.01; Table 4.4).  These included long-term potentiation, long-term 
depression, calcium signaling (Kanehisa and Goto, 2000; Kanehisa et al., 2014), 
glutamate signaling, nerve impulse transmission, and synaptic transmission (Ashburner et 
al., 2000).  Highly-correlated genes also showed over-representation of several 
annotations curated from publications, including some that were used previously to 
define annotation-based gene sets such as genes down-regulated in human frontal cortex 
with age (Lu et al., 2004), genes involved in the mouse nucleus accumbens’ response to 
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cocaine treatment (McClung and Nestler, 2003), and genes down-regulated in human 
hippocampus with Alzheimer's Disease (Blalock et al., 2004). 
 
Annotation term in MSigDB Associated genes 
in dataset 
Occurrences in gene 
set 
KEGG_LONG_TERM_POTENTIATION 32 13 
GLUTAMATE_RECEPTOR_ACTIVITY 17 8 
LU_AGING_BRAIN_DN 77 17 
REACTOME_NEURONAL_SYSTEM 175 27 
CAHOY_NEURONAL 71 16 
REACTOME_TRANSMISSION_ACROSS_CHEMICA
L_SYNAPSES 
130 21 
REACTOME_UNBLOCKING_OF_NMDA_RECEPTO
R_GLUTAMATE_BINDING_AND_ACTIVATION 
12 6 
V$RFX1_02 86 16 
REACTOME_NEUROTRANSMITTER_RECEPTOR_
BINDING_AND_DOWNSTREAM_TRANSMISSION_
IN_THE_POSTSYNAPTIC_CELL 
97 17 
IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVIT
Y 
10 5 
BLALOCK_ALZHEIMERS_DISEASE_DN 461 44 
KEGG_CALCIUM_SIGNALING_PATHWAY 98 16 
GLUTAMATE_SIGNALING_PATHWAY 16 6 
KEGG_LONG_TERM_DEPRESSION 29 8 
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 197 24 
REACTOME_CREB_PHOSPHORYLATION_THROU
GH_THE_ACTIVATION_OF_CAMKII 
8 4 
REACTOME_TRAFFICKING_OF_AMPA_RECEPTO
RS 
18 6 
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 32 8 
BIOCARTA_CK1_PATHWAY 13 5 
GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD
8_TCELL_UP 
67 12 
STARK_PREFRONTAL_CORTEX_22Q11_DELETIO
N_UP 
78 13 
BIOCARTA_NOS1_PATHWAY 14 5 
MCCLUNG_DELTA_FOSB_TARGETS_8WK 27 7 
YOSHIMURA_MAPK8_TARGETS_UP 453 41 
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_A
LS 
28 7 
LEIN_OLIGODENDROCYTE_MARKERS 44 9 
MIKKELSEN_MEF_HCP_WITH_H3K27ME3 240 26 
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MODULE_26 55 10 
REACTOME_ACTIVATION_OF_NMDA_RECEPTOR
_UPON_GLUTAMATE_BINDING_AND_POSTSYNA
PTIC_EVENTS 
22 6 
REACTOME_RAS_ACTIVATION_UOPN_CA2_INFU
X_THROUGH_NMDA_RECEPTOR 
10 4 
TRANSMISSION_OF_NERVE_IMPULSE 107 15 
PLASMA_MEMBRANE 497 43 
MEISSNER_NPC_HCP_WITH_H3K4ME2 194 22 
ST_G_ALPHA_I_PATHWAY 16 5 
V$NRSF_01 58 10 
MODULE_20 24 6 
MCCLUNG_COCAINE_REWARD_5D 41 8 
DOANE_BREAST_CANCER_ESR1_DN 18 5 
KEGG_GAP_JUNCTION 42 8 
METABOTROPIC_GLUTAMATEGABA_B_LIKE_RE
CEPTOR_ACTIVITY 
7 3 
MODULE_415 7 3 
PID_IL8CXCR1_PATHWAY 7 3 
REACTOME_TRAFFICKING_OF_GLUR2_CONTAIN
ING_AMPA_RECEPTORS 
12 4 
SYNAPTIC_TRANSMISSION 104 14 
WATANABE_COLON_CANCER_MSI_VS_MSS_UP 7 3 
Table 4.4.  Annotations over-represented in genes with cross-species correlations in the top 5%.  These terms 
were over-represented with p < 0.01 after correction using FDR. 
  
4.4 Discussion 
 Previous studies have used neuroanatomically-linked gene expression data to 
elucidate the tight relationship between molecular and conventional neuroanatomy and 
have shown that some aspects of this relationship (i.e., specific genes that are 
differentially expressed between pairs of homologous brain regions) persist across 
species as closely related as human and chimpanzees (Khaitovich, 2004; Oldham et al., 
2006) and as distantly related as humans and birds (Pfenning et al., 2014).  Here, we have 
advanced understanding of the correspondences between the molecular neuroanatomical 
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architecture of the human and mouse brain in several ways.  The present study used high-
resolution datasets from the AIBS to enable a direct, systematic comparison of adult 
human and mouse gene expression in a set of 11 broadly defined regions and several 
finer sub-regions throughout the brain.  We developed and applied methods which 
support three approaches to quantifying these comparisons.  The first was global, 
comparing high-dimensional gene expression profiles from each location in the brain of 
one species to expression profiles from all locations in the brain of the other.  The second 
approach was designed to evaluate similar expression patterns between the human and 
mouse brain that are specific to a brain region.  We identified distinct subsets of genes 
which preferentially drive this molecular similarity for different regions, while other 
subsets show negligible similarity for the same region.  Third, we took a gene-centered 
approach, examining the similarity between a gene’s spatial expression pattern across the 
human brain with its orthologous pattern across the mouse brain.  These three approaches 
in sum reveal a highly structured relationship between gene expression profiles 
throughout the human and mouse brains.  They also demonstrate that this relationship – 
and in turn the similarity of the local molecular “environment” – varies considerably, not 
only in its overall strength, but in which genes are co-expressed in similar ways in each 
brain region. 
4.4.1  Brain-wide comparisons of expression profiles 
 Similarities between gene expression profiles from throughout the human and 
mouse demonstrate how the local molecular architecture corresponds with conventional 
neuroanatomical boundaries.  We found this correspondence, based on our full set of 
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3,792 orthologous genes, to vary by neuroanatomical region and by species, but its broad 
outlines appeared in cross-species comparisons as well as the within-species study 
described in Chapter 3.  Correlations between profiles from the two different species 
were overall lower than correlations within-species (compare Fig 4.2 to Fig3.3).  This 
may be a result of comparing microarray data (the AHBA) to ISH data (the AMBA).  Lee 
et al. (2008) found relatively low correlations between the AMBA and microarray data 
from adult mouse brains of similar strains (~0.4-0.5 for most brain regions).  The authors 
suggested that this was due to differences in dynamic range and signal detection 
thresholds for the two types of data. 
 The neuroanatomical organization shared by the two species was, however, 
similar to that appearing within-species in Chapter 3, at both broad and fine scales.  The 
cerebral cortex, hippocampal formation, amygdala, and striatum showed some 
transcriptomic similarity across species that is not shared with the rest of the brain, as did 
the midbrain, pons, and medulla (Figs 4.2 and 4.3A).  The striatum stands out with the 
highest within-region correlations of the broad brain regions, reflecting its consistent 
cellular architecture, while the amygdala and brainstem structures have lower within-
region correlations (Fig 4.3C; note that these lower correlations were still higher than 
expected by chance as shown in Fig 4.4A).  The lack of enhanced transcriptional 
similarity between the thalamus and hypothalamus seen in Chapter 3 also appears in Figs 
4.2 and 4.3A.  The cerebellum remained distinct from other structures, showing a highly 
positively skewed distribution of cross-species correlations only when samples and 
voxels were both chosen from the cerebellum (Fig 4.3A), consistent with the findings of 
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Strand et al. (2007).  Altogether, the relationships that emerge in both within- and across-
species correlation heatmaps point to the developmental plan discussed in Chapter 1.1, 
the basic divisions of which are common to vertebrate brains (Sanes et al., 2012, Ch. 2).  
 Transcriptomic organization seen within both the mouse and human brain in 
Chapter 3 showed cross-species correspondence at a slightly finer scale as well.  Finer 
neuroanatomical regions tended to show somewhat stronger cross-species similarity than 
their parent regions (Figs 4.2 and 4.3); additionally, cross-species similarity within a 
parent region was nearly always significantly greater between homologous than non-
homologous sub-regions. 
4.4.2  Region-specific homology scores 
 We next considered the question of region-specific homology not only using the 
full list of 3,792 orthologous genes but also focusing on groups of genes that might show 
enhanced similarity for different neuroanatomical entities.  Candidate gene sets were 
evaluated in each brain region using a homology score, which provided a continuous 
measure of the extent to which a group of genes encoded a cross-species consistent, 
region-specific "fingerprint."  The full gene list provides such a fingerprint, to some 
extent, for most broad brain regions in that the human region's mean expression profile 
tends to have slightly higher correlations with voxels inside its mouse homolog than 
voxels in other regions (Fig 4.5).  We began with the assumption that these enhanced 
correlations between homologous samples may be driven by different genes for different 
brain regions since each region may require a distinct, though likely overlapping, set of 
gene products that specify its structure and function.  Our approach was not designed to 
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identify a unique gene set responsible for enhanced cross-species similarity for each brain 
region.  Instead, gene sets and brain regions may have a many-to-many relationship in 
which (a) multiple gene sets provide strong signatures for the same region, and (b) the 
same gene set may provide enhanced cross-species similarity for multiple brain regions. 
 The latter possibility can occur if the same gene set provides uncorrelated 
expression profiles for distinct brain regions (i.e., the genes are expressed in a different 
pattern in the two areas).  The penalty term 𝜆 (see Equation 5) enforces the idea that the 
“signature” provided by a given gene set must be uncorrelated with its signatures for 
other regions by decreasing the homology score to the extent that it shows enhanced 
similarity between a human region and a non-homologous mouse region.  For example, 
data-driven Gene Set 23 provides relatively high homology scores for the globus pallidus, 
midbrain, and pons (Fig 4.8A); these homology scores would be reduced if, for example, 
the pattern in which these genes are expressed in the human globus pallidus was highly 
correlated with their expression pattern in the mouse midbrain or pons. Instead, the gene 
set simply provides a “basis” for comparison, with each of the human brain signatures 
defined over that basis both sufficiently distinct from one another and sufficiently similar 
with expression vectors defined over that basis in the homologous mouse brain regions.  
The penalty term also had the unexpected result of sharply increasing percentile ranks for 
certain gene sets primarily because they reduce this kind of "cross-region similarity" as 
compared to chance, particularly for several data-driven sets (i.e., those grouped by 
within-mouse brain-wide co-expression relationships), which showed strong homology 
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scores for the hippocampus only when their unusually low similarity with mouse cortex 
was taken into account by the application of the penalty (Fig 4.11). 
 This region-specific approach is not oriented toward individual genes which mark 
a given brain region in both species, but towards groups of genes whose products may 
have consistent region-specific interactions.  The gene groups tested often showed a 
tendency towards particularly high or low expression values for the brain region in 
question (Fig 4.12), but did not simply contain anatomical marker genes.  In fact, a set of 
genes which all have similar standardized expression values for that region (i.e., a 
relatively “flat” profile) in either species will result in cross-species correlations that may 
be dominated by noise, even if those expression values are large.  The use of correlation 
as the measure of similarity is best suited to identifying gene sets with diverse expression 
values within a given region and its homolog.  These diverse expression values reflect the 
complex, local biological environment within the region, including cell type populations 
of varying densities.  Because expression of a gene depends on many such complex local 
interactions, the identification of consistent local molecular environments defined over a 
set of genes may help to improve our understanding of the appropriateness of knockdown 
/ knockout mouse models of human brain disorders and the effectiveness of 
pharmacological agents that implicitly target specific brain regions. 
4.4.3  Data-driven candidate gene sets 
 Gene sets were defined based on the organization of their brain-wide expression 
patterns in the mouse using WGCNA (Fig. 4.6; Langfelder and Horvath, 2008).  
WGCNA, as applied here, groups genes whose expression patterns show spatial 
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correlations at a broad scale, suggesting potential functional relationships between genes 
assigned to the same module or set.  This approach has the advantage of being a 
discovery method, open to influence by gene-gene relationships that have not yet been 
identified, but which may be important in a local neuronal environment.   However, a 
disadvantage of this approach is limited biological interpretability:  that is, to the extent 
that we do not know specific functions or pathways underlying gene groupings, we 
likewise cannot identify conserved functions that underlie a high homology score. 
 Using this approach, specific gene sets were found that enhanced molecular 
similarity (relative to random gene sets) very strongly for some regions, moderately for 
others, and not at all for the cerebral cortex (Figs 4.7, 4.8).  This variability does not 
appear to correspond with higher or lower variability across the six individual human 
donors.  For example, neither the cerebral cortex nor the striatum showed especially high 
homology scores for any gene set, yet neither had particularly high variability across 
donors (their highest cross-donor interquartile rank for any data-driven set was 0.35 and 
0.14, respectively, which was lower than most other broad regions).  Because there was a 
tendency toward reduced variation in standardized expression values across the cortex 
relative to subcortical regions, co-expression relationships in the latter structures may 
have played a relatively dominant role in the creation of modules in WGCNA.  Overall, it 
is not clear why using WGCNA in this way yielded gene sets with region-specific 
similarity for some brain regions and not others, but it is possible that other approaches to 
clustering genes might reveal different gene sets with stronger homology scores for some 
regions. 
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 For further interpretation of the WGCNA-based gene sets, we used the g:Profiler 
online tool (Reimand et al., 2016) to assess enrichment of Gene Ontology annotation 
terms including "IEAs", or "Inferred from Electronic Annotations" (which are 
automatically assigned and have not been reviewed by a curator).  Using this option and a 
background set consisting of the full list of 3,792 genes, a majority of data-driven sets 
were enriched for several brain-related annotations from the Gene Ontology.  In 
particular, Set 3 over-represented a substantial number of annotations related to functions 
that occur in many areas of the brain (e.g., dendrite development, synaptic transmission, 
and postsynaptic density; note that Set 3 was also enriched for LTP-related genes in the 
previous analysis using MSigDB), and very few GO annotations that are not brain-
related.  Interestingly, Set 3 had higher-ranking homology scores for regions throughout 
the brain than most other data-driven sets (Fig 4.8).  A few GO terms that were over-
represented in data-driven sets have associations with specific regions; for example, 
learning and memory (Set 3), diencephalon development (Set 20) , and response to 
cocaine (Set 23).  However, the only one of these with a clear relationship to a region 
where the gene set showed strong correspondence was diencephalon development (Set 20 
had a percentile rank of 88 for the thalamus). 
4.4.4  Cell-type markers as candidate gene sets 
 Varying distributions of cell types are central to the differentiation of brain 
structures.  Genes whose expression marks certain cell types are thus natural candidates 
for assessment using our homology score.  Neuron markers showed strong region-
specific correspondence in nearly all regions (Fig 4.9).  The relatively weak 
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correspondence of neuron markers for the hippocampal formation as a whole results from 
reduced similarity of the CA fields and subiculum rather than the dentate gyrus (Fig 
4.10), and is due to a strong penalty for similarity to the cerebral cortex (i.e., neuron 
markers are expressed similarly in hippocampus and cortex).  The low correspondence of 
neuron markers for the thalamus is notable, reflecting surprisingly weak correlations in 
cross-species expression profiles defined across neuron marker genes (the mean 
correlation within the mouse thalamus was 0.17, which ranked at the 40th percentile 
relative to random gene sets.)  It is possible that thalamic nuclei with different neuron 
populations have varying degrees of cross-species correspondence, resulting in relatively 
weak correspondence for the thalamus as a whole.  It is also possible that thalamic sub-
structures were sampled differently in the two species, to a greater extent than other brain 
structures which include many nuclei. 
 Astrocyte markers, on the other hand, provided homology scores that were near or 
below chance (random gene sets) for all regions (Fig 4.9).  These results are consistent 
with a comparison of co-expression relationships from Hawrylycz et al. (2015), in which 
modules of genes that were co-expressed in the Allen Human Brain Atlas were assessed 
for preservation in the Allen Mouse Brain Atlas.  In that analysis, better-preserved 
modules showed higher proportions of neuron markers, while the module containing 
predominantly astrocyte markers was poorly preserved.  Astrocytes in the human and 
rodent show structural, functional and molecular differences (Oberheim et al., 2006, 
2009), and evidence of these differences has been found previously in large gene 
expression datasets (Miller et al., 2010).  It is possible that astrocyte markers identified in 
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the mouse, as these were, may simply not provide strong cell type specific markers in the 
human brain.  Our results support a much stronger conservation of neuron-specific 
markers, which are expressed in relatively unique, but cross-species consistent, patterns 
across brain areas.   
4.4.5  Other annotation-based candidate gene sets 
 We additionally identified over-represented annotations across the high-scoring 
data-driven gene sets.  We hypothesized that such annotations would reveal some of the 
highly conserved functions and pathways that drove high homology scores.  If over-
represented attributes are important to cross-species homologies (i.e., due to conserved 
local functions), then the more complete list of genes associated with an annotation might 
serve as an even stronger basis for molecular similarity.  Over-represented annotations 
from the MSigDB for the data-driven gene sets, however, included many general terms 
that could not be clearly related to the brain or nervous system function.  This was 
expected, of course, as many groups of genes work together throughout the body, and 
genes may take on different roles in different tissues.  Therefore, the process of selecting 
which annotations (and resulting gene sets) to examine further was necessarily somewhat 
subjective.  However, the selected annotations included many of those with a clear 
relationship to brain function. 
 Homology scores for these gene groups showed a different pattern from those for 
the data-driven gene sets or cell-type markers (Fig 4.9).  Here, most gene sets showed 
variable performance across the eleven broad regions (unlike cell-type marker sets), 
while nearly all broad regions examined showed multiple gene sets ranking at or above 
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the 80th percentile (unlike our data-driven sets).  One possible reason for the general 
trend toward increased homology scores for the annotation-based gene sets is that genes 
chosen were, in effect, required to have established brain functions.  It is important to 
note that gene sets with unexpectedly low homology scores may also provide important 
insights; for example, a group of genes previously shown to be down-regulated in the 
human hippocampus in Alzheimer's Disease (“Alzdn”; Blalock et al., 2004) showed 
reduced cross-species similarity specific to the hippocampus in comparison with 
randomly selected gene lists of the same size.  This suggests that products of these genes 
may function in distinct molecular environments in the mouse and human hippocampus, 
which should be considered in preclinical research that may target these genes. 
 In some cases, our results revealed enhanced similarity of gene expression 
profiles specific to certain brain regions with known functions that are associated with the 
annotation common to the genes in the set.  For example, a set of genes down-regulated 
with age in the human frontal lobe (“FLdn”; Lu et al., 2004) yielded a higher homology 
score than more than 96 percent of random gene sets of the same size in the cerebral 
cortex (Fig 4.9A).  This set includes genes involved in synaptic plasticity and neuronal 
survival, which, while functionally relevant for the cerebral cortex, are clearly relevant 
across all brain structures. Indeed, the “FLdn” set also scored highly for the hippocampal 
formation, striatum, and cerebellum.  
 A group of 41 genes whose expression in the mouse nucleus accumbens was 
shown to change in response to cocaine treatment (“Coc”; McClung and Nestler, 2003) 
showed strong region-specific similarity between the mouse and human striatum (Fig 
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4.9D).  This cross-species similarity was maintained for both the nucleus accumbens and 
the caudoputamen (Fig 4.10B).  Interestingly though, the human nucleus accumbens 
profile for this gene set has a similar average correlation with both mouse nucleus 
accumbens profiles (r ~ 0.43) and mouse caudoputamen profiles (r ~ 0.49).  The nucleus 
accumbens is a major reward center in the brain, implicated in addiction (Carlezon and 
Thomas, 2009).  McClung et al.'s finding that cocaine treatment regulates expression of 
these genes (McClung and Nestler, 2003) suggests that they are functionally important in 
the mouse nucleus accumbens.  Here, we have shown that these genes show similar co-
expression patterns that are unique to the striatum and are consistent in each of its sub-
structures, and which are conserved between the mouse and human brain.  Thus, these 
genes form the basis of a similar, functionally relevant molecular environment in the 
striatum of the two species, and directly suggest their relevance for mouse models of 
addiction.  Genes associated with this annotation were also over-represented in the only 
data-driven set whose homology score for the striatum ranked above the 50th percentile 
(Fig 8A). 
 Genes involved in the opioid signaling pathway ("Op") provided high homology 
scores for both the dorsal and ventral striatum.  Opioid receptors in the dorsal striatum 
have been implicated in ethanol consumption in rats (Nielsen et al., 2012), and more 
specifically, down-regulation in the dorsal striatum of the opioid peptides PDYN (in the 
gene set Op) and PENK (not in Op) has been implicated in alcoholism (Sarkisyan et al., 
2015).  In the ventral striatum, µ-opioid stimulation affects food intake, most likely 
through an effect on pleasurability of tastes (Kelley et al., 2002).  This gene set also 
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provided a relatively high homology score in the medulla, which includes centers where 
opioids are involved in pain modulation (Lovick, 1985; Fields, 2004), respiratory 
suppression (Lovick, 1985; White and Irvine, 1999; Montandon et al., 2011), and 
cardiovascular function (Lovick, 1985; Tjen-A-Looi et al., 2007).  However, without 
enough samples to analyze individual nuclei in the medulla, it is unclear which function 
or functions affected by the opioid signaling pathway may have contributed to this result. 
 On the other hand, three gene sets originally defined as marking the mouse 
midbrain, pons and medulla (“Mb”, “Po”, and “Med”; Lein et al., 2007) showed weak 
similarity for those specific regions (Fig 9).  In the source paper, the authors identified 
the 100 genes with expression patterns most specific to a given brain region in the 
AMBA, based on the ratio of voxels expressing the gene that were inside and outside the 
region.  The Mb, Po and Med gene sets were subsets of the top 100 genes identified for 
each structure (i.e., those which appear in our common gene set).  Lein et al. note, 
however, that the midbrain, pons, and medulla do not show strongly enriched expression 
even for their "top 100" genes; rather, the most-specific genes for each of these regions 
show brain-wide expression patterns that extend beyond the brain region in question. In 
this study, we found that these gene sets were expressed in different patterns across the 
corresponding regions in mouse and human, suggesting that strong expression in these 
brain regions in mouse does not necessarily predict strong expression in the homologous 
regions in human. 
 There were many cases in which the common annotation used to define a gene set 
had no obvious relationship to brain regions for which it received a high homology score.  
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The cerebellum showed a tendency towards high percentile ranks for nearly all the 
annotation-based gene sets.  FLdn, Coc, and Op are mentioned above for yielding high 
homology scores for brain regions with related functions; however, these sets also 
yielded high scores for other regions for which there is no obvious explanation.  We do 
not know what functions these genes may have in these regions, or why they show 
enhanced cross-species similarity for regions not clearly associated with the annotation.  
In these cases, the implicated molecular mechanisms remain as obscure as with the data-
driven gene sets. 
 In sum, the use of a region-specific homology score makes it clear that (i) there 
exists region-specific molecular similarity across species, and (ii) different sets of genes 
drive or enhance this specificity for different brain regions.  The interpretation of the 
results for any given subset of genes is, at this point, somewhat less clear, and will 
require further examination of known gene functions, gene-gene interactions, and the 
expected composition of each region’s underlying cell types. 
4.4.6  Gene-gene comparisons 
 The AHBA and AMBA together also enabled an analysis of the similarity of 
brain-wide expression profiles for orthologous genes across species. While the median 
correlation between orthologous gene expression patterns (summarized to a set of 16 
neuroanatomical regions spanning the brain) was slightly positive (~0.24), many genes 
had strongly positive or indeed negative correlations across species.  The overall 
distribution of cross-species PCCs was heavily skewed, with the bulk of the density 
focused on positive values (Fig 4.13A).  Highly correlated genes clustered into groups 
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that were preferentially expressed in different regions throughout the brain, suggesting 
their importance to brain-specific and region-specific functions (Fig 4.13B).  Many of the 
most correlated genes are known to be associated with evolutionarily ancient mechanisms 
important for brain function such as long-term potentiation (Sacktor, 2012), use of 
glutamate as a neurotransmitter (Tikhonov and Magazanik, 2009), and use of calcium as 
a signal transductor (Cai et al., 2015; Table 4.4).  Other genes with high cross-species 
similarity have shown changed expression associated with Alzheimer's Disease (Blalock 
et al., 2004), or aging in the human cortex (Lu et al., 2004).  This result suggests that 
normal or pathological processes can impact even the most conserved molecular 
environments, and that mouse models are an appropriate tool for studying how these 
processes impact such genes in the human brain.  Markers of mouse neurons and 
oligodendrocytes (Cahoy et al., 2008) showed strongly conserved brain-wide patterns as 
well, reflecting the similarly varying cell-type populations across the brains of the two 
species (Figs 4.13A, 4.14).  The brain-wide expression patterns of mouse astrocyte 
markers, however, differed between the human and mouse, echoing their weak region-
specific relationships (see "Cell-type markers as candidate gene sets", above).  While the 
region-specific analyses performed were designed to suggest conserved local 
mechanisms using the co-expression relationships between different genes, gene-centric 
studies offer a broader view of the conservation of expression patterns for specific genes 
of interest. Our results suggest cross-species similarities in the brain-wide expression of 
many genes implicated in a variety of brain functions, but also demonstrate an 
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exceptional amount of variability in the degree of conservation of anatomical expression 
patterns across the genome. 
4.4.7  Limitations and future directions 
 More complete interpretation of the present results, particularly those regarding 
region-specific molecular signatures, depends on knowledge of the functions of and 
relationships between both brain regions and genes.  There are many protein-coding 
genes whose functions remain unknown, and many more (indeed a majority) for which 
our knowledge about their roles in the brain is sparse.  Annotating the thousands of genes 
in the mammalian genome is a slow and arduous process; however, as these annotations 
accumulate, information regarding the functions of gene sets which provide consistent, 
cross-species molecular signatures for individual brain regions may enable new 
interpretations of our results.  Because it is not computationally feasible to assess all 
possible gene subsets for region-specific homology, other approaches to defining 
candidate gene sets may also be informative.  In particular, for each pair of homologous 
regions, one might apply optimization techniques, which would iteratively eliminate 
genes in order to optimize a region’s homology score (see, for example, a related 
application to find genes whose co-expression patterns correlate with anatomical 
connectivity; French and Pavlidis, 2011). 
 We have focused exclusively on two large, publicly accessible gene expression 
datasets, the Allen Human Brain Atlas and the Allen Mouse Brain Atlas.  Use of other 
gene expression datasets may offer opportunities to (i) assess generalization of the results 
to a larger human population (though we often observed a high degree of consistency in 
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our results across the six available donor brains) and to other strains of the lab mouse 
(Geurts et al., 2011; Sigmund, 2000), (ii) expand analyses of the neocortex by 
incorporating layer-specific information, which is not available in the AHBA , and (iii) 
ensure that findings are robust across expression data collected using different 
techniques, given that microarray data depend on the somewhat inconsistent 
correspondence between abundance of mRNA and protein level (Greenbaum et al., 
2003).  Further, gene expression is a dynamic process, and the available datasets require 
us to assume a meaningful “snapshot” of this process in the adult animal.  The expression 
of many genes changes rapidly and/or systematically during brain development as they 
regulate, among other things, the differentiation of brain areas (Johnson et al., 2009; 
Thompson et al., 2014).  Some local molecular environments may be similar or different 
across species for reasons that can only be understood by using data from earlier 
developmental stages to study the processes that created them.  Even in later stages, while 
the expression of some genes may remain stable in the brain through adulthood, others 
undergo transient changes in expression which no one gene expression dataset can 
illuminate (for example, the transcription factor c-FOS is expressed following neuronal 
activity; Kovács, 1998).  Other important considerations can only be addressed by 
looking beyond the present technologies.  Gene expression is influenced by alternative 
splicing events, which are ubiquitous in the brain (Grabowski, 1998).  Additionally, 
transcriptional regulatory networks (Vaquerizas et al., 2009; Ravasi et al., 2010) and 
post-transcriptional mechanisms (Day and Tuite, 1998) may also differ across species. 
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CHAPTER 5: THE TRANSCRIPTIONAL LANDSCAPE OF GENES 
IMPLICATED IN SPEECH AND LANGUAGE DISORDERS 
5.1 Introduction 
 Developmental disorders of speech and language are highly heritable, and over 
two dozen genes have been implicated in one or more of these pathologies.  There is an 
extensive body of work indicating that certain measures of speech and/or language ability 
are associated with DNA variants at loci within a given gene, or with structural variations 
of the chromosome which affect the gene (for two reviews, see Fisher et al., 2003; 
Graham et al., 2015).  However, the causal links between genotypic variations and 
phenotypic measures that capture speech and language function remain largely obscure.  
This chapter, which is an extension of previously published work (Bohland et al., 2014), 
reviews the putative associations between genes and speech / language abilities and uses 
gene expression data to suggest relationships between the neuroanatomical localization of 
implicated genes, and how these may be used to suggest hypotheses regarding the roles 
those genes play in speech / language function.  "Candidate" genes, curated from the 
literature on the genetics of speech and language and entered into a database described in 
the next section, are examined to determine where (if anywhere) in the brain they are 
preferentially expressed, and to characterize their co-expression relationships throughout 
the brain. 
 Speech and language disorders are nearly always polygenic: loci within many 
genes each exert a small degree of influence on variation of the phenotype (Fisher et al., 
2003).  These influences are characterized as "quantitative trait loci" (QTLs) and stand in 
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contrast to rare situations in which a variant in a single gene explains a disruption of 
normal speech or language function (e.g., a single FOXP2 mutation is causally implicated 
in developmental verbal dyspraxia, or DVD, in ~2% of cases; MacDermot et al., 2005).  
The predominance of statistically weak QTLs among genetic influences on speech and 
language disorders (and neurological and neuropsychiatric disorders more broadly) poses 
a challenge, since the identification of multiple loci with small effects requires more 
studies with higher statistical power than do monogenic influences.  Indeed, nearly all the 
genotype-phenotype associations reviewed in this chapter were found in only a small 
percentage of the cohorts studied (e.g., mutations in NAGPA and GNPTG were found in 
only 2% and 4% of subjects with persistent developmental stuttering, or PDS, 
respectively; Kang et al., 2010).  Just as a given phenotype may have multiple genetic 
influences, a given gene may influence multiple phenotypes, and these may range from 
cognitive abilities to basic cellular functions.  For example, NAGPA and GNPTG, with 
another PDS candidate (GNPTAB; Kang et al., 2010), are involved in directing enzymes 
to the lysosome, which affects cellular processes such as waste disposal (Settembre et al., 
2013).  Thus, although the phenotypes of interest here are all related to speech and 
language, genes which impact them are not "speech genes" or "language genes", but may 
influence many very different processes, some of which remain unknown. 
 The most obvious mechanism for genetic variants to impact behavior is by 
making specific changes in brain areas where those genes are expressed.  A single gene, 
expressed in multiple functionally relevant brain systems, could therefore impact multiple 
disorders.  Similarly, genes that are co-expressed might therefore impact the same 
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disorder.  This suggests that, though many disorders are polygenic, different disorders 
may often be impacted by the same genes.  In an influential paper proposing what has 
become known as the Generalist Genes Hypothesis, Plomin and Kovas (2005) argued 
that this is the case for most learning disorders (in language, reading and mathematics).  
The hypothesis is based primarily on high genetic correlations between different learning 
disorders, and between aspects of a single disorder.  Briefly, the genetic correlation 
between two traits is the likelihood that a gene associated with one trait will also be 
associated with the other.  Any observed covariation, however, does not guarantee that 
both associations are causal: for example, if one trait directly affects the other trait, this 
will increase their genetic correlation regardless of shared genetic influences.  However, 
the consistently high genetic correlations between several measures of language, reading, 
and mathematical ability are at least suggestive of overlap between the genes influencing 
these abilities (Plomin and Kovas, 2005).  While the Generalist Genes Hypothesis is 
relevant to learning disorders, it should be noted that not all the disorders of speech and 
language function discussed here are always considered learning disorders:  DVD and 
PDS, for example, are usually thought of as speech motor disorders, which concern the 
inability to effectively produce (but not necessarily failure to learn) speech sounds. Most 
genetic studies in this field focus on associations with a single speech / language disorder.  
However, a few of the genes discussed below were originally associated with one such 
disorder, but were then implicated in another as well.  For example,  ATP13A4 has been 
implicated in specific language impairment (SLI) and DVD (Kwasnicka-Crawford et al., 
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2005; Worthey et al., 2013), and CMIP in both SLI and dyslexia (Newbury et al., 2009, 
2011; Scerri et al., 2011). 
 Plomin and Kovas also hypothesized that the same genes which influence 
learning disabilities also influence normal variation in learning ability (Plomin and 
Kovas, 2005).  In other words, learning disabilities are not etiologically distinct from 
learning ability, but are the tail end of the overall population distribution.  Of the genes 
analyzed here, only a few have been tested for association with normal variation (i.e., 
using a typical, large population sample).  DYX1C1, DCDC2, KIAA0319 and TTRAP 
were associated with reading and spelling skill (Paracchini et al., 2011; Lind et al., 2010; 
Paracchini et al., 2008; Luciano et al., 2007), and ROBO1 with nonword repetition and 
short-term storage of verbal sequences (Bates et al., 2011).  However, one study failed to 
replicate the association for DCDC2, or to find association between three other genes 
associated with dyslexia and dyslexia-related behavioral measures in the same large, 
typical cohort (MRPL19, C2ORF3, and KIAA0319; Paracchini et al., 2011).  Thus, the 
extent to which speech / language ability and disability share a genetic etiology is not yet 
clear.  Note also that two genes are included here entirely due to associations found in 
subjects with no neurological disorders: CACNA1C with performance on a lexical access 
task, and GRM3  with neural responses to unexpected phonemes (Krug et al., 2010; 
Harrison et al., 2008). 
 The genes treated in this chapter (see Table 5.1 for a complete list) are curated 
from publications using a range of methods to identify genetic causes of speech / 
language disorders, including genome-wide association studies, whole-exome 
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sequencing, and sequencing of just a few individuals with a disorder or a single family 
with members who have a disorder.  This list of speech / language candidate genes, or 
"SL genes", errs on the side of inclusion: in many cases, the evidence for association is a 
single study that has not been replicated.  Most of these genes are associated with one or 
more of four disorders: dyslexia (also sometimes known as reading disorder), specific 
language impairment, developmental verbal dyspraxia (also known as childhood apraxia 
of speech in the United States), and persistent developmental stuttering.  These are 
discussed in turn below. 
Symbol Aliases Entrez 
ID 
Associated 
phenotype(s) 
Sources 
ADARB2 RED2 105 PDS Kraft (2010) 
AP4E1 CPSQ4, 
SPG51 
23431 PDS(2015) Raza et al. (2015) 
ARNT2  9915 PDS Kraft (2010) 
ATP13A4  84239 SLI 
DVD 
Kwasnicka-Crawford et al. (2005) - SLI 
Worthey et al. (2013) - DVD 
ATP2C2 hSPCA2 9914 SLI Newbury et al. (2009) 
BCL11A  53335 DVD Peter et al. (2014) 
BDNF  627 SLI Simmons et al. (2010) 
CACNA1C  775 SVF Krug et al. (2010) 
CEP63 SCKL6 80254 DYX Einarsdottir et al. (2015) 
CFTR  1080 SLI(O’Brien et 
al., 2003) 
O'Brien et al. (2003) 
CMIP  80790 SLI 
DYX  
Newbury et al. (2009, 2011) - SLI 
Scerri et al. (2011) - DYX 
CNTNAP2  26047 SLI 
DYX 
Vernes et al. (2008) - SLI 
Peter et al. (2011) - DYX 
Newbury et al., (2011) - SLI, DYX 
CTNNA3 VR22, 
ARVD13 
29119 PDS  Kraft (2010) 
CYP19A1  1588 DYX 
DVD 
Anthoni et al. (2012) - DYX, DVD 
DCDC2  51473 DYX Deffenbacher et al. (2004); Meng et al. 
(2005a); Schumacher et al. (2006) 
DGKI  9162 DYX Matsson et al. (2011) 
DIP2A DIP2, 
C21orf106 
23181 DYX Poelmans et al. (2009); Kong et al. (2016) 
DOCK4  9732 DYX Pagnamenta et al. (2010) 
DRD2  1813 PDS1 Lan et al. (2009) 
DYX1C1 EKN1 161582 DYX2 Taipale et al. (2003);  Scerri et al. (2004); Wigg 
et al. (2004); Brkanac et al. (2007); Marino et 
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al. (2007); Dahdouh et al. (2009); Lim et al. 
(2011); Newbury et al. (2011); Paracchini et al. 
(2011); Zhang et al. (2012); Mascheretti et al. 
(2013) 
ERC1 ELKS 23085 DVD Thevenon et al. (2013) 
EYA2  2139 PDS  Kraft (2010) 
FADS2  9415 PDS Kraft (2010) 
FMN1  342184 PDS Kraft (2010) 
FOXP1  27086 ELS Hamdan et al. (2010)  
FOXP2  93986 DVD 
DYX 
SLI 
POV 
Lai et al. (2001); MacDermot et al. (2005); 
Feuk et al. (2006); Lennon et al. (2007) - DVD 
Peter et al. (2011) - DYX 
Rice et al. (2009) - SLI 
Tolosa et al. (2010) - POV 
GNPTAB  79158 PDS Kang et al. (2010) 
GNPTG  84572 PDS Kang et al. (2010) 
GPLD1  2822 DYX Meng et al. (2005a) 
GRM3  2913 MMN Harrison et al. (2008) 
KIAA0319  9856 DYX3 
SLI 
Francks et al. (2004); Cope et al. (2005); 
Harold et al. (2006); Paracchini et al. (2008); 
Venkatesh et al. (2013a) - DYX 
Rice et al. (2009); Newbury et al. (2011) - SLI 
NAGPA  51172 PDS Kang et al. (2010) 
NFXL1  152518 SLI Villanueva et al. (2015) 
NRSN1 VMP 140767 DYX Deffenbacher et al. (2004) 
PCSK5  5125 PDS Kraft (2010) 
PLXNA4  91584 PDS Kraft (2010) 
ROBO1  6091 DYX4 
SLI 
Hannula-Jouppi et al. (2005) - DYX 
Bates et al. (2011) - SLI 
SETBP1  26040 ELS Filges et al. (2011); Marseglia et al. (2012) 
SLC24A3  57419 PDS Kraft (2010) 
SRPX2  27286 DVD Roll (2006) 
THEM2  55856 DYX Francks et al. (2004); Cope et al. (2005); 
Harold et al. (2006); Paracchini et al. (2008); 
Venkatesh et al. (2013a) 
TTRAP  51567 DYX Francks et al. (2004); Cope et al. (2005); 
Harold et al. (2006); Paracchini et al. (2008); 
Venkatesh et al. (2013a) 
Table 5.1.  Candidate speech / language genes included in these analyses ("SL genes").  DVD = developmental 
verbal dyspraxia, DYX = dyslexia, ELS = expressive language skills, MMN = mismatched negativity response to 
unexpected phonemes, PDS = persistent developmental stuttering, POV = poverty of speech, SLI = specific 
language impairment, SVF = semantic verbal fluency.  Note that some of the sources use gene symbols from the 
"Alias" column.  Best-supported / first-found association is listed first in "Associated phenotypes".                                                       
1. Kang et al. (2011a) found no association between DRD2 and PDS.  2. Bellini et al. (2005), Marino et al. (2005), 
Meng et al. (2005b), Ramachandra et al. (2008), and Venkatesh et al. (2011) found no association between 
DYX1C1 and dyslexia.  3. Paracchini et al. (2011) found no association between KIAA0319 and dyslexia.  4.  
Venkatesh et al (2013b) found no association between ROBO1 and dyslexia. 
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 Before delving into the genes and phenotypes listed in Table 5.1, several 
important caveats should be noted.  First, speech / language disorders are complex 
phenotypes.  Defining a phenotype of interest as a disorder simplifies analysis, but does 
obscure the impact of genes on specific aspects of the disorder (endophenotypes).  
Similarly, it is not truly the gene as a whole that impacts the phenotype of interest, but 
one or more variants within the gene (possibly working in concert with variants in other 
genes).  This discussion, and the subsequent analyses, deal with the relatively coarse level 
of genes and (primarily) disorders.  The studies cited in Table 5.1 include more detailed 
information on both implicated genotype and, in many cases, impacted phenotype.  
Second, an association between genotype and phenotype need not be causal.  Variants in 
two different genes may be statistically associated, and if one variant influences a given 
phenotype, the other will show a relationship with that phenotype as well.  Third, certain 
genetic variants known as expression quantitative trait loci (eQTLs) impact the 
expression of other genes.  In other words, the gene indicated by genetic research may 
not always be the same as the gene whose expression is relevant to the speech / language 
phenotype.  The identification of eQTLs requires both genotype and gene expression 
data, and may be key in pointing to genes whose expression profiles are of interest in this 
research. 
5.1.1  Dyslexia candidates 
 The ability to read and spell rests on typical development of cognitive functions 
including orthographic processing, phonemic awareness, and phonological short-term 
memory.  Skill in these areas can be measured with a variety of well-established 
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assessments including reading rate and accuracy measures, non-word repetition, and 
rapid automatized naming.  Several genomic regions have been implicated in 
susceptibility to dyslexia, in particular on chromosomes 15 and 6.  The first region 
(DYX1) includes the gene DYX1C1, which was associated with dyslexia in several 
cohorts (Taipale et al., 2003; Scerri, 2004; Wigg et al., 2004; Brkanac et al., 2007; 
Marino et al., 2007; Dahdouh et al., 2009; Newbury et al., 2011; Paracchini et al., 2011; 
Lim et al., 2011; Zhang et al., 2012; Mascheretti et al., 2013).  DYX1C1 is arguably the 
most-studied gene on this list, and some studies have failed to find an association 
between this gene and dyslexia (Bellini et al., 2005; Marino et al., 2005; Meng et al., 
2005b; Ramachandra et al., 2008; Venkatesh et al., 2011).  CYP19A1 is also located in 
DYX1 and has been associated with dyslexia (Anthoni et al., 2012).  The second region 
(DYX2) includes a haplotype (a set of genomic markers that are usually inherited 
together) which has been associated with dyslexia and which spans some of KIAA0319, 
all of TTRAP, and regulatory regions of THEM2 (Cope et al., 2005; Francks et al., 2004; 
Harold et al., 2006; Paracchini et al., 2008; Venkatesh et al., 2013a), though one study 
found no association between dyslexia and THEM2 (Venkatesh et al., 2013b).  DYX2 
also includes three other genes which have been associated with dyslexia.  DCDC2 has 
received the most attention (Deffenbacher et al., 2004; Meng et al., 2005a; Schumacher et 
al., 2006; Wilcke et al., 2009; Newbury et al., 2011); however, single nucleotide 
polymorphisms (SNPs) in GPLD1 and NRSN1  have each shown association with 
performance on several tests used in the diagnosis of dyslexia (Meng et al., 2005a; 
Deffenbacher et al., 2004). 
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 Additionally, CEP63 (Einarsdottir et al., 2015), DIP2A (Poelmans et al., 2009; 
Kong et al., 2016), DGKI (Matsson et al., 2011), DOCK4 (Pagnamenta et al., 2010), and 
ROBO1 (Hannula-Jouppi et al., 2005) have all been implicated in dyslexia, with one non-
replication of the association with ROBO1 (Venkatesh et al., 2013b).    Finally, there is 
some evidence for involvement of FOXP2 (Peter et al., 2011),  CNTNAP2 (Newbury et 
al., 2011; Peter et al., 2011), and CMIP. (Scerri et al., 2011)  Those two, however, are 
primarily and most commonly associated with other disorders, FOXP2 with DVD and 
CNTNAP2 and CMIP with SLI (see sections on DVD and SLI, below).  
 Most of these genes are known or hypothesized to have roles in brain-specific 
functions, including cortical neuron migration (DYX1C1, Wang et al., 2006; KIAA0319, 
Paracchini, 2006; DCDC2, Meng et al., 2005a), neurite development (NRSN1, Araki and 
Taketani, 2009; DIP2A, Poelmans et al., 2011; DOCK4, Ueda et al., 2008), axon 
guidance (ROBO1; Seeger et al., 1993; Kidd et al., 1998), cerebral cortex growth 
(CEP63; Sir et al., 2011), cortical neuron proliferation, sexual differentiation of brain 
areas, development of the neural circuitry underlying vocalizations in songbirds 
(CYP19A1, Morris et al., 2004; Forlano et al., 2006; Martínez-Cerdeño et al., 2006; 
Diotel et al., 2010), and presynaptic signaling (DGKI; Yang et al., 2011).  CYP19A1 
codes for aromatase, which is also essential to the development of vocal and auditory 
circuits in songbirds and vocalizing fish (Forlano et al., 2006).   The involvement of some 
of these genes in cortical development may be a clue to the anomalies of cortical neuron 
migration found in brains of dyslexic donors (Galaburda et al., 1985), and reading deficits 
in subjects with a cortical migration disorder (Chang et al., 2005).  For a review of 
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possible connections between DYX1C1, ROBO1, KIAA0319, and DCDC2 and issues in 
cortical development, see Galaburda et al. (2006). 
 Interestingly, DOCK4, DGKI, FOXP2, and CNTNAP2 are all located on 
chromosome 7q31-35.  This is within a genomic region that has been linked to autism, a 
disorder that also has a language component (Abrahams and Geschwind, 2008).   
CNTNAP2 and DOCK4 have both been associated with autism (Peñagarikano and 
Geschwind, 2012; Pagnamenta et al., 2010), as has FOXP2 in some populations but not 
others (e.g., Gauthier et al., 2003; Gong et al., 2004). 
 Anthoni et al (2006) have suggested MRPL19 and the adjacent C2ORF3 as 
dyslexia candidates.  MRPL19 is also adjacent to an intergenic region containing a risk 
haplotype, and the two genes are in strong linkage disequilibrium (i.e., variants in these 
genes are statistically associated).  The authors also found co-expression between these 
genes and other dyslexia candidates (DYX1C1, ROBO1, DCDC2 and KIAA0319), and 
attenuated expression of both genes in carriers of the risk haplotype.  However, three later 
studies failed to identify any association between these genes and dyslexia (Paracchini et 
al., 2011; Scerri et al., 2011; Venkatesh et al., 2013b).  Therefore, MRPL19 and C2ORF3 
have been excluded from the list of candidate genes treated here.  
5.1.2  Specific language impairment (SLI) candidates 
 SLI is a deficit in the normal development of expressive and / or receptive 
language skills with no more general explanation (such as hearing impairment or 
intellectual disability).  SLI is therefore a heterogeneous disorder, although children with 
SLI characteristically speak in short, simplified sentences (Newbury et al., 2005).  
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Although the classification of language disorders has changed in the Diagnostic and 
Statistical Manual of Mental Disorders  (DSM-V, American Psychiatric Association, 
2013), all research discussed here uses the term SLI as described.  Phonemic awareness 
and phonological short-term memory are impaired in SLI as in dyslexia (Bishop et al., 
1996; Shaywitz and Shaywitz, 2005), and the relationship between the two disorders is a 
subject of much debate, with some arguing that the underlying deficits are the same and 
that dyslexia should be considered a mild form of SLI (see Bishop and Snowling, 2004, 
for a review).  It is not surprising, therefore, that several genes are associated with both 
disorders. 
 CNTNAP2  and CFTR  are both located near FOXP2 (at the autism susceptibility 
locus on chromosome 7q, discussed above), and all three genes have been associated with 
SLI (Vernes et al., 2008; Newbury et al., 2011; O’Brien et al., 2003; Rice et al., 2009).  
In fact, FOXP2 down-regulates CNTNAP2 (Vernes et al., 2008), which codes for a 
neurexin protein that may have a role in human cortical development (Abrahams et al., 
2007).  ATP2C2 and CMIP, located within a risk locus on chromosome 16q (SLI 
Consortium, 2002), have also been associated with SLI (Newbury et al., 2009, 2011).  
Implicated genes at other loci include NFXL1 (Villanueva et al., 2015), ATP13A4 
(Kwasnicka-Crawford et al., 2005), and BDNF (Simmons et al., 2010).  ATP13A4 has 
been hypothesized to have a role in early neural development (Vallipuram et al., 2010).  
BDNF, or "brain-derived neurotrophic factor", has several important roles especially in 
central nervous system development, including regulation of dendrite growth and 
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synaptic plasticity, and is implicated in many other neurological and neuropsychiatric 
disorders (McAllister et al., 1999; Autry and Monteggia, 2012). 
 KIAA0319, a candidate gene for dyslexia, shows association with SLI as well 
(Rice et al., 2009; Newbury et al., 2011).  It has also been argued that ROBO1's 
association with dyslexia results from an impact on phonological short-term memory, 
which is equally central to SLI (Bates et al., 2011). 
5.1.3  Developmental verbal dyspraxia (DVD) candidates 
 DVD (also known as childhood apraxia of speech, or CAS) is not always 
consistently defined, but is generally considered to be characterized by an impaired 
ability to produce (and possibly sequence) the orofacial movements required for speech, 
in the absence of muscle weakness or paralysis (e.g., Lai et al., 2001; Ferry et al., 2008).  
In rare cases of DVD, mutations in FOXP2 cause or are associated with the disorder (Lai 
et al., 2001; MacDermot et al., 2005; Feuk et al., 2006; Lennon et al., 2007).  FOXP2 is a 
transcription factor that primarily down-regulates the expression of other genes, and its 
hundreds of putative targets have roles in neural transmission, synaptic plasticity, and 
axon guidance (and other cellular functions not specific to the CNS; Vernes et al., 2007). 
 Another DVD candidate, BCL11A, is located in a region linked to dyslexia (Peter 
et al., 2014) and is involved in cortical neuron migration (Wiegreffe et al., 2015).  A 
deletion specific to BCL11A was found in a patient with DVD as well as more 
generalized apraxia, hypotonia, and motor delays.  Although the report acknowledges the 
requirement that difficulty producing speech sounds is not accounted for by muscle 
weakness, it is unclear how the diagnosis of DVD was made given the generalized 
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apraxia and hypotonia (Peter et al., 2014).  SRPX2 is also associated with DVD 
accompanied by other traits, primarily seizures (Roll, 2006).  This gene is down-
regulated by FOXP2 (Roll et al., 2010), and its over-expression in mice affects synapse 
density and interferes with ultrasonic vocalization (Sia et al., 2013).  ERC1 is located in a 
region of overlap between deletions in several people with DVD (Thevenon et al., 2013).  
There is also some evidence that ATP13A4, previously mentioned for its potential role in 
SLI, may be involved in some cases of DVD (Worthey et al., 2013). 
     Finally, in addition to its association with dyslexia, CYP19A1 has been associated 
with speech sound disorder (SSD), which is also characterized by difficulty in producing 
intelligible speech sounds (Anthoni et al., 2012).  It is important to note that the 
distinction, if any, between DVD / CAS and SSD in the view of these researchers and 
those who diagnosed their subjects is unclear; the DSM-V has since defined DVD as a 
sub-type of SSD. 
5.1.4  Persistent developmental stuttering (PDS) candidates 
 PDS is characterized by syllable repetitions and prolongations, and interruptions 
of speech flow, typically developing gradually between ages 3 and 8.  In many children 
who initially develop these dysfluencies, they resolve spontaneously within a few years; 
in PDS, they may persist into adulthood (Ashurst and Wasson, 2011).  While the 
mechanisms underlying PDS are unclear, multiple brain areas and circuits have been 
implicated, in particular the basal ganglia (see Craig-McQuaide et al., 2014 for a review).        
 Mutations in GNPTAB, GNPTG, NAGPA, and AP4E1 have been associated with 
PDS in several populations (Kang et al., 2010; Raza et al., 2015).  The first three are part 
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of a signaling pathway that directs enzymes to the lysosome, an organelle with roles in a 
wide range of processes including waste disposal, nutrient sensing, and membrane repair 
(Settembre et al., 2013).  Mutations in GNPTAB and GNPTG are known to cause 
lysosomal storage disorders.  Kang and Drayna (2012) point out that these disorders do 
sometimes have surprisingly specific effects in which only certain organs show defects, 
and they can include neurological deficits.  However, the mechanistic connection 
between this pathway and the rather specific PDS phenotype is unknown.  AP4E1 is also 
involved in sorting proteins, and in neurons it may mediate the transport of AMPA 
glutamate receptors to the postsynaptic domain (Matsuda et al., 2008).  Cases of 
microcephaly and intellectual disability have also been linked to mutations in AP4E1 
(Moreno-De-Luca et al., 2011; Kong et al., 2013). 
 One unpublished genome-wide association study of PDS, though smaller than 
most genome-wide studies (84 people with PDS and 107 controls), suggested nine 
candidate genes based on statistically significant variants (Kraft, 2010).  Several of these 
genes have known relationships with a variety of brain functions and neurological 
disorders.  ARNT2, PLXNA4, and CTNNA3  have roles in neuroendocrinological cell 
development (Hosoya et al., 2001), axon guidance (Suto et al., 2005), and cell-cell 
adhesion (Smith et al., 2011), respectively.  All three are associated with autism 
(Maestrini et al., 2010; Bacchelli et al., 2014; Di Napoli et al., 2015). Additionally, 
ARNT2 regulates BDNF, an SLI candidate (Pruunsild et al., 2011).  PLXNA4 is also 
associated with Alzheimer’s Disease and Parkinson’s Disease (Jun et al., 2014; Schulte et 
al., 2013), and there is conflicting evidence for CTNNA3's involvement in Alzheimer’s 
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Disease (Smith et al., 2011).  ADARB2  affects glutamate levels in white matter 
(Kawahara et al., 2003), while differences have been found in white matter of people 
with PDS (Connally et al., 2014).  FADS2 modulates the effect of fatty acid intake during 
development, and it has been argued that this affects cognition (Rizzi et al., 2013).  The 
other four genes indicated by this GWAS are EYA2, FMN1, SLC24A3, and PCSK5, 
which are not, based on a survey of current literature, implicated in any neurological 
disorders or brain-specific functions (Kraft, 2010). 
 Finally, the hypothesis that PDS involves excessive dopamine (and in particular 
D2 receptors in the striatum; Alm, 2004) resulted in a study showing an association 
between DRD2 and PDS (Lan et al., 2009).  This association, found in a Chinese cohort, 
did not appear in either a Brazilian or a European cohort (Kang et al., 2011a).  It is 
unknown whether the initial finding in a Chinese cohort was a false positive, or whether 
the association is present in the first population but not the latter two; however, the 
authors of the non-replication point out that the allele associated with PDS in the Chinese 
cohort was far less common in the latter two cohorts, and that this difference may have 
obscured the association in the second study. 
5.1.5  Other phenotypes related to speech and language ability 
 Genes that are examined in this chapter also include FOXP1 and SETBP1.  Both 
are implicated in expressive language impairments, accompanied by broader effects 
(aggressiveness and obsessive-compulsive behavior for FOXP1, Hamdan et al., 2010; 
delayed / impaired motor skills and distinctive facial features for SETBP1, Filges et al., 
2011; Marseglia et al., 2012). 
  
128 
 Schizophrenia has a language component, and two genes implicated in 
schizophrenia also show association with language measures in healthy controls.  The 
first is GRM3 (Harrison et al., 2008), which predicted neural responses to unexpected 
phonemes as measured by mismatch negativity using magnetoencephalography. 
(Kawakubo et al., 2011).  The second is CACNA1C (Green et al., 2010), which was 
associated with performance on a lexical access task (Krug et al., 2010).  There is 
evidence that performance on this task is impaired in dyslexia and SLI; therefore, 
CACNA1C may be a candidate gene for these disorders (Cohen et al., 1999; Weckerly et 
al., 2001). 
 Finally, in addition to connections with multiple disorders discussed above, 
FOXP2 has been associated with poverty of speech in people with schizophrenia (Tolosa 
et al., 2010) and CNTNAP2 with language acquisition (Whitehouse et al., 2011; Al-
Murrani et al., 2012) and response to syntactic violations as measured by event-related 
brain potentials (Kos et al., 2012).   
 For many of these genes, the mechanisms relating genotype to speech and 
language abilities are completely unknown.  For some genes, little or nothing is known of 
their functions.  Given our sparse knowledge of these genes, their roles and their 
relationships, it is not easy to move beyond making lists of candidates that have shown 
statistical associations.  Neuroanatomically-specific gene expression data suggest a first 
step.  As mentioned earlier, the most obvious mechanism for genetic variants to influence 
these phenotypes is through effects on brain areas where those genes are expressed.  The 
expression profiles of candidate genes are therefore of interest, not only across the brain 
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as a whole, but across samples from brain structures of particular relevance to speech and 
language functions. 
 In addition to cerebral cortex, the basal ganglia and cerebellum support many 
aspects of these functions.  Cortico-basal ganglia and cortico-cerebellar circuitry are 
involved not only in speech-related motor control (Kent, 2000; Wildgruber et al., 2001; 
Riecker et al., 2005) but in speech processing, including at the phoneme level (Booth et 
al., 2007; Peeva et al., 2010; see Mariën et al., 2013; Kotz et al., 2009 for reviews of CB 
and BG involvement, respectively).  In these language-related circuits, cortical 
projections from the basal ganglia and cerebellum have different but overlapping 
distributions at the thalamus, suggesting an interplay between their roles (Barbas et al., 
2013). 
 The cerebral cortex, basal ganglia and cerebellum have all been implicated in 
dysfunctions of speech and language as well as healthy functioning.  Dyslexia has long 
been tied to disturbances of cortical neuronal migration, particularly in the temporal lobe 
(Galaburda, 2005; Giraud and Ramus, 2013).  Areas from all four cortical lobes 
(particularly parietal and inferior frontal) show differences between people with dyslexia 
and controls, both in structure and in functional activations during relevant language 
tasks, as do the anterior and posterior lobes of the cerebellum (see Eckert, 2004 for a 
review).  Ullman and Pierpont (2005) have proposed that SLI results from deficits in the 
procedural memory system, including the cerebral cortex, basal ganglia and cerebellum.  
All three structures have also been implicated in PDS (Alm, 2004; Brown et al., 2005) 
and in DVD (Belton et al., 2003; Vargha-Khadem et al., 1998).  Nicolson and Fawcett 
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(2007) hypothesized more generally that many developmental disorders might arise from 
disturbances of cortico-basal ganglia and cortico-cerebellar circuitry. 
 By determining where in the brain candidate genes are expressed, and whether / 
where they are co-expressed, we can consider our knowledge of these genes in light of 
our incomplete, but more substantial, knowledge of larger-scale functional neuroanatomy 
and pathophysiology of the disorders.  The study described in this chapter identifies brain 
areas where these genes are preferentially expressed, and shows their co-expression 
relationships using multi-dimensional scaling and co-expression network analysis 
approaches. 
 
5.2 Speech and Language Disorders Database 
 A major gap exists between studies that aim to identify candidate genes for 
developmental language disorders and brain imaging studies of the neural bases for 
linguistic functions, which may be impacted by those same disorders.  This section 
outlines the construction of a novel web-accessible database that aims to narrow this gap 
by bringing both data types into a common framework.  This database also, in large part, 
provides the list of candidate genes shown in Table 5.1.  The overall database 
(http://neurospeech.org/sldb) contains a series of manually curated results from the 
published literature describing (i) genes or chromosomal regions (genetic loci) for which 
there is evidence of association to speech and language-related phenotypes, and (ii) 
results from the brain imaging literature describing localized structural or functional 
abnormalities observed in populations of individuals with heritable speech or language 
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disorders compared to typically developing control subjects.  Thus these efforts bring 
results from two fundamentally different levels of investigation together into a common 
database system.  This section focuses on the portions of the database concerned with 
candidate genes rather than with brain imaging studies.  The overall database structure is 
further described in Bohland et al. (2014). 
5.2.1  Candidate genes 
 The database currently contains records related to 27 individual genes that have 
been implicated, with varying degrees of evidence, in speech- or language-related 
phenotypes.  The current gene list includes genes for which some association has been 
found to DYX, SLI, DVD, and PDS; it also includes genes that have been specifically 
linked to quantitative measures of speech and language processing. 
 For each of the genotype-phenotype relationships curated from the literature and 
stored in the database, our web-based interface provides users simple access to the 
curated details, and also provides links to the Entrez Gene database 
(http://www.ncbi.nlm.nih.gov/gene), the original publication via Pubmed 
(http://www.ncbi.nlm.nih.gov/pubmed/), and — using simple URL based mapping — to the 
Allen Human Brain Atlas (AHBA) website (http://human.brain-map.org) depicting brain 
expression profiles for the gene of interest.  The Allen Brain Atlas Application 
Programming Interface (API) is used to provide direct links to download a complete set 
of pre-processed, normalized human gene expression data from the AHBA for each gene 
of interest, in either JSON or XML format.  A screen capture demonstrating the primary 
entry point in the database (http://neurospeech.org/sldb), which summarizes database 
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contents for these genes, is shown in Fig 5.1.  The table shown in the screen capture 
shows basic gene metadata, and provides links to AHBA data for each gene in the 
database. It also gives a summary of how many studies with positive association results 
for this gene have been curated and included in the database to date, and the total number 
of gene-phenotype associations reported for each gene.  This allows the novice user to 
quickly ascertain which genes are of highest interest (reflected in many studies), and also 
places responsibility on the curators to ensure that sampling of studies is as free from bias 
as possible. Clicking the row corresponding to an individual gene leads to a page 
summarizing the reports of associations, as well as any replication failures (i.e., studies 
that tested examined the same gene and did not find association with a similar phenotype) 
entered into the database, for that gene. This more detailed view is depicted in Fig 5.2 for 
the gene ROBO1. 
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Fig 5.1.  Screen capture of a (partial) view into the database showing a sortable table of genes implicated in 
speech / language phenotypes, sorted by gene symbol.  From this primary view, the user is able to quickly survey 
the list of genes implicated in speech and language disorders that are currently in the database, as well as the 
number of reports curated by gene, and hyperlink to a number of relevant resources for each record, including 
the Entrez Gene page for the gene of interest, and the Allen Human Brain Atlas page for the gene of interest. 
The right-most links (labeled “JSON/XML) provide a mechanism to download gene expression data for this 
gene using the Allen Brain Atlas API. 
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Fig 5.2.  Screen capture of a (partial) view into the database detailing reports for the gene ROBO1. This view 
provides two sortable tables, the first of which shows positive evidence for association with any speech or 
language phenotype, and the second of which shows negative results. The study at bottom failed to replicate the 
original association of SNPs in ROBO1 to susceptibility for dyslexia, and the corresponding record in the table at 
top is flagged with a blue icon. Users can expand the rows in either table to provide more detailed information 
about study methods. Finally, users can download each record as a JSON or XML structured text file. 
 
5.2.2  Inclusion criteria 
 Genes were selected for entry into the database by a process intended to minimize 
potentially subjective interpretation of results from the literature.  A series of search 
terms form the basis of RSS (Really Simple Syndication) feeds, current versions of which 
are available through the website (see http://neurospeech.org/sldb/help).  These search 
terms take the following forms: 
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1.  gene <phenotype> 
2.  genetics <phenotype> 
3.  linkage <phenotype> 
4.  SNP <phenotype> 
 For example, searches include gene dyslexia and linkage stuttering.  Phenotypes 
with multi-word names are encased in quotations (e.g., gene “specific language 
impairment”).  Initially, an additional search expression beginning with the term locus 
was used; this was dropped because the relevant results were a subset of those turned up 
by the term linkage.  Strings currently used as phenotype names include: stuttering, 
dyslexia, reading disability, "verbal dyspraxia", "specific language impairment", "SLI", 
"childhood apraxia of speech", "language delay", and "fluency." 
 In addition, once a gene of interest is established in the literature, follow-up 
studies can be found by explicitly searching for the gene symbol1 appearing concurrently 
with certain search terms.  Therefore, an additional search expression, and corresponding 
RSS feed, takes the form: 
 
(<gene1> OR <gene2> OR ... <geneN>) AND (speech OR language OR <phenotype1> 
OR <phenotype2> ... OR <phenotypeN>) 
 
                                                 
1 Note that Pubmed will automatically explode search terms with synonymous gene symbols as well as 
synonyms from Medical Subject Headings (MeSH) and Unified Medical Language System (UMLS) 
ontologies. 
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where <gene> terms are replaced by official gene symbols for genes in our database, and 
<phenotype> terms are the same as noted above. 
 These searches return hundreds of results, many of which do not fulfill the above 
criteria.  Pubmed’s Really Simple Syndication (RSS) feeds, coupled with an RSS reader, 
however, provide an efficient method for sifting through new literature as it appears, and 
for flagging new studies for inclusion.  As new studies are located, they are added to an 
electronic queue for inclusion in the database.  (Some genes included in this chapter have 
not yet been entered into the database.) 
5.2.3  Concluding remarks 
 The approach used in this chapter, like any work attempting to bridge the 
molecular and neuroanatomical levels, relies in part upon careful and thorough curation 
of the literature to establish the best candidate gene list according to current knowledge, 
and the ability to refine and expand that list to reflect continuing research.  The database 
described above facilitates this curation, brings information about genotype-phenotype 
relations specific to speech and language disorders together with results from 
neuroimaging research, and provides the ability to link to and / or download spatial gene 
expression data.  Thus, these efforts represent a first step toward bringing molecular level 
information into cognitive and computational theories of speech and language function. 
 
5.3 Preferential expression of genes implicated in speech and language disorders 
 This section focuses on the expression patterns of individual speech / language 
candidate genes across the brain, and particularly on where those genes show unusually 
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high expression levels, or preferential expression.  Intuitively, preferential expression (as 
used here) means that in a given brain area, the gene's expression level "stands out" 
(relative to its expression elsewhere) more than other genes' expression levels stand out 
(relative to their own expression elsewhere).  In other words, we are testing for areas 
where the deviation of a gene's expression from its brain-wide average (or average across 
some other "parent" structure) is large compared to other genes. 
 Importantly, strong expression does not necessarily imply preferential expression.  
A gene showing uniformly strong expression throughout the brain is not considered 
preferentially expressed in a given brain area.  In fact, because of differences in probe 
efficacy, we cannot distinguish between a gene with uniformly strong expression or 
uniformly weak expression throughout the brain in these data.  Conversely, preferential 
expression does not imply strong expression.  A gene may show only slightly higher 
expression levels in an area than it does elsewhere, but if few other genes show even that 
much of an increase, the gene may meet the criteria for preferential expression (see 
Methods).  In practice, higher expression levels in a particular area frequently co-occurs 
with preferential expression. 
5.3.1  Methods 
 Expression values were standardized within-probe across all left-hemisphere 
samples using conventional z-scoring (i.e., not the weighted z-scoring described in 
Chapter 2).  For each of the ~32,000 genes in the AHBA, probes were z-scored across all 
left-hemisphere samples and a mean expression value was calculated for each of 10 broad 
regions by averaging across samples.  For each of 88 sub-regions, the un-standardized 
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probe data was z-scored across left-hemisphere samples within the "parent" region only, 
and values for those samples were then averaged to calculate the sub-region mean 
expression profile.  The above steps were performed within each donor brain (though not 
all donors had left-hemisphere samples available for all 88 fine regions). 
 Each speech / language (SL) candidate gene's mean expression value for a region 
was converted to a percentile rank in the distribution of mean values for all genes in that 
region.  This was also done separately for each donor.  Preferential expression was 
defined as a percentile rank of 95 or greater in all donors with samples available for the 
brain region.  This is equivalent to an uncorrected p-value under 0.05.  The results shown 
here do not survive Bonferroni correction for multiple comparisons (for N = 42 genes x 
10 regions, or N = 42 genes x 88 regions). 
 Of the full set of ~32,000 genes, those that were preferentially expressed in at 
least one of the 11 broad area were identified, and the hypergeometric test was used to 
assess whether the SL genes were overrepresented in this group.  The same test was then 
performed using the 88 fine areas. 
5.3.2  Results 
 Of the 42 SL genes, 12 were among those showing preferential expression in at 
least one broad region (3,041 genes total, p < 1 x 104, hypergeometric test) and 16 in at 
least one fine region (3,498 genes total, p < 1 x 106). 
 Mean expression values of the SL genes appear in Fig 5.3.  In addition to the 
green outlines which flag preferentially expressed genes (those with a percentile rank of 
at least 95 in all donors), yellow outlines indicate a percentile rank of at least 90 in all 
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donors.  Note also that although preferential expression is based on a minimum value 
across donors, values indicated in the heatmaps are mean expression values across all 
donors. 
 
Ctx = Cerebral cortex; Hipp = Hippocampal formation; Amyg = Amygdala; Str = Striatum; GP = Globus 
pallidus; Th = Thalamus; Hyp = Hypothalamus; Mb = Midbrain; Po = Pons; Med = Medulla; Cb = Cerebellum. 
Fig 5.3 (cont. on next page).  Expression heatmaps of speech / language candidate genes.  Values are averaged 
across donors.  Genes are ordered by clusters obtained by hierarchical clustering of values across broad brain 
regions.  Asterisks next to each gene symbol indicate phenotypes the gene has been associated with.  Colored 
outlines indicate expression at or above the 95th percentile (green boxes) or 90th percentile (yellow boxes) for 
that region within each donor.  Parenthetical values following region names indicate the number of donors with 
left-hemisphere samples available. 
 
 Few genes were preferentially expressed in more than one broad region, with the 
exceptions of DOCK4 (HF, STR), SLC24A3 (HF, TH) and KIAA0319 (HF, TH) (Fig 
5.3).  SL genes that showed preferential expression tended to do so in the hippocampal 
formation, striatum, or thalamus (4 genes in each case); also note that cerebral cortex 
ranked five SL genes at the 90th percentile or above for all donors.  Although FOXP2 
was not preferentially expressed in any broad region, its highest percentile ranks were in 
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the cerebral cortex, striatum, and thalamus (minimum across donors of 80th, 81st, and 
87th percentile, respectively). 
 
 
 
 
 
  
141 
 
SFG = superior frontal gyrus; MFG = middle frontal gyrus; IFG = inferior frontal gyrus; SRoG = superior 
rostral gyrus; IRoG = inferior rostral gyrus; LOrG = lateral orbital gyrus; MOrG = medial orbital gyrus; PCLa 
= paracentral lobule, anterior part; PaOG = parolfactory gyri; FP = frontal pole; fro = frontal operculum; GRe 
= gyrus rectus; PrG = precentral gyrus; SCG = subcallosal gyrus; PoG = postcentral gyrus; IPL = inferior 
parietal lobule; SPL = supraparietal lobule; PCu = precuneus; FuG = fusiform gyrus; HG = Heschl's gyrus; 
STG = superior temporal gyrus; MTG = middle temporal gyrus; ITG = inferior temporal gyrus; PLP = planum 
polare; PLT = planum temporale; TP = temporal pole; TG = transverse gyri; Cun = cuneus; SOG = superior 
occipital gyrus; IOG = inferior occipital gyrus; LiG = lingual gyrus; OTG = occipito-temporal gyrus. 
Fig 5.3 (cont. on next page).  Expression heatmaps of speech / language candidate genes.  Values are averaged 
across donors.  Genes are ordered by clusters obtained by hierarchical clustering of values across broad brain 
regions.  Asterisks next to each gene symbol indicate phenotypes the gene has been associated with.  Colored 
outlines indicate expression at or above the 95th percentile (green boxes) or 90th percentile (yellow boxes) for 
that region within each donor.  Parenthetical values following region names indicate the number of donors with 
left-hemisphere samples available. 
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CgGf = Cingulate gyrus, frontal part; CgGp = Cingulate gyrus, parietal part; LIG = Long Insular Gyri; SIG = 
Short Insular Gyri. 
Fig 5.3 (cont. on next page).  Expression heatmaps of speech / language candidate genes.  Values are averaged 
across donors.  Genes are ordered by clusters obtained by hierarchical clustering of values across broad brain 
regions.  Asterisks next to each gene symbol indicate phenotypes the gene has been associated with.  Colored 
outlines indicate expression at or above the 95th percentile (green boxes) or 90th percentile (yellow boxes) for 
that region within each donor.  Parenthetical values following region names indicate the number of donors with 
left-hemisphere samples available. 
 
 These expression patterns did not group by associated disorders (Fig 5.3).  
However, most PDS candidates did have higher expression values (and sometimes 
preferential expression) in either the telencephalon (GNPTAB, NAGPA, ARNT2, 
PLXNA4), the amygdala, striatum, diencephalon, and brainstem (DRD2, EYA2, FADS2), 
or the globus pallidus, thalamus, and brainstem (GNPTG, AP4E1, ADARB2, CTNNA3) 
than in other brain areas. 
 A set of 93 finer brain regions revealed a few more genes with preferential 
expression in areas throughout the brain (though still none in any amygdalar nuclei).  
Most SL genes showed relatively modest variation in either expression percentile rank 
within any given telencephalic or diencephalic broad region, with the exceptions of 
differences between hippocampal sub-structures, lower values in the nucleus accumbens 
than the rest of the striatum, and some distinction between the dorsal and ventral 
thalamus. 
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DG = Dentate gyrus; CA fields = CA fields; S = Subiculum; ATZ = Amygdaloid Transition Zone; BLA = 
Basolateral Nucleus; BMA = Basomedial Nucleus; CeA = Central Nucleus; LA = Lateral Nucleus; COMA = 
Cortico-medial group; BCd = Body of the Caudate Nucleus; HCd = Head of the Caudate Nucleus; TCd = Tail of 
the Caudate Nucleus; Pu = Putamen; Acb = Nucleus accumbens; GPe = globus pallidus, external segment; GPi = 
globus pallidus, internal segment; DTA = Anterior Group of Nuclei; DTP = Posterior Group of Nuclei; DTM = 
Medial Group of Nuclei; DTL = Lateral Group of Nuclei; ILr = Rostral Group of Intralaminar Nuclei; ILc = 
Caudal Group of intralaminar Nuclei; LGd = Dorsal Lateral Geneiculate Nucleus; MG = Medial Geniculate 
Complex; VT = Ventral Thalamus, Left; AHR = Anterior Hypothalamic Region; MamR = Mammillary Region; 
PrOR = Preoptic Region; TubR = Tuberal Region. 
Fig 5.3 (cont. on next page).  Expression heatmaps of speech / language candidate genes.  Values are averaged 
across donors.  Genes are ordered by clusters obtained by hierarchical clustering of values across broad brain 
regions.  Asterisks next to each gene symbol indicate phenotypes the gene has been associated with.  Colored 
outlines indicate expression at or above the 95th percentile (green boxes) or 90th percentile (yellow boxes) for 
that region within each donor.  Parenthetical values following region names indicate the number of donors with 
left-hemisphere samples available. 
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IC = Inferior Colliculus; SC = Superior Colliculus; SN = Substantia Nigra; VTA = ventral tegmental area; 
MBRF = Midbrain Reticular Formation; CGMB = central grey substance of midbrain; RN = Red Nucleus; SOC 
= Superior Olivary Complex; MPB = medial parabrachial nucleus; LPB = lateral parabrachial nucleus; LC = 
locus ceruleus; SubC = nucleus subceruleus; PPRF = Paramedian Pontine Reticular Formation; 5 = Trigeminal 
Nuclei; Bpons = Basal part of pons; Arc = arcuate nucleus of medulla; Cu = cuneate nucleus; IO = inferior 
olivary complex; MeRF = medullary reticular formation; Sp5 = spinal trigeminal nucleus; Cb-AL = Anterior 
Lobe; Cb-PL = Posterior Lobe; CbN = Cerebellar nuclei. 
Fig 5.3.  Expression heatmaps of speech / language candidate genes.  Values are averaged across donors.  Genes 
are ordered by clusters obtained by hierarchical clustering of values across broad brain regions.  Asterisks next 
to each gene symbol indicate phenotypes the gene has been associated with.  Colored outlines indicate expression 
at or above the 95th percentile (green boxes) or 90th percentile (yellow boxes) for that region within each donor.  
Parenthetical values following region names indicate the number of donors with left-hemisphere samples 
available. 
 
 In contrast, several genes had high expression values in only one or two nuclei of 
the midbrain, pons, and / or medulla (e.g. FOXP2, BCL11A, DYX1C1, PCSK5, and 
SLC24A3).  However, few of these met the criteria for preferential expression.  In the 
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midbrain, three genes were preferentially expressed (SRPX2) or had minimum ranks of at 
least 90 in the substantia nigra (DRD2, ADARB2).  In the medulla, the inferior olivary 
complex ranks PCSK5 and AP4E1 at or above the 90th and 95th percentile for all donors, 
respectively.  Several other genes show stronger expression there than elsewhere in 
medulla or, for the most part, the rest of the brainstem (e.g. FOXP2, FMN1).  This is 
maintained when expression values are converted to percentile ranks: five genes have 
higher minimum percentile ranks (across donors) in the inferior olivary complex than in 
any other brainstem area (FOXP2, GRM3, FMN1, FOXP1, AP4E1). 
 In the cerebellum, most genes showed higher expression in either the cerebellar 
cortex or cerebellar nuclei.  In particular, GPLD1 and ERC1 are preferentially expressed 
in the cerebellar cortex, and THEM2 and EYA2 in the cerebellar nuclei. 
 
5.4  Co-expression modularity 
 This section examines potential enrichment of co-expression for a given gene set 
within specific brain regions.  Enriched co-expression may point to particular brain 
regions through which candidate genes could influence behavioral phenotypes, and 
ultimately may suggest mechanisms for that influence.  Here, a "modularity score" is 
used to measure the extent to which a group of genes is co-expressed across samples 
within a given region (i) relative to other genes within the region, and (ii) relative to their 
own co-expression across randomly selected samples. 
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5.4.1  Methods 
 AHBA gene expression profiles were converted to z-scores across samples.  
Gene-gene co-expression networks were then generated using the PCC computed across 
expression profiles for pairs of genes.  All PCC matrices were of size 32,536 x 32,536 
(the number of unique genes in the dataset).  Each co-expression network used samples 
from a particular brain region and its sub-regions.  To account for tissue sampling biases 
(i.e., an overrepresentation of samples from one brain region), the PCC approach was 
adjusted to allow weighting of individual samples given a partition set S containing K 
regions, R1, R2,. . .RK, where Rj contains the integer indices of all samples in that brain 
region.  The resulting equation for weighted correlation between gene m and gene n is 
given by: 
𝑟𝑚𝑛
S =  
∑ (∑
1
|𝑅𝑘|
𝑖∈𝑅𝑘
(𝐸AHBA(𝑚,𝑖)−𝜇𝑆(𝑚))(𝐸AHBA(𝑛,𝑖)−𝜇𝑆(𝑛)))𝐾𝑘=1 𝐾⁄
𝜎𝑆(𝑚)𝜎𝑆(𝑛)
         (1) 
 For each AHBA region analyzed, the partition function S was set to represent the 
set of its child regions in the reference hierarchy. For example, the children of the region 
Cerebral Cortex in the hierarchy are Frontal Lobe, Insula, Limbic Lobe, Occipital Lobe, 
Parietal Lobe, and Temporal Lobe, each of which receives equal weight (despite non-
uniform sampling) in computing the correlation coefficient for the cortical co-expression 
network.  In order to obtain reasonable correlation estimates, only regions with at least 30 
samples available were included. 
 Enrichment of co-expression within a brain region was characterized by 
comparing the modularity of a provided gene set to values expected by chance in each 
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AHBA region-specific co-expression network. The modularity score for a given gene set 
G was defined as: 
𝑀𝐺 =
1
|𝐺|(|𝐺|−1)
∑ ∑ abs (𝐹(𝑟𝑖𝑗))𝑗∈𝐺,𝑗≠𝑖𝑖∈𝐺 −
1
|𝐺|(|?̅?|)
∑ ∑ abs (𝐹(𝑟𝑖𝑗))𝑗∈?̅?𝑖∈𝐺        (2) 
where F( ) denotes the Fisher r to z transformation, and ?̅? is the complement of gene set 
G (i.e., the genes in the dataset that are not in set G). The value MG then indicates the 
difference between the average co-expression score between pairs of genes in G and the 
average co-expression score between pairs of genes where one gene is in G and one gene 
is not in G. 
 Two methods were used to assess the extent to which a given gene set had high 
modularity in a given brain region (and its subregions), both using randomization 
approaches. In the first method (gene permutation), a series of 1000 randomly selected 
gene sets of the same cardinality as the gene set of interest are used to generate a 
distribution of expected modularity scores, for each region-specific network.  Then, the 
modularity score for set G is standardized by subtracting the mean and dividing by the 
standard deviation of scores obtained in these random draws. Thus the final, region-
specific standardized modularity score reflects how modular a given gene set is in a given 
brain area relative to other gene sets in units of standard deviation (i.e., a score of 5 is 
five standard deviations higher than average).  P-values are also obtained by calculating 
the percentile rank of MG  in the relevant empirical chance distribution (i.e., without 
assuming chance distributions were Gaussian). In results presented here, the p-values are 
Bonferroni corrected for multiple comparisons across brain regions (N = 60). 
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 A second randomization procedure (sample permutation) compared the 
modularity of a gene set in a given brain region to the modularity of the same gene set in 
randomly selected samples.  Specifically, a null distribution was generated by 
recomputing MG  across randomly selected groups of left-hemisphere samples from the 
AHBA, with the number of samples matched to the number of samples available in the 
brain region of interest. It should be noted that the sample permutation method is more 
computationally intensive than the gene permutation approach above because it requires 
recalculating a weighted correlation network for every permutation using a new subset of 
available samples. As above, a set of 1000 random selections of samples was used to 
calculate each empirical null distribution. Based on these chance distributions, 
standardized modularity scores and Bonferroni-corrected p-values were calculated as 
described above.  Scores based on the sample permutation approach describe how 
modular the gene set is in samples from a specific brain area – i.e., the anatomical 
specificity for this gene set – whereas scores based on gene permutations reflect how 
modular the gene set is in a brain region relative to other gene sets.  These 
complementary pieces of information are presented separately for each gene set of 
interest. 
5.4.3  Results 
 Fig 5.4 shows co-expression modularity based on the gene permutation approach 
(left column) and the sample permutation approach (right column) of the five groups of 
genes defined by associated disorders.  The first row corresponds to the complete set of 
42 SL genes.  These genes showed higher co-expression modularity than average for 
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random genes (i.e., positive modularity z-scores) in all 60 regions.  The genes' modularity 
was significant (p < 0.05 after correction for multiple comparisons) in the cerebral cortex, 
as well as specifically in the frontal, temporal and limbic lobes.  Within those lobes, the 
inferior frontal, inferior temporal, fusiform, frontal cingulate, and parahippocampal gyri 
also showed enhanced modularity for these genes.  Other regions showing significant 
modularity included the diencephalon, pons, and medulla. 
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Fig 5.4 (cont. on next page).  Enrichment of speech / language gene candidates in region-specific AHBA 
networks.  Each row represents regional enrichment of a gene set based on co-expression modularity relative to 
other gene sets (gene permutation, left column) and relative to random samples (sample permutation, right 
column).  Rows illustrate results for the full set of 42 candidates (A, B), and for subsets consisting of genes 
implicated in dyslexia (C, D), and specific language impairment (E, F).  See panel K for a legend indicating the 
brain regions corresponding to each individual wedge.  Bold outlined wedges indicate significant results (p < 
0.05, Bonferroni-corrected).  For sample permutations, values for the brain and grey matter are set to 0 (since it 
is impossible to select random samples outside of those structures), as well as the telencephalon and cerebral 
cortex (because slightly fewer than half the samples are outside these structures). 
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Fig 5.4 (legend on next page).  Enrichment of speech / language gene candidates in region-specific AHBA 
networks.  Each row represents regional enrichment of a gene set based on co-expression modularity relative to 
other gene sets (gene permutation, left column) and relative to random samples (sample permutation, right 
column).  Rows illustrate results for developmental verbal dyspraxia (G, H), and persistent developmental 
stuttering (I, J).  See panel K for a legend indicating the brain regions corresponding to each individual wedge.  
Bold outlined wedges indicate significant results (p < 0.05, Bonferroni-corrected).  For sample permutations, 
values for the brain and grey matter are set to 0 (since it is impossible to select random samples outside of those 
structures), as well as the telencephalon and cerebral cortex (because slightly fewer than half the samples are 
outside these structures). 
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K. 
Fig 5.4.  Enrichment of speech / language gene candidates in region-specific AHBA networks.  Panel K is a 
legend indicating the brain regions corresponding to each individual wedge in panels A-J. 
 
 Neither dyslexia, SLI nor DVD candidate genes (Fig 5.4, second through fourth 
rows) reached significant modularity in any brain region.   However, the dyslexia 
candidate group showed largely positive values that were highest (over 3) in the temporal 
lobe and inferior temporal gyrus, as well as the limbic lobe, thalamus and both sub-
structures of the medulla.  PDS candidate genes (Fig 5.4, fifth row) showed enhanced 
modularity in the basal ganglia and diencephalon.  The parietal lobe, and specifically the 
angular gyrus, also reached significance, as well as the lingual gyrus and spinal 
trigeminal nuclei. 
 The SL candidates as a group, dyslexia candidates, and SLI candidates showed 
similar or slightly lower modularity in most brain regions than across randomly selected 
samples, though the full SL gene list and the SLI candidates both yielded modest positive 
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values in the cerebellum.  In contrast, the DVD candidates showed enhanced modularity 
relative to random samples in the frontal and temporal lobes, lingual and frontal cingulate 
gyri, and the pons, and the PDS candidates in the basal ganglia. 
 
5.5  Co-expression landscape 
 The following analysis uses the similarity / dissimilarity between expression 
profiles of the SL genes to visually analyze their overall co-expression landscape, and to 
examine whether genes implicated in certain subclasses of these disorders cluster in this 
co-expression space.  In the two-dimensional landscape, calculated using non-metric 
multi-dimensional scaling (MDS), distances between genes are based on their co-
expression.  Genes with either positively or negatively correlated expression values 
across samples  (either of suggests a regulatory relationship) are represented as nearby 
locations, while genes whose expression profiles have no clear relationship are 
represented as distant locations.  This technique does not create a perfect representation 
of the distance relationships, but does provide a useful visualization for exploration of the 
anatomical expression patterns of genes implicated in related phenotypes.  In this way, 
the co-expression landscape of candidate genes is examined here both within the brain as 
a whole and separately within the cerebral cortex, basal ganglia, and cerebellum. 
5.5.1  Methods 
 Pearson's Product-moment Correlation Coefficients (PCCs) were calculated 
between each pair of SL genes, based on their expression profiles across an anatomically 
relevant set of samples.  Correlation distance between two genes was then defined as one 
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minus the absolute value of this PCC.  Using the magnitude of the PCCs allows the 
distance measure to treat inverse relationships, such as one gene down-regulating 
another, as constituting "similar" expression. 
 Distance matrices were calculated by pooling samples from all donors for each of 
four sample subsets: (i) the entire left hemisphere, (ii) left cerebral cortex only, (iii) left 
basal ganglia only and (iv) left cerebellum only.  In each case, probes were z-scored 
across the samples in the subset (using conventional, i.e. un-weighted z-scoring).  
Cerebral cortex was defined to include the frontal, parietal, temporal, and occipital lobes, 
the cingulate gyrus, and the insula.  Basal ganglia included the striatum, pallidum, 
subthalamic nucleus, and substantia nigra. 
 For each disorder (dyslexia, SLI, DVD, and PDS), pair-wise distances "within-
group" were compared to those "across-group".  Genes within a group included all those 
associated with the disorder (including those also associated with one or more additional 
disorders).  Across-group distances were calculated between all possible pairs of a gene 
in the group with a gene outside the group.  For each group, a one-tailed, two-sample t-
test was performed on the two sets of distances to test for significantly smaller within-
group than across-group differences.  The Bonferroni method was used to correct for 
multiple comparisons (i.e., 4 groups x 4 sample sets = 16 comparisons). 
 Donor variability was assessed by calculating within-donor distance matrices and 
performing a Mantel test (Mantel, 1967) for each pair of donors.  In the Mantel test, the 
PCC between two distance matrices is compared to a distribution of PCCs between the 
first matrix and randomly permuted versions of the second.  The proportion of the 
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distribution that is greater than the original PCC determines the PCC's statistical 
significance.  This corrects for the dependence between values in a distance matrix (i.e., a 
change in one value of the matrix entails a change in the other values, since the gene's 
"location" relative to all the other genes has been altered).  10,000 random permutations 
per donor pair were used. 
 To visualize the co-expression distance relationships between genes, non-metric 
multi-dimensional scaling was applied to calculate the genes' coordinates in a two-
dimensional space.  This method solves an optimization problem such that the distances 
between pairs of points (genes) in the 2D embedding space approximate a monotonic 
transformation of the input distance matrix.  The method specifically minimizes "stress", 
or the squared difference between the input and output distance matrices, normalized by 
the sum of all squared input distances. 
5.5.2  Results 
 PDS candidate genes were the only group to show a smaller mean within-group 
than across-group distance in all sample subsets except the cerebellum (Fig 5.5).  Within-
group distances f or PDS candidates were significantly smaller than across-group 
distances (p < 0.05 after correction for multiple comparisons) only in the basal ganglia (p 
= 0.0005). 
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Fig 5.5.  Within- and across-group correlation distances.  Bar height is mean distance across pairs of genes.  
Asterisks indicate differences with p < 0.05 after multiple comparisons correction. 
 
 The mean pair-wise PCC between donor distance matrices was 0.63 for the brain, 
0.43 for cerebral cortex, 0.45 for the basal ganglia, and 0.44 for the cerebellum.  For each 
sample subset, each of the fifteen donor pairs had a higher PCC than the maximum of the 
empirical null distribution (i.e., p = 0, Mantel test). 
 The two-dimensional "landscapes" based on samples from all donors are shown in 
Fig 5.6.  While there is some loose grouping of genes in the cortex and a single tight 
cluster in the cerebellum, for the most part genes do not appear to separate by phenotype.  
Genes with high proximity in the cerebellum (Fig 5.6D) include GPLD1, ERC1, THEM2, 
and EYA2, which all showed preferential expression for either the cerebellar cortex or 
cerebellar nuclei (Fig 5.3B).  Other genes shown in the expanded area of Fig 5.6D (e.g., 
BDNF, SETBP1) had percentile ranks in a cerebellar structure that did not meet the 
criteria for preferential expression, but nevertheless did a preference for one or the other.  
Most genes outside of that densely populated area of Fig 5.6D did not show a preference 
(e.g., AP4E1, BCL11A). 
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Fig 5.6 (cont. on next page).  Two-dimensional representation of gene expression pattern relationships, using 
multi-dimensional scaling.  For genes associated with multiple disorders, datapoint color is based on the best-
supported or first association. 
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Fig 5.6 (cont. on next page).  Two-dimensional representation of gene expression pattern relationships, using 
multi-dimensional scaling.  For genes associated with multiple disorders, datapoint color is based on the best-
supported or first association. 
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Fig 5.6 (cont. on next page).  Two-dimensional representation of gene expression pattern relationships, using 
multi-dimensional scaling.  For genes associated with multiple disorders, datapoint color is based on the best-
supported or first association. 
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Fig 5.6 (cont. on next page).  An expanded view of the boxed area is shown in the next plot.  Two-dimensional 
representation of gene expression pattern relationships, using multi-dimensional scaling.  For genes associated 
with multiple disorders, datapoint color is based on the best-supported or first association. 
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Fig 5.6.  Expanded image of tightly clustered datapoints from the previous plot.  Two-dimensional 
representation of gene expression pattern relationships, using multi-dimensional scaling.  For genes associated 
with multiple disorders, datapoint color is based on the best-supported or first association. 
 
5.6  Co-expression networks using topological overlap 
 The previous analyses deal with comparisons of gene spatial expression profiles.  
An alternative approach to examining relationships between genes is to instead compare 
patterns of co-expression with the other genes.  In other words, rather than asking only if 
FOXP2 and CNTNAP2 are co-expressed, we might ask whether FOXP2's co-expression 
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relationships to the other SL genes resemble those of CNTNAP2.  One distance measure 
that is based on similarity of co-expression relationships is topological overlap (Zhang 
and Horvath, 2005; Yip and Horvath, 2007).  Briefly, each gene is treated as a node in a 
co-expression network.  Genes are then hierarchically clustered based on similarity 
between their patterns of co-expression, or topological overlap.  The resulting 
dendrograms can reveal the overall structure in the relationships between gene expression 
patterns. 
5.6.1  Methods 
 Weighted gene co-expression analysis (WGCNA; Zhang and Horvath, 2005) was 
applied to the 42 SL genes using a publicly available R package (Langfelder and 
Horvath, 2008). A network of genes was defined in which edge weights encoded the 
absolute value of the correlation between pairs of genes' spatial expression patterns.  Co-
expression similarity was measured by topological overlap (Zhang and Horvath, 2005; 
Yip and Horvath, 2007), a measure which quantifies the degree to which two nodes' 
neighborhoods overlap.  Because of the small number of genes, resulting in a dendrogram 
with easily distinguishable branches, the "dynamic tree-cutting algorithm" included in the 
R package was not used (Langfelder et al., 2008). 
 WGCNA was applied separately across each of the four sample subsets used in 
the previous section: (i) the entire left hemisphere, (ii) left cerebral cortex only, (iii) left 
basal ganglia only and (iv) left cerebellum only.  Samples from all donors were used.  
Similarity matrices (topological overlap matrices) were also calculated for each donor 
individually.  As in the previous section, the Mantel test was applied to each pair of donor 
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matrices by computing the PCC between vectors composed of the upper-triangular parts 
of the two matrices, and comparing it to PCCs resulting from 10,000 random 
permutations of one of the matrices. 
5.6.2  Results 
 The dendrograms in Fig 5.7 show small groups of genes at shorter distances than 
others (i.e., with more similar patterns of co-expression relationships with the other SL 
genes).  These groups vary somewhat by structure, but for the most part do not reflect 
associated disorders.  The cerebellum alone does not show this tendency to cluster (Fig 
5.7D).  Genes that appeared very close to each other in the cerebellum's co-expression 
landscape have similar co-expression relationships with other genes (compare genes in 
the expanded area of Fig 5.6D to genes at the far right of Fig 5.7D).  After that, genes are 
merged into the dendrogram with fairly regular spacing, reflecting the circle of datapoints 
around the tight cluster in Fig 5.6D. 
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Fig 5.7 (cont. on next page).  Hierarchical clustering of genes in a co-expression network.  Asterisks next to each 
gene symbol indicate disorders the gene has been associated with. 
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Fig 5.7.  Hierarchical clustering of genes in a co-expression network.  Asterisks next to each gene symbol 
indicate disorders the gene has been associated with. 
 
 The mean pair-wise PCC between donor topological overlap matrices was 0.68 
for the brain, 0.34 for cerebral cortex, 0.55 for the basal ganglia, and 0.57 for the 
cerebellum.  Using the Mantel test, the largest p-value for any pair of donors in any of the 
sample subsets was p = 0.0095 (i.e., the lowest PCC between donors was higher than 
99.05% of PCCs in the empirical null distribution). 
 
5.7 Persistent developmental stuttering candidate genes in the basal ganglia 
 Both the regional networks and co-expression landscape analyses pointed to co-
expression relationships between PDS candidates specifically in the basal ganglia.  These 
relationships were stronger than expected by chance relative not only to randomly 
selected genes (Fig 5.4I), but also to the other SL genes (Fig 5.5C).  These observations 
motivated a closer examination of PDS candidate gene expression within the basal 
ganglia. 
5.7.1  Co-expression in the basal ganglia 
 Correlations between PDS candidate gene expression profiles, defined across 
samples from the basal ganglia are shown in Fig 5.8.  In the basal ganglia, these genes 
fell into two groups which had positively correlated expression profiles within-group, but 
almost entirely negative profile correlations across-group.  These groups were designated 
"Group A" (8 genes) and "Group B" (6 genes).  To a lesser extent, these relationships 
appear to be maintained in the striatum and its sub-regions as well, but not the globus 
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pallidus.  Group A genes showed significantly higher within-group than across-group 
correlations in the basal ganglia, striatum, caudate nucleus, putamen, and nucleus 
accumbens, and Group B genes only in the basal ganglia (one-tailed two sample 
Kolmogorov-Smirnov test, p < 0.05 after Bonferroni correction for 5 regions x 2 gene 
groups = 10 comparisons).  With the exception of the nucleus accumbens, the effect size 
decreased with greater neuroanatomical specificity: the difference between mean 
correlation with Group A and mean correlation across the two groups for the basal 
ganglia was 0.68, for the striatum 0.39, and for the caudate, putamen, and nucleus 
accumbens 0.25, 0.37, and 0.60 respectively.  The difference between Group B's mean 
correlation and the mean cross-group correlation in the basal ganglia was 0.47.  (Note 
that only 25 left-hemisphere samples were available for the globus pallidus and 13 for the 
nucleus accumbens; hence their exclusion from Section 5.4's co-expression modularity 
analysis, where only brain regions with at least 30 available samples were included.) 
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Fig 5.8.  Correlation heatmaps of persistent developmental stuttering candidate genes in the basal ganglia and 
sub-structures.  Genes are ordered to group those with high correlations.  A.  Basal ganglia (146 samples).  B. 
Globus pallidus (25 samples).  C.  Striatum (121 samples).  D.  Putamen (46 samples).  E. Caudate nucleus (62 
samples).  F. Nucleus accumbens (13 samples). 
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5.7.2  Differential expression across sub-structures of the basal ganglia 
 As shown in Chapter 3, sample expression profiles from the striatum and 
pallidum tend to be distinct from each other, but relatively consistent within-region (Fig 
3.2A).  This suggests that many genes may have consistently higher expression values 
across striatal than pallidal samples, and others consistently higher expression across 
pallidal than striatal samples: i.e., many genes may be differentially expressed across the 
two structures.  Strong positive correlations between gene expression profiles within the 
basal ganglia may therefore result from genes that are consistently higher in either the 
striatum or the pallidum. 
 Fig 5.9A confirms that the eight "Group A" genes consistently (though sometimes 
weakly) showed stronger expression in the globus pallidus than the striatum, while the six 
"Group B" genes showed the opposite tendency.  This may partially explain the high 
within-group correlations shown in Fig 5.8A, and the decrease of this effect within the 
striatum.  Group A genes (which had shown significantly enhanced correlations in the 
striatum as well) also showed consistently (though weakly) higher expression in the 
putamen than either the caudate or nucleus accumbens, with the exception of EYA2.  
However, none of these genes had a log2 fold change of at least 0.5 between the striatum 
and globus pallidus or between any two sub-regions of the striatum, so they were not 
differentially expressed by the criteria used in Chapter 3. 
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Fig 5.9.  Stuttering candidate gene expression in basal ganglia substructures.  A. Expression in the striatum and 
globus pallidus.  Sub-set of heatmap shown in Fig 5.3A.  B. Expression of "Group A" genes in striatal sub-
structures.  This differs from Fig 5.3C in that expression values for the head, body and tail of the caudate 
nucleus have been averaged together. 
 
5.8 Discussion 
 The analyses discussed here constitute an early step in using the transcriptome to 
investigate genes implicated in speech and/or language disorders ("SL genes") in a 
neuroanatomical context, which may provide clues about their association with those 
higher-level functions.  Because each of these genes probably accounts for only a small 
part of the associated disorder's prevalence, identifying some form of convergence or 
consistency among the different candidate genes is necessary for moving beyond a list of 
genes with few known relationships and, ultimately, understanding their shared influence 
on speech and language.  The current approach seeks this convergence in common 
elements of expression profiles across the brain, which could help to illuminate how these 
genes have similar impacts on complex behavioral phenotypes. 
 The Speech and Language Disorders Database described above is intended in part 
to aid the growth and refinement of this gene list (Figs 5.1 and 5.2).  The rest of the 
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chapter, which examined the expression and co-expression of genes associated with 
speech and language functions in the adult human brain, may also be helpful in focusing 
on the most relevant genes by revealing relationships (or lack thereof) between those with 
little evidence supporting their inclusion, and those with relatively well-established 
relevance.  For example, the genes implicated by Kang et al. (2010) in persistent 
developmental stuttering, while surprising in their general role in encoding proteins 
within the lysosomal enzyme targeting pathway, have strong evidence for involvement 
with stuttering in three cohorts.  Here we showed that an additional set of genes – those 
with strongest evidence based on a single genome-wide association study (Kraft, 2010) – 
showed strong co-expression relationships with the four lysosomal pathway genes 
specifically in the basal ganglia, a set of brain structures with relevance to PDS. This 
result lends support to the possibility that alterations in the genes from Kraft (2010) may 
have at least some similar impacts on the brain, and encourages attempts to validate these 
genes, such as future association studies with larger sample sizes or more detailed case-
control studies using established cohorts of people who stutter. 
5.8.1  Preferential expression 
 The importance of a thorough examination of the overall set of candidate genes in 
neuroanatomically-specific datasets is confirmed by the fact that many of them showed 
preferential expression in one or more brain regions (a statistically significant number, at 
two different anatomical scales; Fig 5.3).  That is, these genes have expression patterns 
that are more anatomically specific than observed for randomly selected genes.  The 
broad-scale regions most often preferred--the cerebral cortex, hippocampal formation, 
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striatum, and thalamus--all have important roles in speech and / or language functions 
(e.g. Gabrieli et al., 1998; Kotz et al., 2009; Duff and Brown-Schmidt, 2012; Barbas et 
al., 2013).  Four genes showed high percentile ranks in the cerebellar cortex (GPLD1, 
ERC1) or cerebellar nuclei (THEM2, EYA2), also important for speech and language 
(Mariën et al., 2013).  FOXP2, though not preferentially expressed by the current 
criterion in any broad region, had minimum percentile ranks (across all donors) of at least 
80 in the cerebral cortex, striatum, and thalamus.  These results, as well as FOXP2's high 
expression and minimum percentile rank of 89 in the inferior olivary complex, are 
consistent with Lai et al. (2003).  That study showed restricted FOXP2 expression in the 
developing human brain, particularly in the cortex, striatum, thalamus, inferior olivary 
complex, and cerebellum, suggesting that associations between FOXP2 and speech / 
language phenotypes may be due to an important role for this gene in the development of 
structures related to speech and language, and particularly motor control. 
 Notably, the inferior olivary complex showed increased relative expression and 
percentile ranks compared to other areas for several other SL genes as well (Fig 5.3C).  
This structure is involved in motor learning and timing, and projects to both the 
cerebellar cortex and cerebellar nuclei (e.g. Martin et al., 1996; De Zeeuw, 1998).  It is 
possible that some of these genes could, when disrupted, in turn disrupt speech- or 
language-related functions due to changes of expression in the inferior olive.  The 
superior olivary complex is involved in both ascending and descending auditory 
pathways; therefore, it is interesting that four PDS candidate genes as well as CNTNAP2 
(implicated in SLI and dyslexia) and THEM2 (implicated in dyslexia) all showed 
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relatively strong percentile ranks there (Fig 5.3C; ADARB2, AP4E1, CTNNA3, and 
GNPTG had mean ranks over 80, but in each case one donor fell under 80).   Finally, the 
substantia nigra, which yielded high percentile ranks of two PDS candidates (DRD2 and 
ADARB2) and a DVD candidate (SRPX2), is integral to basal ganglia function (Graybiel, 
2000). 
 Many SL genes showed (not always preferential) expression across multiple brain 
areas, usually either cortical or subcortical (Fig 5.3).  As noted in Section 5.1, the 
functions of SL genes are not limited to their potential importance to speech and 
language.  The impact of variants in these genes may depend on the molecular 
environment of a given brain areas, which makes points of convergence between 
expression profiles of multiple gene candidates particularly interesting.  The expression 
patterns of SL genes as a group were indeed often restricted to brain areas with known 
roles in speech and language.  Despite this, genes associated with a specific disorder did 
not, for the most part, have common preferences for certain brain areas. 
5.8.2  Regional networks 
 Co-expression relationships often imply common functions or pathways (Eisen et 
al., 1998; Lee, 2004; Wei et al., 2006), through which different genes might influence the 
same processes.  Strong co-expression of SL genes in a given brain structure, therefore, 
suggest that their shared influence on speech and language might be effected through 
changes in that structure.  Here, we looked in different brain structures for unusual co-
expression modularity of the SL genes:  i.e., an exaggerated difference between the genes' 
co-expression with each other and their co-expression with other genes. 
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 The SL genes as a group showed significantly enhanced co-expression modularity 
in several brain areas already known to play important roles in speech and language, 
including the inferior frontal gyrus and the temporal lobe.  This enhancement was 
observed when compared to randomly selected genes in each brain area; however, when 
the same values were compared to the co-expression modularity scores for these genes 
but random neuroanatomical samples, no results reached significance (Figure 5.4A, B). 
This suggests that, while the overall set of genes has some modular network structure, it 
does not appear to have strong neuroanatomical specificity.  It is more likely that 
meaningful neuroanatomical results should arise for smaller gene sets related to more 
specific phenotypes. 
 The set of PDS candidates showed their highest co-expression modularity 
(compared to random gene sets) in the basal ganglia, as well as significant values in the 
thalamus, parietal lobe, and trigeminal nucleus of the medulla (Fig 5.4I).  Importantly, 
when the co-expression scores were compared to those obtained for the same genes and 
random brain samples, only the basal ganglia showed a significant result (Fig 5.4J).  
Thus, this set of subcortical nuclei shows enhanced co-expression modularity across the 
set of PDS candidate genes (including nine genes with only suggestive evidence from 
Kraft, 2010) both compared to other gene sets of the same size, and compared to different 
anatomical areas.   
 Neither dyslexia nor SLI candidates showed significant co-expression modularity 
in any of the brain regions examined.  Dyslexia genes did show their highest co-
expression modularity in the thalamus, cerebral cortex as a whole, and temporal lobe (Fig 
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5.4C).  Though the significance of these values did not survive multiple comparisons 
correction and the modularity is not neuroanatomically specific (Fig 5.4D), it is worth 
noting given that the thalamus is an important structure in speech / language circuits, that 
phonological processing deficits are a central feature of dyslexia (Shaywitz and Shaywitz, 
2005), and that the disruption of cortical neuron migration associated with dyslexia 
occurs in the temporal lobe (Galaburda et al., 1985).  Finally, DVD candidates showed 
enriched co-expression relative to random samples in the frontal and temporal lobes, 
frontal cingulate and lingual gyri, and pons (Fig 5.4H); however, their co-expression was 
not significant in these brain areas relative to other genes (Fig 5.4G). 
 In a few cases, a group of genes showed high co-expression modularity in a brain 
area with no clear relationship to the associated phenotype; in particular, the fusiform, 
frontal cingulate, and parahippocampal gyri for SL genes as a whole, and the parietal lobe 
and lingual gyrus for PDS candidates (these also stood out for SLI candidates, but were 
not significant; Fig 5.4A, I, E).  However, none of these showed anatomical specificity 
(Fig 5.4B, J, F). 
 Overall, though co-expression modularity was higher in several areas known to 
support speech and language functions, only co-expression of PDS candidate genes in the 
basal ganglia was significantly stronger than chance relative to both other genes and 
random brain samples. 
5.8.3  Stuttering and the basal ganglia 
 Neither correlation distances nor topological overlap networks (Figs 5.5, 5.6, and 
5.7) indicated clear correspondence between the transcriptomic relationships of the SL 
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genes and the phenotypes with which they are associated, with the sole exception of PDS 
candidate genes in the basal ganglia (Fig 5.5C).  This result reinforces the co-expression 
modularity analysis discussed above (Fig 5.4I, J).  Within the basal ganglia, the PDS 
candidates appear to separate into two groups of genes which are positively correlated 
within-group and negatively correlated with across-group (Fig 5.8).  This grouping might 
be due to (often slightly, and never significantly) higher expression in either the pallidum 
(ADARB2, AP4E1, CTNNA3, EYA2, FADS2, FMN1, PCSK5, and GNPTG) or the 
striatum (GNPTAB, NAGPA, DRD2, ARNT2, PLXNA4, and SLC24A3; Fig 5.9). 
 The basal ganglia have long been thought to play a key role in stuttering (see 
Alm, 2004 for a review).  Because the basal ganglia subnuclei are small and contain large 
populations of inhibitory neurons, differences between people with PDS and controls are 
difficult to identify and interpret through neuroimaging (Civier et al., 2013).  However, 
lesions of the basal ganglia have been associated with acquired stuttering (Ludlow et al., 
1987; Tani and Sakai, 2011; Theys et al., 2013).  The implication of the basal ganglia in 
stuttering, a disorder that interferes with proceeding from one motor action to the next, is 
consistent with their proposed role in the selection of actions (see e.g. Redgrave et al., 
1999).  Pharmacological evidence also supports basal ganglia involvement, as blocking 
type D2 dopamine receptors (D2Rs) has been shown to reduce stuttering (Stager et al., 
2005).  D2Rs are heavily expressed in the striatum, and necessary for its dense 
dopaminergic innervation.  Civier et al. (2013) have developed a computational model 
suggesting that dopaminergic excess in the striatum, as well as abnormalities of cortico-
striatal projections from ventral primary motor cortex, could result in the dysfluencies 
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characteristic of stuttering.  Briefly, excessive dopaminergic activity in the striatum is 
hypothesized to put a "ceiling effect" on the outgoing signal to produce the next syllable, 
preventing this signal from gaining sufficient strength relative to signals representing 
competing syllables and leading to its re-selection. 
 The findings of the current study suggest that the 14 PDS candidate genes may be 
working in concert, perhaps with a similar impact on basal ganglia circuitry.  This is 
particularly interesting given the varying genetic evidence supporting the inclusion of 
these genes as candidates.  Although the pharmacological evidence and model discussed 
above suggests a connection between PDS and DRD2, which codes for type 2 dopamine 
receptors, genetic evidence for the association is weak (Lan et al., 2009 found an 
association in a Han Chinese cohort; Kang et al., 2011a failed to replicate the finding in a 
Brazilian and a European cohort).  Similarly, 9 genes are implicated by a single genome-
wide association study with a relatively small sample size (Kraft, 2010).  In contrast, 
larger studies in multiple populations provide support for GNPTG, GNPTAB, and 
NAGPA (Pakistani, British, and North American cohorts; Kang et al., 2010) as well as 
AP4E1 (Pakistani, Cameroonian, and North American cohorts; Raza et al., 2015).  The 
strong co-expression relationships between these four genes and the less well-
investigated candidates, which are strongest within a structure implicated in PDS, lends 
support to the inclusion of the genes from Lan et al (2009) and Kraft (2010) as candidate 
genes. Further, these results suggest that the basal ganglia may be of particular 
importance in attempting to establish the mechanisms by which alterations to these genes, 
and possibly others yet to be identified, impact fluent speech. 
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5.8.4  Limitations and future directions 
 Evidence implicating the genes treated here in disorders of speech and language 
varies substantially.  The inclusion of CNTNAP2, for example, is supported by multiple 
studies as well as the fact that it is a regulatory target of the extremely well-established 
candidate transcription factor FOXP2 (Vernes et al., 2008; Peter et al., 2011; Newbury et 
al., 2011).  DRD2's association with PDS, on the other hand, was found in only one study 
of a Han Chinese cohort (Lan et al., 2009), while a study of a European and a Brazilian 
cohort failed to replicate the finding (Kang et al., 2011a).  This raises the possibility of a 
false positive, or perhaps (as the authors of the second study suggest) that the association 
is not causal but is due, for example, to linkage disequilibrium with variants in a different 
gene in some populations.  The current list of candidate genes undoubtedly includes some 
implicated by false positives or non-causal associations.  Many genes with important 
roles in these complex phenotypes are also undoubtedly missing from the list.  
Continuing genetic research into these phenotypes will probably both refine and expand 
the current set of gene-disorder associations, as well as associations between specific 
variants and endophenotypes.  This will create an increasingly solid basis for future 
analyses of their transcriptomic profiles using the general approach defined here. 
 This attempt to relate genotype to phenotype through gene expression makes the 
assumption that variants impact expression of the genes that contain them.  As a result, 
the approach in its current form will not yield useful results in situations where a variant 
influences a behavioral phenotype by altering the expression of a different gene (unless 
that gene is co-expressed with the gene in which the variant resides).  Some variants may 
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indirectly change the expression of another gene through a co-expression network (in 
which genes up- or down-regulate each others' expression).  In other cases, a variant may 
directly change the expression of a different gene; these are found in expression 
quantitative trait loci (eQTLs; see Section 5.1).  Efforts to map eQTLs may allow future 
transcriptomic analyses to address some of these cases. 
 Transcriptomic analyses of implicated genes will also benefit from a 
comprehensive use of current knowledge regarding the brain structures and circuits 
underlying language functions.  The fact that certain structures (such as the cerebral 
cortex, basal ganglia, and cerebellum) have major roles in language functions was used to 
focus the co-expression landscape and co-expression network analyses presented here, 
and to interpret the regional co-expression of genes associated with different phenotypes.  
A more detailed and nuanced use of the neuroimaging results represented in the Speech 
and Language Disorders Database and the vast surrounding literature could provide 
further insight into the transcriptomic results presented here, and might suggest further 
avenues of investigation.  In particular, systematic use of this literature could focus the 
analyses on particular cortical areas supporting different speech and language functions, 
rather than treating the cerebral cortex as a whole. 
 Speech and language production and comprehension are, of course, dynamic 
processes, and some research has directly related gene expression to functional activity in 
the brain.  As early as 1991, expression of the gene c-fos was shown to reflect tonotopic 
maps in the mouse dorsal cochlear nucleus and inferior colliculus (Ehret and Fischer, 
1991).  In human subjects with Fragile X syndrome, expression of the gene FMR1 
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(implicated in intellectual disability) in lymphocytes was correlated with activity in the 
middle frontal and supramarginal gyri (Menon et al., 2000).  Richiardi et al. (2015) 
related functional activity to gene expression across the brain (as opposed to expression 
in blood cells) by defining resting state functional networks in human subjects and 
comparing these to gene expression in the AHBA.  If such a relationship exists between 
speech / language networks and gene expression, it would be worth identifying genes 
responsible for that relationship.  These may become candidate speech / language genes 
(or, if already candidates, such a finding would provide additional support for their 
inclusion). 
 A major limitation of the current study is its exclusive focus on the adult brain.  
Dyslexia, SLI, DVD, and PDS are all developmental disorders, manifesting as children 
learn to speak or to comprehend spoken or written language (and in the case of SLI, 
signed language; see Marshall et al., 2006; Mason et al., 2010).  A small influence at an 
early stage could have a serious impact on the developmental trajectory of brain 
structures and circuits, and many transcriptomic events through which an individual 
genotype may impact a behaviorally-defined phenotype occur transiently in the rapidly-
changing molecular environment of the developing brain. 
 Genome-scale transcriptomic data for donor brains from 8 post-conceptional 
weeks (pcw) to 40 years of age are available as part of the publicly available dataset 
BrainSpan: Atlas of the Developing Brain (http://brainspan.org/).  The BrainSpan Atlas 
includes RNA sequencing (RNA-Seq) expression data for each of 41 neurologically 
normal donors from 8 post-conceptional weeks to 40 years of age.  RNA-Seq allows 
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direct quantification of expression by counting the number of transcripts in a sample 
(rather than quantifying image intensity based on a fluorescent label, as with microarray 
and ISH data), including measurement of alternative transcripts.  This dataset has a low 
sample count and low spatial resolution; for most donors, only one sample per brain 
structure is available from 8-16 structures.  There are also high spatial resolution 
microarray data (including ~300 structures) from four donor brains, from 15-21 post-
conceptional weeks.  The BrainSpan Atlas offers the possibility of examining the 
transcriptomic profiles of speech and language candidate genes at early stages 
corresponding to the onset of the disordered phenotype, and tracing those profiles over 
time.  If some of these genes impact the normal development of brain systems supporting 
language function without leaving lasting evidence in the adult brain, then such data will 
be invaluable for quantifying transient preferential expression or co-expression in key 
brain structures. 
 The restriction to left-hemisphere samples in the current study is also worth 
considering, given asymmetry in the human brain.  Human frontal cortex typically shows 
both functional and structural asymmetry of language-related areas.  Abnormalities of 
cortical asymmetry have also been associated with dyslexia (e.g. Galaburda et al., 1985; 
Hynd et al., 1990; note however that some studies found normal asymmetry in people 
with dyslexia, e.g. Best and Demb, 1999; Rumsey et al., 1997), SLI (Gauger et al., 1997; 
De Fossé et al., 2004), and PDS (Chang et al., 2008; Foundas et al., 2004).  Watkins et al. 
(2002) initially found reduced grey matter in the left inferior frontal gyrus associated with 
DVD, but using a more specific and selective model, concluded that the difference was in 
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fact bilateral (Belton et al., 2003).  There is evidence that the basal ganglia also show 
structural asymmetry as well as hemispheric dominance related to motor control (e.g. 
Kooistra and Heilman, 1988; Scholz et al., 2000), and that the cerebellum's role in 
language as well as other cognitive and motor tasks is lateralized (Mariën et al., 2013; 
Stoodley, 2012).  These asymmetries indicate the desirability of cross-hemispheric 
comparison of the expression profiles of genes implicated in those processes.  In this 
study, such a comparison was precluded by the exclusion of right-hemisphere expression 
data, due to the lack of this data in four of the six donor brains in the AHBA (see Chapter 
2).  The expression and co-expression of the candidate genes could be compared either in 
the two donors with data available from both hemispheres, and in other datasets. 
 Thus far, however, studies of molecular neuroanatomy have revealed little 
difference in the expression of individual genes between hemispheres in adulthood 
(Hawrylycz et al., 2012; Pletikos et al., 2014) or even mid-fetal stages (Sun, 2005; 
Johnson et al., 2009; Lambert et al., 2011; Pletikos et al., 2014).  One study found global 
transcriptomic symmetry from early fetal stages on (beginning 10 weeks post-conception; 
Pletikos et al., 2014).  However, another identified 27 genes showing differential 
expression across cortical hemispheres from about 12-19 weeks post-conception (Sun, 
2005), after which most (not all) of cortical neuron proliferation and migration is 
complete (de Graaf-Peters and Hadders-Algra, 2006).  Therefore, hemispheric 
comparison may be most productive in developmental data from fetal stages before 19 
weeks in datasets that include samples from both hemispheres and label the hemisphere 
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of origin (in the BrainSpan Atlas, the high-resolution microarray data is restricted to the 
left hemisphere and the RNA-Seq data does not indicate hemisphere of origin). 
 The connection suggested by these results between the PDS candidates, the basal 
ganglia, and the disorder itself could be validated by postmortem studies from people 
with PDS, should such data become available.  If the expression or co-expression of these 
genes varied significantly between people who stutter and neurologically normal 
controls, the location and nature of the differences could provide a starting point for a 
model of the mechanisms by which the products of these genes impact fluent speech.  
Nine of the PDS candidate genes studied here are implicated by a single, small genome-
wide association study, and little is known of most of them.  Some are implicated in 
another neuropathology or brain-specific function by a single study (see Section 5.1.4), 
and four by none at all (EYA2, FMN1, SLC24A3, and PCSK5).  As more is learned of the 
roles these genes play in the brain, this information might suggest more specific 
hypotheses (beyond anatomical localization) regarding their influence on fluent speech. 
 Some, but not all, of these analyses include cross-donor comparisons.  Distance 
and topological overlap matrices based on individual donors were all strongly (and 
significantly) correlated, and our definition of preferential expression required that all 
donors show a minimum percentile rank of 95.  However, the analyses of co-expression 
modularity and of PDS candidates in the basal ganglia would benefit from comparison of 
donors, where this is reasonable given the within-donor sample counts for a given brain 
area. 
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 Finally, as with nearly all results based on human data in this dissertation, those 
presented in this chapter use only the AHBA.  Application of these methods to other adult 
datasets is necessary to increase confidence in the results.  Expansion of this work to 
datasets that distinguish between cortical layers would also make examinations of gene 
expression in the cerebral cortex potentially more fruitful, as laminar variation in cell 
type densities results in neocortical layers showing amplified differences in gene 
expression patterns (Belgard et al., 2011; Bernard et al., 2012). 
5.8.5  Conclusion 
 The transcriptomic profiles of genes that impact speech and language ability offer 
the possibility of relating our knowledge of these disorders across very different levels of 
organization.  This study is, to our knowledge, the first systematic examination of the 
brain-wide expression and co-expression relationships of speech and language candidate 
genes.  It represents an important first step towards illuminating the roles of these genes 
and defining points of neuroanatomical convergence in the potential impact of a variety 
of DNA alterations driving similar, sometimes overlapping phenotypes.
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CHAPTER 6: CONCLUSION 
 Though features such as cytoarchitecture and myeloarchitecture are more easily 
observable than are multivariate profiles at a molecular scale, the latter are no less 
integral to the structural and functional organization of the brain.  Large gene expression 
datasets, while sparse in annotation and somewhat overwhelming in scope, contain 
extensive information about that scale.  The work presented here examines the 
correspondence between transcriptomic organization and conventional neuroanatomy 
within and across species, and attempts to lay groundwork for the use of transcriptomic 
data to relate genotype and phenotype in behaviorally-defined disorders. 
 The approach taken in this work often blurs the distinction between exploratory 
data analysis (EDA; Tukey, 1977) and more traditional hypothesis-driven research.  Even 
the first part of dissertation (Chapter 3), which makes heavy use of the sort of simple 
statistical summaries and visualizations that are central to EDA, is informed by prior 
knowledge of neuroanatomical labels, and tests simple hypotheses such as, "samples 
from within the cerebral cortex are more transcriptomically similar to each other than to 
other samples."  The mouse-human comparative study (Chapter 4) selects genes with 
known common functions and poses the hypothesis that they will show conserved 
expression across species.  In Chapter 5, genes were curated from relevant literature, and 
knowledge of the roles of different brain regions in speech and language functions 
informed both design and interpretation.  These hypotheses, however, are very general 
and not always subjected to strict significance tests.  This is because the nature of this 
approach is largely data-driven (as in EDA), using data from “experiments” not 
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specifically designed to address the questions posed but of sufficient scale to provide new 
insight.  A data-driven approach can reduce bias, which is advantageous when faced with 
large, sparsely annotated datasets where it is difficult to know what will be relevant.  
However, in order to move towards more specific hypotheses, prior knowledge of genes, 
brain structures and complex phenotypes were used to inform these studies. 
 
6.1 Summary of contributions 
 Molecular and conventional neuroanatomy have a close correspondence in both 
the mouse and human brain (e.g. Bohland et al., 2010; Roth et al., 2006).  Chapter 3 took 
advantage of two high-throughput gene expression datasets with unusually high spatial 
resolution to reveal this relationship.  These analyses showed the transcriptomic 
similarities and distinctions between brain structures at multiple levels.  Additionally, this 
chapter compared two human datasets and identified consistencies between the 
expression profiles of different brain regions, in spite of the very different sampling 
properties of the datasets. 
 Homological relationships between the mouse and human brain have fundamental 
importance for the use of mouse models in both basic and clinical research.  
Conventional neuroanatomy (i.e., basic histochemical stains and tract tracing studies of 
connectivity) has been used extensively to understand these putative homologies, but less 
is known about the extent to which they are verifiable at the molecular level.  Chapter 4 
described the development and application of tools for identifying similarities and 
differences in brain-wide and regional molecular environments (defined by expression 
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levels across a pre-defined gene set) in the mouse and human brain, using two gene 
expression datasets with high anatomical resolution.  The results revealed conserved 
molecular organization at multiple scales, as well as particular groups of genes whose 
expression patterns form unique regional fingerprints that are consistent between the two 
species. The diverse patterns of conservation of gene expression across the mouse and 
human brain is further reflected by the similarity of individual genes’ brain-wide profiles, 
which was highly variable across the genes studied here.  By applying these and related 
analyses to additional gene expression datasets and interpreting results in light of the 
larger context for gene expression (e.g. alternative splicing and post-transcriptional 
mechanisms), it may ultimately be possible to quantify homologies in the molecular 
architecture of the human and mouse brain, helping to bridge a seemingly vast divide 
between genomics and systems neuroscience. Such directions are of particular 
importance for understanding the mechanisms of heritable diseases of the nervous system 
and for improving and understanding the efficacy of drugs targeting the brain. 
 Genetic, neuroimaging and behavioral lines of research into speech and language 
disorders tend to be conducted in relative isolation.  Chapter 5 provides the first detailed 
analysis of the expression patterns of genes implicated in these disorders throughout the 
human brain, a move in the direction of bridging the gap between genotype and 
phenotype through intervening brain regions and neural systems.  The preferential 
expression and co-expression of many of these genes in regions already known to be 
important to speech and language supports their proposed roles in such functions.  The 
most salient point identified in this study was the strong co-expression relationships 
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between genes associated with persistent developmental stuttering (PDS), which were not 
only preferentially expressed and co-expressed in the basal ganglia, but also showed 
stronger co-expression relationships with each other than with the other speech / language 
gene candidates specifically in that structure.  These genes are differentially expressed 
across the striatum and pallidum, with one group more strongly expressed in the former 
and another in the latter, suggesting potentially different targets and mechanisms for 
impacting the same overall system.  Finally, the co-expression relationships (especially 
within the basal ganglia) between genes identified in a genome-wide association study 
with relatively few subjects (Kraft, 2010) and genes with stronger evidence in PDS (Kang 
et al., 2010; Raza et al., 2015) provides a new source of support for roles for some of 
these genes in PDS. 
  
6.2 Future directions 
 Chapters 3-5 include more detailed discussions of future work; however, there are 
common threads to those discussions that are worth reiterating here.  First, this work has 
focused primarily on two high-throughput gene expression datasets out of many that have 
been made available since their advent in the 1990s.  Chapter 3 implemented one cross-
dataset comparison, showing relatively high consistency between anatomical region 
profiles in two expression datasets from the adult human brain.  Further validation 
studies, and the application of similar methods to other datasets, will be necessary to 
identify most robust results.   
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 Second, molecular neuroanatomy in the adult is the outcome of complex 
developmental processes intricately regulated by gene expression.  Expanding this 
approach to transcriptomic data from a range of developmental stages may elucidate not 
only developmental mechanisms themselves, but also the latent causes of some features 
of the mature transcriptome.  Most particularly, the study of speech and language 
disorders calls for attention to early development, when the processes forming key 
structures and circuitry are so rapid and precise that small differences could have 
profound effects, as well as to later developmental stages (i.e., childhood) when these 
disorders first appear. 
 Finally, functional annotations of genes are vital for both focusing analyses of 
transcriptomic data and interpreting their results.  With prior knowledge of gene 
functions, computational resources can be allocated to the expression profiles of genes of 
interest, and hypotheses may be suggested regarding the biological significance and 
interpretation of some results.  Such prior knowledge is still sparse relative to the number 
of protein-coding genes in the human and mouse genomes, and relative to the number of 
processes some of those genes impact.  Furthermore, knowledge of their function within 
brain tissue specifically is even more sparse.  Continuing genetic research, from knockout 
studies in model organisms to association studies in humans, may support or otherwise 
illuminate some of the results shown here, and suggest further avenues for future study. 
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